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1 MD Summary  
 
Decision making in surgery and cancer care is an interesting, challenging, and 
yet little explored area of surgical sciences research. This research addresses 
that paucity. In performing this research, health outcomes research (HOR) 
literature was comprehensively reviewed. Health outcome measures including 
quality of life and health-related quality of Life were described, in addition to 
their measurements. Subsequently health outcome measures in relation to 
oncoplastic and aesthetic breast surgery were described, and health outcome 
measures in a number of benign breast and colorectal pathologies were 
studied.  
  
Decision making in surgery and cancer care was explored using a mixed 
methodology of quantitative and qualitative studies. To derive a more 
comprehensive view, different specialties were explored: breast, colorectal, and 
head and neck surgery. To address socio-cultural factors the qualitative focus 
group discussions were undertaken in England, Wales, and India.  
 
Quantitative studies included literature reviews, prospective studies, 
retrospective studies, and questionnaire surveys. Qualitative studies were 
based on focus group discussions.  
 
The results showed that raw quantitative data is only one of the factors 
influencing the decision making process (Diagram 1). A number of other factors 
play an important role in the decision making process. These include: health 
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outcome measures (quality of life, health-related quality of life), clinician factors 
(knowledge, skill, expertise, judgment), patient factors (socio-economic, 
education, cultural), nursing factors, translational research, and resource 
infrastructure.  
Important themes and outcomes emerged from the qualitative studies. The 
focus group discussions showed that decision making in surgery and cancer 
care varies not only between the developing and the developed world, but also 
within different regions in the western world. In England, a small minority of 
patients was driving the decision making process, compared with Wales, where 
joint decision making is the norm. However, in India decision making is 
predominantly led by the clinicians and the patient’s family members.  
 
As modern health care moves towards a patient centered care approach, 
evidence based patient choice and patient decision making clearly has a 
greater role to play, and the cultural and practical issues demonstrated in this 
thesis must be considered. 
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Diagram 1. Factors affecting decision making. 
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Background: Every day, an ever-increasing number of surgical procedures are 
performed to treat a spectrum of benign, malignant, functional, and aesthetic 
disorders.  
Surgery is obviously not without risk. Clinical decisions should be evidence-
based, and involve judgment, experience, expertise, and informed patient 
choice. Different treatment options carry their own risks of morbidity and 
mortality, and it is important to assess them considering both quality of life and 
survival. It is therefore vital to try to attain as comprehensive an evidence base 
as possible for each treatment option, using both quantitative and qualitative 
data.  
Little is known about what influences decision making in surgery. Clinical 
decisions are made about patients, and it is paramount that their preferences 
should be taken into account. 
Weighing the treatment options for cancer patients, in terms of quality of life and 
survival, is a particular issue. Greater understanding of this area would provide 
information for both patients and clinicians that would enable them to make 
appropriate individualised decisions on cancer management. 
 
Hypothesis: Clinical decisions are not multi-factorial and are solely 
based/dependent on hard quantitative research data.  
 
Aims: To evaluate the multi-factorial nature of decision making, and to 
undertake an exploratory analysis of the factors affecting decision making, and 
the decision-making process itself, in surgery and cancer care.  
 
Methods: A mixed methodology was used. Quantitative and qualitative studies 
were incorporated. Quantitative studies included literature reviews, prospective 
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studies, retrospective studies, and questionnaire surveys. Qualitative studies 
were mainly based on the concept of grounded theory, utilizing focus group 
discussions. Grounded theory is a systematic methodology in the social 
sciences involving the generation of theory from data (1). 
  
Study groups included patients with various benign, malignant, and functional 
problems in relation to surgery. In order to get a more comprehensive 
assessment, colorectal, breast, and head and neck specialities were studied. 
Focus group discussions and postal questionnaire surveys were utilised for the 
qualitative arm. Care-providing clinicians in breast, colorectal, and head and 
neck surgery formed the participant group in focus group discussions.  
  
Results: Decision making in surgery and cancer care is influenced by a 
multitude of factors. It is a complex process dependent on a number of patient 
and clinician factors, including evidence based practice, research translation 
(translating the results of research into clinical practice), quality of life, risks of 
associated mortality and morbidity, infrastructure, and resources. Quality of life 
seemed to be one of the more important factors when decisions were made in 
surgery. Increasingly, quality of life and health related quality of life measures 
are playing an important role in measuring treatment outcomes. The results are 
summarised below.  
 
A. Health outcome measures  
Background knowledge about health outcome measures and their applications 
in various sub-specialities of surgery have been seen to be important to the 
decision making process in surgery. Such measures influence both the 
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clinicians providing care and the patient, during the decision making process. 
The subsection of this thesis on aesthetic breast surgery may influence the 
decision making process of the relevant clinicians and patients.  
 
B. Benign breast conditions  
Evaluation of reduction mammoplasty data suggested that higher resect weight; 
increased BMI; older age, and smoking are some of the risk factors associated 
with complications in reduction mammoplasty. An attempt should be made by 
clinicians to reduce the risk factor profile for modifiable risk factors, prior to 
offering patients reduction mammoplasty. 
 
C. Benign colorectal conditions and quality of life 
Evaluation of efficacy and acceptability of rectal irrigation (RI) using health 
outcome measures was undertaken. One hundred and seventy-five patients 
underwent RI. One hundred and eleven cases were successful, 64 failed. 
Analysis was done only for successful cases. General standardised 
questionnaire (GSQ) analysis showed significant improvement in symptoms of 
straining, incomplete emptying, wind leakage, and urinary leak (95% CI) pre 
and post RI. SF-36 demonstrated significant differences in physical functioning 
(PF), social functioning (SF) and general health (GH), pre and post RI (95% CI). 
Faecal Incontinence Quality of Life Scales (FIQL) analysis showed no 
statistically significant difference in the quality of life post RI. RI can offer 
symptomatic improvement to patients with faecal evacuatory disorders where 
other conservative and pharmaco-therapies have failed. Most patients find the 
treatment acceptable which was well tolerated and pain free. They chose RI 
over other treatments. 
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D. Malignant colorectal, breast, head, and neck conditions 
The process of decision making was evaluated using focus group discussions. 
Common themes and outcomes were generated from the focus group 
discussions (FGDs) undertaken in England, Wales, and India.  
 
In England, patient decision making in cancer care is gradually becoming more 
common, although currently only occurs in a minority of cases. This minority of 
the patient population will play an increased role in decision making, and will 
possibly drive decision making, in the future. This group, when making 
decisions, will consider the tradeoffs and risks between survival and quality of 
life. In the majority of patients remaining, decision making jointly with the 
clinician seems to be the norm.  
In the Welsh population, a drive towards joint decision making can be seen. In 
the future, patients are likely to have increased involvement and a greater role 
in decisions about their treatment, within the multidisciplinary team setting. 
In contrast, the findings from India (a developing country), show that evidence-
based patient choice (EBPC) has not developed to the extent seen in the 
western world. Decisions seem to be predominantly clinician led. There is not 
much of an emphasis on quality of life, and there is a clear need for patient 
groups and a stronger patient voice. Is it suggested that in the future, not just in 
England in Wales, but globally, patients are likely to have increased 
involvement and a greater role in decisions about their treatment, within the 
multidisciplinary team setting. The process of decision making is currently 
slowly evolving and will see metamorphosis in future. However, it is important 
for clinicians and nurses to play a role in encouraging this change. Decision 
making in cancer care has to be handled delicately and sensitively, and must 
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work within the framework both of financial constraints, and the traditions and 
culture of the society.  
The role of radiotherapy in rectal cancer was investigated using a national 
questionnaire surveys involving members of the Association of Coloproctology 
of Great Britain and Ireland (ACPGBI). Results suggest that approximately two 
thirds of consultant surgeons in the UK have yet to implement neo-adjuvant 
short course radiotherapy as a routine treatment regime. A change in practice in 
39% of surgeons following the early dissemination of trial results indicated that 
colorectal surgeon practice is guided by scientific evidence.  Qualitative analysis 
undertaken of survey results gave rise to various themes and outcomes. 
Themes that emerged from thematic analysis are: patient groups, treatment, 
evidence based practice, professional consensus, and service provision. The 
desired outcomes that emerged are: to individualize treatment; because the 
treatment group tends to be elderly, to provide safer and less harmful treatment 
(attempting to avoid some of the complications associated with radiotherapy); to 
increase the role of multidisciplinary teams; to overcome a lack of consensus; to 
increase awareness of current evidence based literature, to address the existing 
lacunae in evidence based practice; to develop protocols and guidelines; and to 
shorten the delay in implementing evidence based practice. A need for 
improvement in service provision, infrastructure, and resources was highlighted.  
A further national questionnaire survey with the same group investigated 
thrombo-prophylactic practice in colorectal surgery. The study revealed that 259 
(100%) surgeons routinely used thrombo-prophylaxis. Two hundred and forty 
three (93.8%) surgeons followed departmental guidelines. The majority of 
respondents (247, 95.40%) used combined chemo and mechanical prophylaxis, 
while 12 (4.6%) used chemo-prophylaxis only. Low molecular weight heparin 
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(LMWH) was the chemotherapeutic agent chosen by the majority (243, 93.8%), 
whilst 9 (3.5%) chose un-fractionated heparin (UFH). Timing of thrombo-
prophylaxis varied. One hundred and seventy-six (68%) started chemo-
prophylaxis (CP) on admission, 22 (8.5%) on induction, 38 (14.7%) 6 hrs post-
operatively, and 6 (2.3%) 24 hrs post-operatively. The majority 201(77.6%) 
discontinued CP upon discharge whilst 31 (12.0%) discontinued prior to 
discharge. Thirteen (5.0%) discontinued on mobilisation, whilst 4 (1.5%) 
discontinued 6 weeks following discharge. When asked about recommending 
continuing prophylaxis after hospital discharge 71 (27.4%) did so, whilst 178 
(68%) were against it. 
 
Conclusions: Decision making in surgery and cancer care is a challenging 
cognitive task. The various quantitative and qualitative studies undertaken 
demonstrated that decision making in surgery and cancer care is multi-factorial, 
and is not solely dependent on hard quantitative data. It is influenced by a 
number of factors. These include patient, clinician, and nursing factors, along 
with quantitative and qualitative data, resource, infrastructure, and translational 
factors. In addition, emerging models in decision making, for example decision 
aids, decision trees, and artificial intelligence techniques, may have an 
increasing role. The identified issues in decision making should be addressed. It 
is important to individualise the decision making process.  
 
Key words : Association of Coloproctology of Great Britain and Ireland, 
Cancer, Decision analysis, Decision making, Decision tools, Health outcome 
measures, Health related quality of life, Mortality, Neoadjuvant radiotherapy, 
Outcomes, Patient preference, Qualitative analysis, Quality of life, 
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Questionnaire survey, Rectal cancer, Surgical decision making, Survival, 
Themes 
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9 Introduction 
 
Approximately 32.7 million surgical procedures were undertaken in the US 
during 2006 (2). The spectrum of disorders includes benign, malignant, 
functional, and aesthetic. Cancer is one of the most important pathologies for 
which major surgery is undertaken. 
 
Cancer is a major cause of morbidity in the United Kingdom. Each year, more 
than a quarter of a million people are newly diagnosed with cancer (3), (4), (5), 
(6). Overall, it is estimated that more than one in three people will develop some 
form of cancer during their lifetime. Whilst there are more than 200 different 
types of cancer, four of them, breast, lung, large bowel (colorectal), and 
prostate, account for over half of all new cases (3), (4), (5), (6).  
Cancer was responsible for 26% of all deaths in the UK in 2005 (29% for males 
and 24% for females) (7), (8), (9). 
 
Disease management poses difficult choices, where the most appropriate 
treatment option is not always obvious. Different treatment options have their 
own risks of morbidity and mortality. Weighing them in terms of quality of life 
and survival is important.  
Patient preferences should play an important role in clinical decision making. 
For this, it is important that actual patient preferences are determined. The 
literature increasingly demonstrates that surgeons and physicians have 
divergent preferences for treatment options compared with both their patients 
and each other (10), (11), (12).Thirty to forty percent of critical medical 
decisions are made by doctors for their patients (13), (14), (15), (16), (17) . This 
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rate increases when patients are acutely unwell, elderly, or dealing with cancer 
(14), (15). When this is the case, it is important to know what influences clinician 
decision making. Solomon et al (10) in their study titled “What 
do patients want? Patient preferences and surrogate decision making in 
the treatment of colorectal cancer.” demonstrated that patients are willing to 
trade survival for quality of life and can do so differentially between treatment 
scenarios. They proved that patients’ preferences do not always accord with 
those of clinicians. They stated that unless patients' preferences are explicitly 
sought and incorporated into clinical decision making, patients may not receive 
the treatment that is best for them. 
 
Cancer psychology is a vitally important part of cancer management. Assessing 
the treatment options in terms of quality of life and survival is obviously 
important.  
Decisions taken when dealing with benign and functional problems also pose a 
challenge to the clinician. Decision making is dependent on a number of factors, 
including evidence based practice, research translation, quality of life, risks of 
associated mortality and morbidity, infrastructure, and resources. Health 
outcome measures, including quality of life and health related quality of life 
measures play an important role in measuring the treatment outcomes. Patient 
preferences should also be considered, in addition to the available evidence 
base. Qualitative results gathered from focus group discussions, semi-
structured interviews and questionnaire surveys can form a valuable qualitative 
evidence base. Health outcomes research plays a vital role in building the 
evidence base to help clinicians and patients with decision making.   
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Decisions for surgical conditions often rely on the available evidence base. 
However, in a significant proportion of cases, they are based on clinicians’ 
experience. The last decade has seen subtle changes in the use of patient 
preferences and joint decision making in clinical care. A variety of instruments 
including questionnaires, focus group discussions, patient satisfaction surveys 
and patient questionnaires can potentially inform the decision making process 
and improve clinical outcomes and health outcome measures.  
 
The author has investigated decision making in surgery and cancer care by 
using validated quantitative and qualitative methods in a range of surgical 
conditions (benign, malignant, and functional problems).  
Decision making can be regarded as an outcome of mental processes 
(cognitive process) leading to the selection of a course of action among several 
alternatives. Every decision making process produces a final choice.  
 
Decision making in surgery and in cancer care has never been easy. In the 
current political climate, the patient and patient care are the main focus. There 
is now widespread realisation that patients’ views are not optional, but are 
essential, to achieving high quality care (18), Patients are playing an important 
role in NHS funded research in England, which is contained and protected in 
the national advisory group INVOLVE (19). During the years 2008-09, the NHS 
operating framework took the first step in making patient reported outcomes a 
mandatory requirement for audit (20). In addition, within the past decade, 
national surveys of patients’ experiences of healthcare have become a feature 
of NHS regulation (21). Black et al have detailed the importance of patient 
surveys using questionnaires in their article “Measuring patients’ experiences 
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and outcomes”, thus highlighting the increasing importance being placed on 
patients’ views of the humanity and effectiveness of their care (22). Patient 
preferences are beginning to play a role, at least in a minority of cases, with 
joint decision making achieving rapid progress. 
 
Clinical decision making is multifactorial, involving clinician factors, patient 
factors, the translational factors involved in translating research to clinical 
practice, and patient satisfaction surveys. 
 
 
Clinician factors: Awareness of the available evidence base, experience, 
clinical judgement, and clinical intuition. 
 
Patient factors: Educational level, sociocultural level, current circumstances, 
and associated patient co-morbidities. 
 
Research translational factors: Integration of current best evidence from 
research into clinical policy and practice. This can be done by using new 
evidence based services to access current best practice and ensure that 
evidence and policy are applied at the right time. Some of factors, more 
specifically, involve synthesizing the evidence (COCHRANE Library), creating 
evidence based clinical policies (development of guidelines), and applying 
evidence based policy into practice.  
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Patient satisfaction surveys: Give a strong indication of patient needs based 
on feedback. Other related factors that might play a role are organizational 
factors, and those dependant on infrastructure and resources. 
 
Decision Analysis: The last few decades have seen an emergence in 
Decision Analysis (DA), a discipline comprising of philosophy, theory, 
methodology, and professional practice, and is necessary for addressing 
important decisions in a formal manner. The term decision analysis was coined 
in 1964 by Ronald A. Howard, a professor at Stanford University. He has been 
instrumental in developing the practice and professional application of DA. He 
developed a model to help decision making by estimating the risk of mortality 
and significant morbidity to the patients and then communicating this risk to 
them. He called the model ‘Micro risks for medical decision analysis’ (23). 
Graphical representation of decision analysis problems commonly 
use influence diagrams and decision trees. An influence diagram (also called 
a decision network) is a compact graphical and mathematical representation of 
a decision situation. A decision tree (or tree diagram) is a decision support tool 
that uses a tree-like graph or model of decisions and their possible 
consequences, including chance event outcomes, resource costs, and utility. 
However, there is a growing controversy over the usefulness of these tools in 
improving the decision making process. Klien (24) pointed out that people do 
not make decisions based on decision trees and mathematical probabilities, 
and that an intuitive style of decision making needs to replace the 
disaggregated approaches commonly used by most decision analysts. 
Nyatanga et al in their article “Intuition in clinical decision-making: a 
psychological penumbra” concluded that intuition has traceable cognitive and 
physiological bases. Those working in acute and palliative care, where there 
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are difficult ethical, as well as clinical, patient situations, can benefit from using 
intuitive ideas to arrive at complex decisions (25). 
Various communication models have been described in the development of 
decision making. Siminoff and Step, in their article “A communication model of 
shared decision making: accounting for cancer treatment decisions” (26), 
present a communication model of shared decision making (CMSDM) that 
explicitly identifies the communication process as the vehicle for decision 
making in cancer treatment.  They describe socio-communicative processes 
whereby people enter into a relationship, exchange information, establish 
preferences, and choose a course of action. In the CMSDM, decisions depend 
on (a) antecedent factors that have potential to influence communication, (b) a 
jointly constructed communication climate, and (c) treatment preferences 
established by both the physician and the patient. In another study “Patient 
Preferences Versus Physician Perceptions of Treatment Decisions in Cancer 
Care” (27), by Bruera and colleagues, they conclude that an individual approach 
is needed, and each patient should be assessed prospectively for decision 
making preferences. Poor communication between the clinicians and the 
patients can lead to poor outcome. Barry et al, in their study titled, “Patients' 
unvoiced agendas in general practice consultations: qualitative study” (28), 
concluded that steps should be taken in both daily clinical practice, and 
research, to encourage the voicing of patients agendas.  
 Annette O'Connor in her review “Decision aids for patients facing health 
treatment or screening decisions: systematic review” (23), concluded that  
decision aids improve knowledge, reduce decisional conflict, and stimulate 
patients to be more active in decision making, without increasing their anxiety. 
Decision aids have little effect on satisfaction, and a variable effect on decisions. 
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The effects on outcomes of decisions (persistence with choice, quality of life) 
remain uncertain.  
Kassirer JP in his article “Incorporating patients' preferences into medical 
decisions” (24), describes that, with time, medical decisions become more and 
more standardized and codified, and state that one should take care to ensure 
that critical therapeutic choices are not based exclusively on formal guidelines. 
Authors stress that decisions need to be individualized, especially when they 
involve choices between possible outcomes that may be viewed differently by 
different patients. The author recommends that patient's preferences should be 
identified scrupulously in the process of medical decision making.  
Barton, in an editorial on clinical evidence, posits that  future decision support 
systems may help to tailor information for individuals in their decision making 
(25).  
Overall, a good decision maker should understand all the approaches available 
in medical decision making, and individualize them according to patient need 
and preference. In the current political climate, where the mantra of ’patient 
centered care’ is repeated often, clinicians should involve the patient in every 
stage of their care. In addition, patients have been shown to desire patient 
centered care, as demonstrated by Little et al (26), (27). The authors answered 
crucial questions about patient centered medicine: What is it? Do patients want 
it? Do doctors practice it? What are its benefits? Little et al focused on the first 
two questions, and demonstrated that patients did indeed want patient centered 
care.  
Patient centered care includes: 
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(a) Exploration of the patients' main reason for the visit, concerns, and need 
for information; 
(b)  Seeking an integrated understanding of the patients' world – that is, their 
whole person, emotional needs, and life issues; 
(c)  Finding common ground on what the problem is, and mutually agree on 
management. 
(d)  Enhance prevention and health promotion; and  
(e) Enhance the continuing relationship between the patient and the doctor.  
Qualitative research conveys the qualities of patient centred care (28). 
Asking patients is an important way to assess this process. However, since 
clinicians form an integral part of patient care, exploring their thoughts was 
vital.  
There is active interest amongst policy makers and politicians in patient 
centred care. An analysis and commentary by Epstein et al (29)  from the 
University of Rochester on “Why the nation needs a policy push on patient-
centred health care”, described patient centred care, why it matters, and how 
policy makers can advance it in practice. They highlighted that patient-
centred care is determined by the quality of interactions between patients 
and clinicians. They rightly pointed out that patient centred care improved 
disease outcomes and quality of life, and that it is critical to address racial, 
ethnic, and socioeconomic disparities in health care and health outcomes. 
Policy makers need to look beyond such areas as health information 
technology to shape a coordinated and focused national policy in support of 
patient-centred care. This policy should help health professionals acquire 
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and maintain skills related to patient-centred care, and it should encourage 
organizations to cultivate a culture of patient-centeredness (29).   
Communication can be the Achilles heel of an otherwise good decision 
making process. Literature suggests that doctors and patients not only talk to 
each other with different voices (30), but also have communication 
misunderstandings (31). (32)  
Charles et al from Ontario, Canada, describe the importance of doctor and 
patient communication, in their article “How to improve communication 
between doctors and patients. Learning more about the decision making 
context is important” (33), it is recommended that efforts should be made to 
improve communication between doctors and patients in the treatment 
decision making process. The team responsible for that article were 
developing educational interventions targeted at doctors to address these 
issues. Patient focused interventions, although not mentioned in that article, 
are also likely to help patients voice their agendas.  Charles et al conclude 
that treatment decision making in the medical encounter is a complex and 
dynamic process, the course of which is not predictable in advance because 
no two encounters are exactly the same. They recommend that doctors 
should practise shared treatment decision making with their patients, and 
unspoken patient agendas pose barriers to this goal. 
A number of approaches to treatment decision making between doctors and 
patients have been described. They are the paternalistic, the shared, and the 
informed (or consumerist) approach. Each has different implications for the 
roles of doctors and patients in communicating information, and for the 
amount, and flow of information between the two (34). Some approaches are 
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more amenable in incorporating patients' voices and eliciting patients' 
agendas than others. 
 
Paternalistic approach: In the ‘pure type’ of this approach, doctors can 
make a treatment decision that they think is in their patients' best interest, 
without having to explore the patient's values and concerns. Instead, the 
doctor is more likely to want short descriptions of physical symptoms that 
they can transform into diagnostic categories. In the paternalistic approach, 
doctors are unlikely to have much interest in discussing patient concerns 
expressed ‘in the voice of the life world’ (30). 
Informed approach: Here, patients are accorded a more active role in both 
defining the problem for which they want help, and in determining 
appropriate treatment. In the pure type of this approach, the doctor's role is 
limited to providing relevant research information about treatment options 
and their benefits and risks, so that the patient can make an informed 
decision. 
Shared approach: Doctors commit themselves to an interactive relationship 
with patients in developing a treatment recommendation that is consistent 
with patient values and preferences (34). To enable this to happen, the 
doctor needs to create an open atmosphere in which patients feel able to 
express all relevant concerns. In this approach, information exchange helps 
the doctor understand the patient, and ensures that the patient is informed of 
treatment options and their risks and benefits. It also allows patients to 
assess whether they can build a relationship of trust with their doctor. 
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Charles et al says that actual behaviour rarely corresponds to ideal types, 
and most doctor-patient encounters combine elements from different models 
(35). 
They feel the approach adopted at the beginning of an encounter may 
change as the doctor gains a better sense of whether the patient has a good 
understanding of the available treatments. 
The authors (33) conclude that there is a need to develop effective 
interventions to promote better communication. Understanding the reasons 
for communication problems is important. It will help researchers develop 
interventions designed specifically to address potentially different types of 
communication issues (36), (37). 
In recent years, there has been increased emphasis on using mixed 
methodologies for achieving better outcomes from studies. There are 
techniques designed to combine the results of qualitative and quantitative 
studies to provide researchers with more knowledge than separate analysis 
(38). O’Cathain et al (38) describe three techniques for integrating data in 
mixed methods studies. The three techniques are triangulation protocol, 
following a thread, and the mixed methods matrix. There is more to be learnt 
from bringing together data from quantitative and qualitative methods than 
from using one method alone. It is for this reason that this study adopted a 
mixed methodology approach.  
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10.0 Aims of the study  
 
Aims:  
• To evaluate health outcome measures in benign, aesthetic, and 
oncological surgery. 
• To evaluate the multi-factorial nature of decision making, and undertake 
an exploratory analysis of the decision making process in surgery and 
cancer care, along with factors affecting decision making. 
 
Hypothesis: Clinical decisions are not multi-factorial and are solely 
based/dependent on hard quantitative research data.  
 
11.0 Materials and methods 
 
A mixed methodology was adopted. Quantitative and qualitative studies were 
incorporated. Quantitative studies included literature reviews, prospective 
studies, retrospective studies, and questionnaire surveys. Qualitative studies 
were based on the concept of grounded theory utilizing focus group 
discussions. Study groups included patients with various benign, malignant, and 
functional problems in relation to surgery. Colorectal and breast specialities 
were studied. Focus group discussions and postal questionnaire surveys were 
utilised for the qualitative arm of the research. Clinicians in breast, /colorectal, 
and head and neck surgery formed the participant group in focus group 
discussions. The various methods used are highlighted below. 
 
Health outcome measures: A series of literature reviews were undertaken.  
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Benign breast conditions: Risk factors for complications following reduction 
mammoplasty were evaluated using data from a randomised trial. The effects of 
resection weight, BMI, age, and smoking on complication rates following 
reduction mammoplasty were investigated. 
 
Benign colorectal conditions and quality of life: Retrospective reviews based on 
prospective databases, bowel dairies, quality of life and health-related quality of 
life instruments were used.  
 
Malignant colorectal, breast, head and neck conditions: National questionnaire 
surveys and qualitative research tools were used  to undertake focus group 
discussions based on grounded theory.  
 
 
Questionnaires: Wherever standard externally validated questionnaires were 
available, they were used. In the absence of externally validated questionnaires, 
they were developed by expert groups based on the opinions of the members of 
the academic surgical unit. Questionnaires with psychological components were 
further validated by the clinical psychologists in the University. The 
questionnaires developed in-house are illustrated in the respective chapters and 
appendix.  
 
Analysis: Quantitative analysis was undertaken using the Statistical Package 
for the Social Sciences (SPSS® version 11.5, Chicago, Illinois, USA). 
Health outcome measures were analysed used dedicated software, the. SF36 
analysis package (SPSS® version 11.5, Chicago, Illinois, USA). Analysis of the 
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qualitative data was undertaken by a systematic, thematic process, where the 
data was analysed to derive most commonly reoccurring concepts. These 
reoccurring concepts are referred to as ‘themes’. Repeated analysis leads to 
saturation of themes. Analysis of themes leads to the evolution of solutions for 
problems identified in the themes. The solutions carved out of this data are 
‘outcomes’. 
 
                              Page 35 of 215 
  
12.0 Results:  
 
Prior to investigating the various disease pathologies and their associated 
decision making processes, health outcome measures,  as the basis of quality 
of life assessments, were evaluated. 
 
12.1 Quality of life and its measurements  
 
Health is multi-dimensional. Mortality, morbidity, and cost are traditional health 
indicators. In addition to these, personal assessments of functional status and 
well-being, customers’ reports, ratings of care, services and health plans, are all 
driving healthcare towards a patient based assessment. Quantification of health 
indicators is important. Outcomes research relates to quality of life and health-
related quality of life. Health outcome measures are becoming increasingly 
important in health care, and health research. 
 
Methods / data sources: A non-systematic review was undertaken using the 
available literature. Health outcome measures, quality of life, health related 
quality of life, breast surgery, cosmetic surgery, and aesthetic surgery, were 
some of the search terminologies used. An extensive literature search was 
conducted till November 2006 on Ovid MEDLINE(R) and August 2006 on Pub 
med. Google scholar was used for non-peer reviewed literature. The Science of 
Health measurement (an educational series by the Tufts University School of 
Medicine) was referred to for understanding health outcome measures.  
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Health and its concepts 
In 1948, the World Health Organization (WHO) defined health as ’a state of 
complete physical, mental, and social well-being, and not merely the absence of 
disease or infirmity’. Health is multi-dimensional (physical, mental, and social). It 
is important to quantify these health indicators or measures.  
The traditional indicators of health care outcomes are mortality, morbidity, and 
cost. In addition to these, personal assessments of functional status and well-
being, customers’ reports, ratings of care, services and health plans are all 
driving health indicators towards a patient based assessment. Ware et al (39) 
defined quality of life: 
‘Quality of life is a state of mind … how good it is to you, and only you can 
decide that. If I want to know your quality of life, I have to ask you. I can’t know 
it by observing you; I have to ask you. And that’s the way we gather quality of 
life data. The health-related quality of life is that part of your quality of life that is 
more affected by disease and health care treatment.’ 
 
Health concepts (Ware et al, 1984) (44) 
Ware et al defined health as a balance between the biological function, physical 
and mental health, and the social and role function (Figure 1). 
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Figure 1. Dimensions of health (40)  
 
 
Disruption in any one of these dimensions of health can compromise functioning 
and well-being in other areas. Ill health can come from any one dimension, and 
all of these states must be in balance in order for a person to have perfect 
health. 
 
Quality of life and health-related quality of life 
 
It is important to understand the distinction between quality of life and health-
related quality of life. Quality of life is a global concept with many themes, 
including overall satisfaction with life as well as the specific domains of life 
including family, community, work, and health. Health-related quality of life 
takes into account the values of the individual, narrowing the focus to health 
concepts, such as functioning, that are affected by disease and treatment (41). 
 
 
Outcomes research and health surveys 
Biological function 
Physical and mental health 
Social and role function 
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Outcomes research examines the end results of medical interventions, taking 
into account patients' experiences, preferences, and values. The purpose of 
assessing outcomes is to provide evidence on which to base clinical decisions. 
Health surveys are tools used for evaluating various concepts of health, and 
provide a patient-based assessment of health. They are broadly categorized 
into generic and specific health measures.  
 
1. Generic Health Measures 
Generic health measures assess health concepts that represent basic human 
values, and are relevant to one’s health status and well-being, regardless of 
age, disease, or treatment group (42). Some of the generic health measures 
used are shown in Table 1. The SF-36 provides an illustrative example: 
 
Medical Outcome Study (MOS): Short Forms (SF-36)  
The SF-36 was designed to serve as a core general health measure. It is a 36-
item survey, and requires 6 to 9 minutes, on average, to complete. Survey items 
capture eight health concepts (physical functioning, role-physical, bodily pain, 
general health, vitality, social functioning, role-emotional, and mental health). 
Scale construction studies support several scoring options, including a profile of 
health states across the eight concepts, summary measures of physical, and of 
mental health outcomes, and a single utility index of health. Published scoring 
algorithms include data quality checks. Results of extensive validity studies 
have been published, and norm based scoring further improves the 
interpretation of scores. 
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2. Specific health measures 
Specific measures focus on the particulars of a specific disease or diagnostic 
group (e.g. cancer),condition (e.g. congestive heart failure), or treatment (e.g. 
hip replacement), and are designed to capture areas of health specifically 
affected by that disease or treatment (43). Some of the specific health 
measures used are shown in Table 2. 
 
Table 1. Generic health measures 
European Quality of Life Index (EuroQoL) (44)  
MOS Short Forms (SF-36 (45) and SF-12 (46))  
Nottingham Health Profile (NHP) (47) 
Quality of Well-Being Scale (QWB) (48) 
Sickness Impact Profile (SIP) (49) 
Health Utilities Index (HUI) (50) 
Quality-of-Life Index (51) 
Subjective quality of life profile (SQLP) (52) 
General health questionnaire (GHQ12) (53) 
 
Table 2. Specific health measures   
Breast 
Breast Evaluation Questionnaire (54) 
Breast Chest Ratings Scale (BCRS) (55) 
Derriford Scale (DAS59) (56) 
Multidimensional Body-States Relations Questionnaire 
(MBSRQ) (57) 
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Psychosocial 
Psychosocial Adjustment to Illness Scale (58) 
Courtauld emotional control (CEC) scale (59) 
Folkman and Lazarus Ways of Coping questionnaire (60) 
Modified Folkman and Lazarus Ways of Coping questionnaire 
Profile of Mood States (61) 
LOT-R – Measure of optimism (62) 
Hospital Anxiety and Depression Score (63) 
Pain 
Pain Disability Questionnaire (64) 
McGill Pain Questionnaire (65) 
MOS Pain Measures (66)  
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12.2 Quality of life, Health-related quality of life, and breast surgery 
Oncoplastic surgery and quality of life issues   
Post surgery, younger women experience a lower quality of life due to the 
effects of medical treatment (67). The effects of surgery and removal of the 
breast result in more negative feelings regarding body image (67). Systemic 
treatments make many younger women experience sudden onset of 
menopause, and many suffer relationship issues contributing to a high level of 
sexual concern. Psychosocially, the effect is present in both female patients and 
their partners. Emotional support from the partner is important for the woman's 
adjustment to the altered body image. There is encouraging evidence that 
couple-based psychosocial interventions might be of particular assistance to 
both parties (67). 
In a study carried out in the Far East, looking at the early effect of surgery in 
women with operable breast cancer on quality of life, patients were interviewed 
prior to and after the surgery, using the Functional Assessment of Cancer 
Therapy-Breast quality of life (FACT-B) instrument. There was no significant 
change in overall quality of life immediately after surgery, probably reflecting 
strong family and social support for these women. Similar results have been 
reported by studies from other countries (68). 
After breast-conserving surgery, and during subsequent radiation therapy (RT), 
young women experience changes in quality of life, psychosocial adjustment, 
and adaptation to survivorship issues. Changes may not reflect what is 
observed in clinical practice. As such, there is a need to understand and 
support young women during RT (69). 
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Schultz et al (70) studied the quality of life issues in long-term survivors of 
breast cancer. He described the relationship between menopausal symptoms, 
physiologic health effects of cancer treatment and physical constraints. He 
concluded that breast cancer and menopause are independent issues, and 
should not be confused with the quality of life or psychosocial issues of the 
cancer survivor. Understanding these issues is important before it is possible to 
provide holistic nursing care. 
Casso et al (71) examined the correlates of quality of life of a well-defined group 
of 5–10 year breast cancer survivors, who were diagnosed between the ages of 
40 and 49, using questionnaires. CARES-SF and SF-36 were some of the 
measures used. Breast-related symptoms, use of adjuvant therapy, lower 
income, and type of breast surgery were significantly associated with lower 
quality of life 5 to 10 years post-diagnosis. The authors emphasized that 
younger long-term survivors have a high quality of life across several 
standardized measures. The long-term consequences of adjuvant therapy and 
management of long-term breast-related symptoms are two areas that may be 
important for clinicians and women with breast cancer to enable understanding 
and optimizing of long-term quality of life.  
A survey done among the British Association of Surgical Oncology members to 
frame the attitude and perception of breast surgeons in the UK demonstrated 
age as not a criteria in identifying a patient as elderly in 44% (72). The surgeons 
surveyed felt that the decision making process was based on multiple factors, 
used to tailor the most appropriate treatment with the aim of improving quality of 
life (42%) and quality adjusted survival (40%). No routine elderly care 
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assessment was utilized (82%). The survey confirmed a lack of knowledge in 
the management of elderly patients affected by breast cancer.  
Reconstructive surgery and quality of life  
Reconstructive surgery plays an important role in the physical and emotional 
outcome amongst breast cancer survivors. The psychosocial impact of primary 
surgery occurs largely in areas of body image and feelings of attractiveness, 
with women receiving lumpectomy experiencing the most positive outcome (73). 
The type of primary surgery has no significance on emotional, social, or role 
function (73). Beyond the first year following diagnosis, a woman's quality of life 
is influenced more by her age or exposure to adjuvant therapy, than by her 
breast surgery (73). In the case of mastectomy, reconstruction will restore lost 
femininity, sexuality, and normality, in most cases, not because of the 
procedure but because of elimination of prostheses (74).  
 
Older patients post reconstruction do well when it comes to mental health 
scores, compared to younger women. Girotto et al (75) studied breast 
reconstruction after mastectomy in women older than 65 years of age, and 
looked at its impact on quality of life. The SF-36 outcome measure was used. 
Older patients scored lower (worse outcomes) in the areas related to physical 
function. They maintained superior scores (better outcomes) over younger 
patients in the subscales influenced by mental health.  
 
In breast cancer, apart from improving disease free survival, quality of life, body 
image, and cosmetic outcome are important issues. Cocquyt VF et al (80) 
evaluated health-related quality of life and body image in patients treated with 
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preoperative chemotherapy followed by breast conserving surgery, or skin-
sparing mastectomy (SSM) and perforator-flap breast reconstruction. 
Participants were evaluated by SF-36 and a study-specific questionnaire. The 
authors showed that breast conserving treatment or mastectomy with 
reconstruction may yield comparable quality of life results, but cosmetic 
outcome was better after SSM and perforator-flap reconstruction. Patients 
should be offered both options, and clinicians should stress that both are 
equally effective.  
 
Quality of life, patients' satisfaction, and aesthetic outcome after pedicle or free 
TRAM (Transverse Rectus Abdominis Myocutaneous) flap breast surgery were 
studied to evaluate the aesthetic result of breast reconstruction, both objectively 
and subjectively (76). No statistically significant difference between pedicle and 
free TRAM flap were seen regarding patient satisfaction with the reconstruction. 
In the patients' self-assessment of cosmetic outcome, the degree of symmetry 
was assessed to be higher in the free TRAM flap group. SF-36 revealed no 
difference between the pedicle and free flap groups. A strong correlation 
between patient and panel evaluation of cosmetic outcome was seen.  
        
The psychosocial impact of breast surgery has been extensively studied in the 
West. There is a relative paucity of comparable data in oriental women who are 
increasingly affected by breast cancer. Fung et al (77) studied the effects that 
different types of primary breast surgery have on the quality of life of Chinese 
women. Aspects of quality of life included general psychological well-being, 
body image, and sexual and social function. The results showed that breast-
conserving treatment (BCT) had significantly improved body image scores 
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compared to mastectomy. The three groups, namely BCT, mastectomy and 
mastectomy with immediate breast reconstruction, did not differ significantly in 
the other aspects of quality of life measured. 
       
Nissen et al (78) looked at women’s expectations following post mastectomy 
reconstruction, and factors affecting their quality of life. Qualitative focus groups 
revealed that women wished they had been better informed about some issues. 
Ratings of satisfaction were generally high. There were concerns about 
cosmetic outcome and persistent anxiety about recurrence. Women appreciated 
information which enabled them to prepare for reconstruction and recovery.  
 
Quality of life after breast carcinoma surgery compared between breast 
conservation surgery (BCS), mastectomy alone, and mastectomy with 
reconstruction, was shown to be equally effective for the treatment of early 
stage breast carcinoma, using the Mischel Uncertainty in Illness Scale, Profile 
of Mood States, and FACT for Breast Cancer (79). In conclusion, aspects of 
quality of life other than body image were no better in women who underwent 
BCS or mastectomy with reconstruction, than in women who had mastectomy 
alone. Mastectomy with reconstruction was associated with greater mood 
disturbance and poorer well-being (79).  
       
Harcourt et al (80) have examined the research literature relating to the 
psychological aspects of breast reconstruction. Particular attention was given to 
the role of specialist breast care nurses and psychological benefits. There is a 
lack of studies examining breast reconstruction in terms of relevant 
psychological constructs, especially in relation to coping and decision-making. 
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They concluded that existing research into the psychological aspects of breast 
reconstruction is limited, and not sufficiently conclusive to inform changes to 
policy and the provision of care.  
 
Complications and quality of life  
Lymphoedema and post-mastectomy pain are complications that can have an 
impact on the QOL. Patients with lymphoedema may experience pain and body 
image issues. Complete decongestive therapy (CDT) is effective in treating 
lymphoedema. The FACT-QOL measure and a visual analogue scale for pain 
showed successful reduction in girth, volume, and pain with increased quality of 
life. Quality of life and pain are improved by treatment, and continue to improve 
after the treatment has ended (81).  
Pain after quadrantectomy and radiotherapy for early-stage breast cancer 
affecting quality of life was studied using self-completed questionnaires (82). 
The outcome measures used were the McGill Pain Questionnaire and a quality 
of life questionnaire. The authors supported the hypothesis that pain is a 
frequent sequelae of CBS and radiotherapy, and that such symptoms can 
cause postoperative psychosocial distress, thus limiting patient adaptation and 
reducing the beneficial effect of CBS on body image.  
Macdonald et al (83) looked at long-term follow-up of breast cancer survivors 
with post-mastectomy pain at 7-12 years postoperative. Chronic pain and 
quality of life were assessed using the McGill Pain Questionnaire and SF-36. 
Quality of life scores were significantly lower in women with persistent post 
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mastectomy pain syndrome, compared to those women whose pain had 
resolved. 
Psychological factors 
In breast cancer, the psychological response, such as a fighting spirit, or an 
attitude of helplessness and hopelessness, toward the disease has been 
suggested as a prognostic factor. 
 
Watson et al (84) in a population based study, investigated the effect of 
psychological response on disease outcome in a large cohort of women with 
early-stage breast cancer. Psychological response was measured by the mental 
adjustment to cancer scale, the Courtauld emotional control scale, and the 
hospital anxiety and depression scale. The authors found that for 5-year event-
free survival, a high helplessness/hopelessness score has a moderate 
detrimental effect. There were no significant results found for the category of 
‘fighting spirit’. A high depression score is linked to a significantly reduced 
chance of survival.  
 
Watson et al (85) assessed the psychological responses of 
helplessness/hopelessness, fighting spirit and depression in early-stage breast 
cancer patients between 1 and 3 months post-diagnosis. In order to ascertain 
the effect on cancer prognosis, patients were followed-up for 10 years. There 
was a continuing effect of helplessness/hopelessness on disease-free survival, 
but not of depression. Longer follow-up also indicated that a high fighting spirit 
conferred no survival advantage. The results showed that, in patients who were 
disease-free at 5 years, baseline helpless/hopeless response still exerted a 
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significant effect on disease-free survival beyond 5 (and up to 10) years. The 
effect is therefore maintained for up to 10 years.  
 
Reynolds et al (86) evaluated the association between coping strategies and 
breast cancer survival among black and white women. An emotion-focused 
coping strategy was associated with survival. Expression of emotion was 
associated with better survival, suggesting that the opportunity for emotional 
expression may improve survival among patients with invasive breast cancer. 
 
In a qualitative study on metastatic disease by Cunningham and Watson (87), 
common themes emerged. ‘Authenticity’, or a clear understanding of what was 
important in one's life; ‘autonomy’, the perceived freedom to shape life around 
what was valued; and ‘acceptance’, a perceived change in mental state to 
enhanced self-esteem, greater tolerance for and emotional closeness to others, 
and an affective experience described as more peaceful and joyous. The 
authors looked at the concept of remarkable survivors. They found a mirrored 
symmetry between the psychological patterns possibly promoting disease, and 
the changed adaptations that may lead to longer survival in some cases. The 
authors suggested that the progression of cancer, or other chronic disease, is 
favoured by a distorted psychological adaptation, and that healing may be 
assisted by a reversal of that adaptation in the case of cancer, toward greater 
authenticity of thought and action (87). 
  
Petticrew (88), in his systematic review, analysed the influence of psychological 
coping on survival and recurrence in people with cancer and summarised the 
evidence that psychological coping styles (including fighting spirit, helplessness, 
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hopelessness, denial, and avoidance) affect survival and recurrence in patients 
with cancer. He concluded that there is little consistent evidence that 
psychological coping styles play an important part in survival or recurrence. 
People with cancer should not feel pressured into adopting particular coping 
styles to improve survival or reduce the risk of recurrence. Although the relation 
is biologically plausible, there is at present little scientific basis for the popular 
lay and clinical belief that psychological coping styles have an important 
influence on overall or event-free survival in patients with cancer. 
 
Service provision and quality of life 
Day case surgery and the role of nurses: Margolese and Lasry (89) 
compared inpatient to same-day discharge surgery for breast cancer on 
unselected patients. Outpatient and hospitalized patients reported similar 
levels of pain, fear, anxiety, health assessment, and quality of life. 
Ambulatory patients manifested a significantly better emotional adjustment 
and fewer psychological distress symptoms. Same-day discharge patients 
are not at a disadvantage compared to hospitalized patients; i.e. they report 
faster recovery and better psychological adjustment. Outpatient surgery may 
thus foster patient emotional well-being better than routine hospitalization.  
 
Education for women being fitted for breast prostheses is best done by 
nurses who are instrumental in educating women about issues related to 
breast surgery and in helping to promote psychosocial adjustment. 
Prostheses and bras that fit properly are very important in the recovery 
process, and ultimately improve quality of life (90).  
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Physical exercise and quality of life 
Aerobics and resistance training exercises can improve the quality of life for 
women recovering from breast cancer treatment. Long-term fatigue with 
subsequent decrease in quality of life is a serious problem for cancer survivors. 
Up to 30 per cent may experience this symptom for years after termination of 
treatment (91). 
 
Complementary and alternative therapies and quality of life 
Sanskrit is an ancient language of India. Yoga is a Sanskrit word meaning 
‘union of the body, mind and spirit’. Studies have shown that breast cancer 
patients who do yoga tend to enjoy better health, less fatigue and experience 
less daytime sleepiness. Short yoga programmes, including meditation, 
relaxation, breathing exercises, stretching, imagery, and physical movements, 
are shown to be useful at reducing the side effects of breast cancer treatment.  
 
Shannahoff-Khalsa (92) showed that the Kundalini yoga meditation technique 
for psycho-oncology is a potential therapy for patients with anxiety and 
depression. A pilot study of yoga for breast cancer survivors (93) showed 
physical and psychological benefits of lessening the impact of detrimental 
cancer-related symptoms and treatment side-effects (e.g. fatigue, nausea), and 
improving overall well-being and quality of life.  
Carlson et al (99) investigated the relationships between mindfulness-based 
stress reduction (MBSR) in relation to quality of life, mood, symptoms of stress, 
and immune parameters in breast and prostate cancer outpatients. The 
participants were enrolled into an 8-week MBSR program that incorporated 
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relaxation, meditation, gentle yoga, and daily home practice. Demographic and 
health behaviour variables, quality of life (EORTC QLQ C-30), mood (POMS), 
stress (SOSI), and counts of NK, NKT, B, T total, T helper, and T cytotoxic cells, 
as well as NK and T cell production of TNF, IFN-gamma, IL-4, and IL-10 were 
assessed pre and post intervention. The authors concluded that MBSR 
participation was associated with enhanced quality of life, and decreased stress 
symptoms, in breast and prostate cancer patients. This study is the first to show 
changes in cancer-related cytokine production associated with programme 
participation.  
 
In another study, Carlson (94) concluded that MBSR program enrolment was 
associated with enhanced quality of life and decreased stress symptoms in 
breast and prostate cancer patients, and resulted in possibly beneficial changes 
in hypothalamic-pituitary-adrenal axis functioning.  
 
 
Health outcome measures specific to breast cancer 
There are a few generic and specific health outcome measures associated with 
breast surgery. Reliable and valid assessment instruments in cosmetic surgery 
are a vital factor in assessing patient satisfaction with physical appearance. 
Appearance and satisfaction assessments are needed to adequately evaluate 
quality of life. The Breast Evaluation Questionnaire was designed to assess 
satisfaction with breast attributes. It is a 55-item with subscales including 
comfort not fully dressed, comfort fully dressed, and satisfaction with breast 
attributes. The assessment is easy to administer and inte
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recommended for assessing outcomes among breast augmentation patients, 
breast reconstruction patients, mastectomy patients, lumpectomy/breast-
sparing surgery patients, breast reduction patients, and patients who have 
sustained trauma or injury to their breasts (54). 
 
Ching et al (55), in their literature review on measuring outcomes in aesthetic 
surgery, identified body-image and quality of life measures to be of the greatest 
value in determining cosmetic surgery outcomes. These conclusions were 
based on a critical evaluation of the feasibility, validity, reliability, and sensitivity 
to change of these measures. The Multidimensional Body-States Relations 
Questionnaire (MBSRQ), a psychological assessment of body image, was 
selected as a potential candidate for further study. The Breast Chest Ratings 
Scale (BCRS) was said to be useful in the assessment of breast surgery. The 
Derriford Scale (DAS59), an instrument that assesses appearance-related 
quality of life, was also selected. In addition, the authors recommend the use of 
a generic, utility-based quality-of-life instrument, such as the Health Utilities 
Index (HUI) and EuroQoL (EQ-5D). 
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12.3 Benign breast conditions  
 
12.3 a: Quality of life issues in aesthetic breast surgery 
 
Introduction 
Evaluation of quality of life is an important measured outcome in the field of 
breast surgery. Measuring health-related quality of life is also an important 
endpoint in aesthetic surgery. However, not all surgeons are familiar with the 
basic concepts and uses of quality of life assessments. The following is a 
review of the existing literature on quality of life issues in aesthetic breast 
surgery. 
 
Methods / data sources: An extensive literature search was conducted from 
January 1996 to November 2006 on Ovid MEDLINE(R) and January 2000 to 
August 2006 on PubMed. Google scholar was used for non peer reviewed 
literature. Search terminologies used for literature search included breast 
surgery, cosmetic surgery, aesthetic surgery, and quality of life. Studies relating 
to cancer were not considered. The Science of Health measurement (an 
educational series by the Tufts University School of Medicine) was referred to 
for understanding health outcome measures.  
 
Health and its concepts 
A detailed description of health and its concepts has been given in chapter 12.1. 
The earlier chapter also describes quality of life and health-related quality of life 
in detail. The remit of the current chapter is to undertake an exercise to look into 
the quality of life issues in aesthetic breast surgery. 
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Aesthetic surgery 
Reduction, augmentation mastopexy, and correction of asymmetry are common 
aesthetic procedures performed on the breast.  
Reduction mammoplasty and quality of life: 
In 2007 there were 3,402 reduction mammoplasty procedures in the UK (95). 
Macromastia interferes with the patient’s physical, social and emotional health.  
The physical issues include pain, discomfort, poor posture, under breast rashes, 
and tiredness. Feeling tired, worn out, depressed or nervous, having issues with 
undressing, fear of being teased by the partner, and suffering social 
embarrassment are some of the emotional and psychological issues involved. 
Breast reduction improves quality of life, physical and psychosocial issues (96), 
(97) along with providing a long term improvement in health status (98). This 
could be put into context with other procedures, such as total hip replacement 
which has been proven to benefit quality of life (99). 
 
Brown and Khan showed that patient satisfaction with breast reduction was 
high, with major improvement in psychological well-being and physical benefits. 
All patients noted improvement with breast, neck, and back pain, and with under 
breast rash, and shoulder grooving (100). Reduction mammoplasty is shown to 
offer substantial relief of macromastia associated symptoms, with a low 
complication/revision rate (101) along with significant improvement in all quality-
of-life factors (108).  
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Iwuagwu et al in a RCT, assessed the effects of bilateral breast reduction on 
anxiety and depression in women with macromastia. The Hospital Anxiety and 
Depression Score showed significant improvements (p<0.001) in symptoms of 
anxiety and depression, and improvement in symptoms of clinical depression 
(102). There were highly significant differences in quality of life and 
psychosocial functioning between groups in scores measured on the Functional 
Assessment of Non-Life Threatening Conditions version 4, EuroQoL, and both 
mental and physical scales of Short Form 36 (p<0.001). The Eysenck 
Personality Questionnaire-Revised demonstrated a statistically significant 
increase in extroversion and emotional stability in the early treatment group. 
The authors concluded that reduction mammoplasty significantly improved 
quality of life, and increased extroversion and emotional stability(103). 
Reduction mammoplasty was also responsible for physiological improvement in 
pulmonary function (104).  
Augmentation mammoplasty and quality of life: 
In 2007, a total number of 6,497 augmentation mammoplasty procedures were 
undertaken in the UK (95). The number of 18-year-olds in the United States, 
who underwent breast-implant surgery, rose from 3,872 in 2002 to 11,326 in 
2003, according to the American Society for Aesthetic Plastic Surgery. Breast 
augmentation is the third most commonly performed cosmetic surgical 
procedure in the United States. In 2005, 291,000 breast augmentation 
procedures were performed (105) in USA.  
Studies have shown improvement in the subjective quality of life and mental 
health after bilateral breast augmentation on the basis of indices of patient 
satisfaction and psychological evaluation. Chahraoui et al (106), using the 
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subjective quality of life profile (SQLP) and the general health questionnaire 
(GHQ12), along with interviews, revealed the benefits of cosmetic surgery for 
the patients' subjective quality of life. The subjects' mental health and quality of 
life improved in a number of dimensions: physical health, pain, physical 
appearance, social life, and inner life. The study also showed that improved 
physical health during the postoperative period was associated with the quality 
of the relationship with the doctor, whereas deterioration in health was 
associated with excessively high initial expectations concerning the relationship 
with doctors, and physical health. 
 
 
Mastopexy for asymmetry:  
Mastopexy, or breast lift, is a procedure designed to improve the appearance of 
sagging or ptotic breasts (107) . The prevalence of breast ptosis is difficult to 
estimate, but the frequency of mastopexy clearly is increasing. In 1992, the 
American Society of Plastic Surgeons reported that fewer than 8000 
mastopexies were performed. The 2004 report indicates that more than 98,000 
mastopexies were performed in the United States alone (107) . 
A retrospective review by Spear et al (108) highlighted that the end results of 
augmentation and mastopexy depend on a number of factors that must work in 
harmony to yield an excellent result. The authors reported that what is 
aesthetically pleasing to the surgeon may not be pleasing to the patient, and 
vice versa. Acknowledging the complex nature of the patient’s problems and the 
surgical procedure, they concluded that overall results of one-stage breast 
augmentation and mastopexy are good, and the patients generally are satisfied 
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Mental health benefits of aesthetic surgery: 
The mental health benefits of breast augmentation and reconstruction are 
widely acknowledged and supported by surveys, but objective research does 
not support those claims. From 2001-2006, five studies were published 
indicating an increase in deaths from suicide among women with breast 
augmentation (109). Most studies compared women with implants to women in 
the general population, raising questions about whether women who choose 
plastic surgery have other traits (age, race, social class, low self-esteem) that 
make them more likely to commit suicide than other women. However, a study 
by scientists at the National Cancer Institute found a higher suicide risk among 
breast implant patients compared to other plastic surgery patients, although the 
women were similar in terms of age, race, social class, health status and health 
habits (109). All these studies do not determine whether women choosing 
breast augmentation are less psychologically healthy than other women before 
surgery, or if the mental health problems contributing to suicide are related to 
pain or other complications from breast augmentation. 
 
In the only studies that objectively compared women before breast implants to 
two years later, the women who undergo breast augmentation or reconstruction 
have the same or lower scores on most tests of self-esteem and quality of life 
two years after getting silicone breast implants compared to those same women 
just before surgery (110).  
 
Psychosocial issues, psychologists, and quality of life: 
It is known that psychological factors are important in aesthetic surgery for a 
good outcome. While most people do well, some do badly. It is important to pick 
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up the right people for surgery. Selecting patients for aesthetic procedures is a 
challenging task.  
 
Aesthetic surgery has positive effects on psychological and psychosocial 
functioning including improvements in body image and quality of life. However 
unrealistic expectations or a history of depression and anxiety are predictors of 
poor outcome.  
 
Degree of deformity, patient expectations and outcome:  
With increased degree of deformity and low patient expectation, bilateral breast 
reductions do well, with a very good outcome and generally resulting in a happy 
patient. With minimal deformity and a very high patient expectation, mastopexy 
patients will have poor outcome, resulting in an unhappy patient. Patients with 
bilateral breast augmentations lie half way between this, with moderate 
deformity and reasonable patient expectations, resulting in a satisfied patient.  
Research studies (111), (112) suggests that patients who are dissatisfied with 
surgery may request repeat procedures, or experience depression and 
adjustment problems, social isolation, family problems, self-destructive 
behaviours, and anger toward the surgeon and his or her staff. 
Honigman et al (111) state, ‘While most people do well in terms of 
psychosocial adjustment after cosmetic procedures, some do not, and the 
field needs to be aware of this and to arrange screening for such individuals’. 
Psychologist Diana Zuckerman states, ‘Cosmetic surgery affects patients' 
relationships, self-esteem and quality of life. These are fascinating issues for 
psychologists to look at from the cultural phenomena, to the interpersonal 
phenomena, to the mental health and self-esteem issues.’ (113).  
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 David Sarwer, another psychologist, is of the opinion that plastic surgery 
issues will affect clinician psychologists more and more, and the area will 
offer new roles for them, such as conducting pre- and post-surgical patient 
assessments. He stresses that with the growing popularity of plastic surgery, 
it will become important for psychologists to be able to talk with patients 
about their appearance concerns and make decisions on patients being 
good or bad candidates for cosmetic surgery (113).  
 
In a recent study, Sarwer et al (112) found that a year after receiving 
cosmetic surgery, 87% of patients reported satisfaction following their 
surgery, including improvements in their overall body image and the body 
feature altered. They also experienced less negative body image emotions in 
social situations. 
 
In contrast, this group (114) has also shown a link between plastic surgery 
and poor post-surgical outcomes for some patients, particularly for those with 
a personality disorder, or those who have body dysmorphic disorder (BDD) 
where they repeatedly change or examine the offending body part to the 
point that the obsession interferes with other aspects of their life. The 
majority of BDD patients who have cosmetic surgery do not experience 
improvement in their BDD symptoms, often asking for multiple procedures. 
Psychologists can help plastic surgeons identify patients who may not adjust 
well psychologically or psychosocially after surgery. Empirically based 
screening questionnaires are used in certain centres around the world to 
help plastic surgeons select cosmetic surgery patients likely to experience 
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positive psychosocial outcomes. More psychologists will begin to examine 
issues related to cosmetic surgery, because of its increasing popularity and 
the link between appearance, body image, and many psychiatric disorders, 
such as eating disorders, social phobia, and sexual functioning. 
 
Cook et al (115), in their recent systematic review on aesthetic surgery as an 
effective psychotherapeutic intervention, concluded that there is neither good 
evidence to justify elective cosmetic surgery in the absence of physical need, 
nor there is strong enough evidence to justify withholding cosmetic surgery. 
They suggested several improvements in study designs whereby future 
prospective cohort studies could provide higher standards of evidence. 
  
Service provisions and quality of life 
Apart from surgery, other factors also play a role in patient’s psychosocial 
adjustment.  
 
Role of nurses: Patient education for women with breast prostheses is best 
done by nurses who are involved in educating women about issues related to 
breast surgery and in helping to promote psychosocial adjustment. Nurses 
should ensure that patients considering breast surgery understand the risks 
involved (116).  
Health outcome measures specific to breast surgery 
There are a few generic and specific health outcome measures used in breast 
surgery. Reliable and valid assessment instruments in cosmetic surgery are a 
vital factor in assessing patient satisfaction with physical appearance. 
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Appearance and satisfaction assessments are needed to adequately evaluate 
quality of life related to changes in the female breast across a variety of surgical 
interventions. 
 The Breast Evaluation Questionnaire (54) was designed to assess satisfaction 
with breast attributes. The Breast Evaluation Questionnaire is a 55-item scale, 
with subscales addressing comfort when not fully dressed, comfort fully 
dressed, and satisfaction with breast attributes. The assessment is easy to 
administer and interpret, and is recommended for assessing outcomes among 
breast augmentation patients, breast reconstruction patients, mastectomy 
patients, lumpectomy/breast-sparing surgery patients, breast reduction patients, 
and patients who have sustained trauma or injury to their breasts. 
The Derriford Appearance Scale (DAS59) (56) is a psychometric scale for the 
evaluation of patients with disfigurements and aesthetic problems of 
appearance. The DAS59 has been designed and developed to meet the need 
for an objective measure of the spectrum of psychological distress and 
dysfunction that is characteristic of disfigurements, deformities and aesthetic 
problems of appearance. 
 
Ching et al (55), in their literature review on measuring outcomes in aesthetic 
surgery, identified body-image and quality of life measures to be of the greatest 
value in determining cosmetic surgery outcomes. These conclusions were 
based on a critical evaluation of the feasibility, validity, reliability, and sensitivity 
to change of these measures. The Multidimensional Body-States Relations 
Questionnaire (MBSRQ), a psychological assessment of body image, was 
selected as a potential candidate for further study. The Breast Chest Ratings 
Scale (BCRS) was said to be useful in the assessment of breast surgery. The 
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Derriford Scale (DAS59), an instrument that assesses appearance-related 
quality of life, was also selected. In addition, the authors recommend the use of 
a generic, utility-based quality-of-life instrument, such as the Health Utilities 
Index (HUI) or EuroQoL (EQ-5D). 
 
Conclusion: The magnitude of aesthetic breast surgery is on the rise. 
Reduction mammoplasty and augmentation mammoplasty have increased 
significantly in the last decade. Understanding the concepts of health outcome 
measures is important. Evaluation of quality of life and health-related quality of 
life are important measured outcomes. Understanding the concepts of health 
outcome measures is important. Applying them to the clinical practice of 
aesthetic breast surgery is vital for good surgical practice.  
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12.3 b: Risk factors for complications following reduction mammoplasty 
 
Introduction: Macromastia interferes with patient’s physical, social and 
emotional health.  
A number of operations have been described to reduce breast volume. The 
inferior pedicle technique is the procedure most commonly used by plastic 
surgeons in the western world (117), (118). However, there are some 
recognised complications with every technique used. These include the general 
complications of surgery, such as chest infection, deep vein thrombosis and 
thrombo-phlebitis. More specific complications include wound infection, seroma, 
haematoma formation, altered breast skin sensation, fat necrosis, wound 
dehiscence, poor wound healing especially involving the T- junction, and scar 
formation. Others specific and serious complications include skin necrosis, 
glandular flap necrosis, and nipple/areola necrosis.  
The complication rates following reduction mammoplasty vary in different series 
from 7 to 53% (119), (120), (121), (122), (123). Although a number of factors 
such as resection weight, age, BMI, and smoking have been implicated as risk 
factors, there is paucity in prospective data examining these factors as risk 
factors for complications following reduction mammoplasty.  
 
Aim: To determine the effects of resection weight, BMI, age and smoking on 
complication rates following reduction mammoplasty.  
 
Methods: Ethical approval was granted from the Humber Research Ethics 
Committee bearing no. LREC Ref 07/02/130 for research project titled ‘Quality 
of life biomechanical and cost effectiveness of reduction mammoplasty – a 
prospective randomised controlled trial’. The data for the study detailed below 
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was gathered from this original study. Data was gathered as a part of 
randomised control trial examining psycho-social and quality of life benefits of 
reduction mammoplasty. Sixty-seven consecutive female patients referred to 
either the Hull Breast Unit or Hull Plastic and Reconstructive Surgery Unit who 
underwent inferior pedicle reduction mammoplasty were recruited. 
Complications were recorded prospectively. Patients were selected based on 
the inclusion and exclusion criteria. All female patients requesting bilateral 
reduction mammaplasty for symptoms of macromastia, who gave written 
informed consent to participate in the study, were included. The exclusion 
criteria were patients with male gynaecomastia, unilateral reduction 
mammoplasty, or candidates for breast conservation surgery (breast cancer 
patients). All patients had a standard anaesthetic regimen given by a single 
consultant anaesthetist, and underwent inferior pedicle bilateral breast reduction 
by a consultant surgeon. All patients received the same post-operative wound 
care and pain management. Outpatient care also followed a routine protocol of 
a week post-operative review; subsequently, those that required more intensive 
wound care were seen accordingly. In addition to the basic demographics, data 
gathered included resection weight, BMI, age, and smoking status. Smoking 
status was categorised into current smoker, ex-smoker, and never smoked. 
Prospective records of all complications were noted. SPSS was used for 
purposes of statistical analysis (SPSS® version 11.5, Chicago, Illinois, USA). 
 
Results: Of the 67 patients, 16 (23.9%) had complications (Table 3). Higher 
resect weight, increased BMI and older age are associated with high rate of 
complications with significance reaching P values of p<0.001, p= 0.034 and 
 p=0.004 respectively (Table 4).  
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Table 3. Complications after reduction mammoplasty. 
 
Table 4. Effect of resection weight / BMI / age on complications. 
Mean value 
(SD) 
No complications 
(n=51) 
Complications (major or minor) 
(n=16) 
Resect weight 1,253 (SD 469.5) 1,813** (SD 763.7) 
BMI 27. 9 (SD 4.4) 30.5* (SD 3.3) 
Age (in years) 36.9 (SD 11.5) 47.1** (SD 12.7) 
 
* Significant difference at 95% confidence interval 
** Significant difference at 99% confidence interval 
Sl 
No.  
Age Res. Wt. 
(gms) 
BMI Smoking Complications 
1. 57 880 30 Never Minor- T junction 
breakdown 
2. 55 1243 26 Never Major-MRSA wound infection 
3. 62 2874 31 Current Minor-dusky nipples initially-
recovered 
4. 41 1187 32 Never Minor(excision dog ears) 
5. 46 1336 31 Current Major fat necrosis / wound 
infection 
6. 21 2163 34 Never Major - non healing T-junction / 
wound infection 
7. 52 2216 29 Ex – 
smoker 
Minor – Wound infection 
8. 38 2446 34 Current Major - wound infection MRSA 
9. 63 1549 26 Current Major – haematoma 
10. 42 2468 36 Never Minor rev. scar 
11. 27 714 27 Never Minor fat necrosis 
12. 50 1878 29 Never Minor – T junction breakdown 
13. 64 1596 33 Never Minor - wound infection 
14. 56 - 27 Ex – 
smoker 
Minor – wound infection 
15. 38 1744 36 Ex – 
smoker 
Minor - wound infection 
16. 47 3603 35 Current Major - wound infection / fat 
necrosis 
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Effect of smoking and complications. 
Among the 67 women who had surgery, 9 (13.4%) are current smokers, 20 
(29.9%) are ex-smokers and 38 (56.7%) have never smoked. The incidence of 
complications is highest amongst current smokers, and lowest amongst those 
who have never smoked (Table 5).  
 
Table 5. Effect of Smoking on complications. 
 Current smoker 
(n=9) 
Ex-smoker 
(n=20) 
Never 
smoked 
(n=38) 
No complications 4 (44.4%) 16 (80%) 31 (81.6%) 
Complications 5 (55.6%) 4 (20%) 7 (18.4%) 
 
When comparing the current smokers with those who are not currently smoking, 
there is a 37% difference in the occurrence of complication (Table 6). The chi 
squared test shows that this is a significant difference (p<0.01) at 99% 
confidence interval. 
 
Table 6. Effect of current smoking on complications 
 Current smoker 
(n=9) 
Not current smoker 
(n=58) 
No complications 4 (44.4%) 47 (81.0%) 
Complications 5 (55.6%) 11 (19.0%) 
 
Major complications: Among the 67 who had surgery, 6 had major 
complications culminating in either operative treatment, or prolonged wound 
care and adjunctive antibiotic treatment. Two patients had MRSA wound 
infection and breakdown of the T-junctions, which required prolonged wound 
care and antibiotic treatment for 8-12 weeks. The wounds have now healed and 
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the scars have become less obvious over the ensuing months; both women did 
not require any further surgery. Another patient developed a breakdown of both 
T-junctions with non-healing of the wounds. She required prolonged wound care 
on a daily basis. Despite having healthy granulation tissue, complete healing 
was difficult to achieve, she eventually underwent split skin graft treatment with 
good result. Two heavy smokers developed severe fat necrosis with loss of 
volume, with superadded wound infection which also required prolonged wound 
care and debridements of tissue. A female patient developed a large 
haematoma approximately a week post operation, this was managed by several 
episodes of percutaneous ultrasound guided aspiration, this complication has 
resolved satisfactorily. 
 
Minor Complications: Ten women had minor complications. Of these, four 
were women with low grade wound infection, all of which responded to 
antibiotics, two women required minor revision of the scar, mostly for ‘dog ears’ 
in the lateral aspect of the horizontal scar, Two women had minor T-junction 
breakdown that required no surgery, and eventually healed satisfactorily, One 
patient had a solitary area of fat necrosis measuring approximately 4cm x 4cm 
which required excision using a vacuum assisted breast biopsy device, another 
woman who had a massive resection (2874 gram-specimen weight) developed 
a dusky and pale right nipple in the immediate post operative period, but the 
colour rapidly improved over the next few days in the post-operative period. 
 
Multivariate analysis of all complications and development of risk 
prediction model: 
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Logistic regression is used to predict the likelihood of a patient developing 
complications given the information collected concerning the independent 
variables (smoking, BMI etc). The variables included in the multivariate analysis 
are current smoking status, past smoking status, BMI (actual value), age (in 
years), and resect weight (actual value).  
The model works well at predicting levels of complication giving a significant 
model. The details are shown below (Table 7). The model includes both age 
and resect weight, but does not include either of the smoking variables or the 
BMI. 
 
Table 7. Risk prediction model. 
 Model details 
 
B (SE) 
 
Exp B 
Included in model   
Resect Weight 
 
0.001* (0.001) 1.001 
Age 
 
0.06* (0.03) 1.061 
Constant 
 
-5.90* (1.60) 0.003 
 
Note 2R = 0.198 (Cox & Snell), 2χ = 14.6, p<0.001. * p<0.05, ** p<0.01 
 
The model shows that the likelihood of a patient developing a complication 
following surgery increases for older patients, and increases with the size of 
resect. This is shown by a value of Exp B greater than 1. 
 
Discussion: There are a number of techniques in use for reduction 
mammoplasty. The inferior pedicle technique is the procedure most commonly 
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used by plastic surgeons, from a survey of board certified plastic surgeons in 
America (117). A questionnaire survey by Iwuagwu et al looking at the current 
trends in reduction mammoplasty in UK and Ireland demonstrated that nearly 
67% of the consultant surgeons used the inferior pedicle technique (118).  
The reported complication rates for reduction mammaplasty range from 5% 
(117) to 53% (124). Complications following breast reduction can be broadly 
categorised into local vs. systemic, early vs. late, or major vs. minor. Ferreira 
(125) categorised them into early complications (i.e. haematoma, seroma, 
wound dehiscence, infection, and necrosis) and late complications (i.e. 
problems of volume, shape, symmetry, areola and scars). 
An overall view of some of the important studies highlights the risk factors 
associated with complications following reduction mammaplasty. In a 9-month 
prospective, multi-centre trial from the BRAVO study, analysis of complication 
data showed an overall complication rate of 43%. Complication data revealed 
resection weight correlated with increased risk and absolute number of 
complications. Delayed healing correlated directly with resection weight, and 
inversely with increasing age (123). It has been suggested that the complication 
rate of reduction mammaplasty is directly correlated with the amount of breast 
tissue resected (126). A higher mean BMI predicted delayed healing, wound 
dehiscence, and infection (127). Mandrakes et al  (128)in their study looked at 
371 patients who had inferior pedicle reduction mammoplasty over 10 years, 
with an overall complication rate of 11.4%. Their specific complications were 
haematoma 0.3%, nipple and/or pedicle necrosis 0.8%, wound dehiscence 
4.6%, fat necrosis 0.8%, carcinoma 0.5%, loss of sensitivity of the nipple 1.3%, 
hypertrophic scars 3.3%, dermoid cysts 0.3%, and marked lower fullness 0.3%.  
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Zubowski et al (126), in their attempt to derive a relationship between obesity, 
specimen weight, and complications in reduction mammaplasty, conclude that 
obesity and specimen weight are both associated with a higher incidence of 
complications. The authors retrospectively reviewed 395 patients who 
underwent reduction mammaplasty over a 10-year period, and showed a 
statistically significant increase in complication rate in the obese (p=0.01), and 
demonstrated a stronger linear relationship between specimen weight per 
breast and incidence of complications.  
A number of studies have indicated that smokers are at increased risk of 
developing complications compared to the non smokers. Bikhchandani et al 
(122) showed that smokers were 2.3 times more likely to develop any 
complication. This is similar to the results from Schumacher  (129), who 
reported the incidence of wound complications to be 3.4 times higher in 
smokers. Chan et al (130), in their study on smoking and wound healing 
problems in reduction mammaplasty, suggested introduction of urine nicotine 
testing at the preadmission clinic, and prior to the operation, to provide objective 
verification of patients' smoking history, minimize morbidity, and enable 
healthcare cost savings.  
Reduction mammoplasty is a procedure with potential for complications, the 
complications in the author’s series being comparable to other published series 
in the literature and is in the mid range. Complications are particularly likely to 
occur in operations that involve larger resections of breast tissue, high BMI, 
older patients, and smokers. 
Thus in this study, of the 67 patients who had already undergone surgery, there 
was a 9% incidence of major complication and 18% incidence of minor 
complication. None of the women  complained of altered skin sensation, 
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although all were warned of this risk prior to surgery. Although previous studies 
have demonstrated the risk factors for complications following reduction 
mammoplasty, the prospective RCT nature of this study strengthens and 
reinforces the previous evidence.  
Patients should be adequately counselled beforehand about possible 
complications. They should be strongly encouraged to modify the reversible risk 
factors by reducing weight, and stopping smoking. The relationship between 
smoking status and complications emphasises the importance of stopping 
smoking in the peri-operative period, until the wounds have completely healed. 
Health education, professional counselling, de-addiction services, and active 
exercise programmes should all be utilised. Clinical preventive services, which 
include risk factor education and counselling by primary care physicians, can 
improve short-term health-related behaviour of patients (131). Health advocates 
might play an important role by increasing patient's receipt of preventive 
recommendations by assisting in patient education, referral, and encouraging 
physician recommendations (132) . The role of counselling in stopping smoking 
cannot be overemphasised.  
Conclusion: Reduction mammoplasty is a procedure associated with 
complications. It is therefore necessary for every attempt to be made to modify 
the possible risk factors for complications following reduction mammoplasty. 
Higher resect weight, increased BMI; older age, and smoking are some of the 
risk factors. Patients should be adequately counselled about losing weight and 
stopping smoking by active counselling services. Clinical preventive services 
and health advocates might have an increased role to play in the coming future. 
Whether adopting smoking abstinence in the peri-operative period should be an 
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essential eligibility criterion for breast reduction is an issue that needs 
consideration. 
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12. 4. Benign colo-rectal conditions and quality of life  
 
12.4 a: Rectal irrigation in the treatment of evacuation disorders  
 
Introduction:  
Disorders of faecal continence present through a wide spectrum of symptoms 
and aetiologies (133). A recent review (134) highlighted the social and 
psychological distress along with impairment of quality of life that faecal 
continence disorders cause. The underlying anatomical and patho-physiological 
changes are complex, often incompletely understood, and cannot always be 
determined. As a consequence, many medical, surgical, and behavioural 
approaches have been described, with no panacea (134). 
The problem persists widely in the community and the patients represent a 
diverse group. A systematic review reported a prevalence of 0.4–18% for faecal 
incontinence in community dwelling adults (135). The prevalence is 
approximately 50% among the institutionalised , with an annual incidence of 
20% developing incontinence(136). Most of the patients are managed through 
conservative and pharmacological methods. However, there exists a group of 
patients which do not respond to either treatment. An important measure of 
severity of faecal continence disorders is its effect on quality of life. More than 
50% of patients with major faecal incontinence report a significant negative 
impact on quality of life (137). There are various therapies which can be tried to 
relieve the patients of their symptoms, and improve their quality of life. Rectal 
irrigation (RI) is one such therapeutic method (138). The colo-rectal unit in Hull 
has been offering RI since 2002. The following are the results of an evaluation 
into such treatment. 
Aims and objectives: The aims of this study were: 
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• To evaluate the efficacy and acceptability of rectal irrigation in the 
treatment of patients with disorders of faecal continence.  
• To assess the health outcome measures, namely the generic quality of 
life measure SF-36, health-related quality of life measure faecal incontinence 
quality of life (FIQL), and generic standardized questionnaire (GSQ). 
The generic standardized questionnaire looked into various symptoms of faecal 
continence disorders. The efficacy of rectal irrigation was evaluated by 
examining self reported improvement of symptoms in response to rectal 
irrigation in terms of GSQ and the visual analogue scale (VAS). The general 
and specific health outcome measures namely SF-36 and FIQL evaluated the 
acceptability. 
Patients and methods:  
The study was a review of a prospective database of patients who had RI 
between 2002 and 2005. Symptom quantification determined efficacy of RI 
using general standardized questionnaires (GSQ). The acceptability of RI was 
determined using the general health outcome measure SF-36, and health 
related quality of life questionnaire FIQL. In addition, patient bowel diaries were 
looked into. All patients deemed suitable were referred to the Rectal Irrigation 
clinic. They were seen by a consultant surgeon who assessed their suitability 
for rectal irrigation after a detailed history, examination and investigation. The 
patients were predominantly those who had either no improvement or minimal 
improvement after using pharmacological agents and conservative measures 
prior to surgical intervention. 
These patients were further referred to a colorectal nurse practitioner for 
explanation and to obtain informed written consent. The nurse practitioner 
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would spend time with them explaining RI and the technicalities associated with 
it. Patients would be sent home after the informed consent was gained, with 
patient dairies and questionnaires to fill in. After three weeks, the patients would 
return the pre irrigation questionnaires, and start rectal irrigation. RI would be 
either gravity assisted or pump assisted. 6 weeks post RI the questionnaires 
were returned. Patients quantified their symptoms (before and after RI) to 
determine the efficacy of RI.  
 
The questionnaires used included general health outcome measure SF36, 
Health related quality of life measure for faecal incontinence FIQL (Faecal 
incontinence Quality of Life) and a general standardized questionnaire exploring 
the symptomatology of faecal continence disorders. 
 
Health outcome measures: SF-36 is a general health outcome measure. It 
includes both physical and mental component scores. The eight health 
concepts captured by the questionnaire are physical functioning (PF), physical 
health (PH) / role physical, emotional problems (EP) / role emotional, energy 
fatigue (EF) / vitality, emotional wellbeing (EW) / mental health, social 
functioning (SF), pain (P) / bodily pain, and general health (GH). 
 
FIQL questionnaire: This is a health related quality of life questionnaire. The 
four health concepts captured by the questionnaire are lifestyle, coping 
behaviour, depression/self perception, and embarrassment. 
 
General standardized health questionnaire: The general standardized health 
questionnaire was developed in the academic surgical unit in Hull. It was 
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internally validated. It assessed the common symptoms associated with faecal 
continence disorders. This tool was used to compare the symptoms of faecal 
continence disorders pre and post RI. The symptoms included frequency of 
bowel movement, consistency of the stools, mucous leakage, liquid leakage, 
solid leakage, wearing pad for bladder symptoms, wearing pad for bowel 
symptoms, swollen area between anus and vagina, feeling of bowel pushing 
forwards into vagina, rush to pass water, need to self help to empty the bowel, 
micturition urgency, frequency of straining at stools, feeling of incomplete 
emptying, wind leakage, pressure application on the area between the anus and 
vagina, leak urine on coughing, sneezing, urgency to empty the bowels, and 
bowel problems affecting life. 
The efficacy of RI was determined by using the GSQ. The acceptability was 
assessed using a general quality of life questionnaire SF-36 and specific health 
related quality of life questionnaire for faecal incontinence (FIQL - Rockwood). 
Data regarding presenting symptoms, previous therapies, surgeries were 
obtained. There were reminders sent to non responders who failed to return the 
questionnaires. A review was undertaken using the prospectively maintained 
database and RI folders. 
The broad overlap in symptoms and etiologies made this diverse group 
particularly challenging to study and treat. For the purposes of this paper, the 
definitions for continence disorders have been kept deliberately broad. The 
patients were divided into two categories, depending on their primary symptom 
of either incontinence or constipation. The term incontinence is used to describe 
the involuntary escape of faeces, and includes those patients with primary 
sphincter problems, patients with rectal compliance problems, leading to urge 
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incontinence, and patients who describe faecal soiling (139) Constipation is 
defined as the inability to evacuate the rectum when desired, and includes with 
obstructed defaecation and dyssynergic defaecation (140).  
Technique of RI : The equipment used were Coloplast stoma irrigation set for 
gravity assisted RI which included a hook, water bag, stoma irrigation cone, 
tubing, connector, and lubricant, or a pump assisted irrigation set which was 
Irrimatic pump from B Braun (Figure 2). Apart from the hook these items are 
available on prescription or via nurse specialist from Coloplast and B Braun.  
Figure 2. Irrimatic rectal irrigation set  
 
Initially patients undertook irrigation on a daily basis, using 1.5l of tap water at 
body temperature. Irrigation was commenced sitting on the toilet with the water 
bag hanging on a hook with the bottom of the water bag just above head height. 
The cone was lubricated and inserted into the anus holding it firmly, in order to 
give a good seal. Between 300 and 500 mls of water was instilled under gravity 
in a gravity assisted method, or the same amount using a pump, where the 
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pump was at ground level. Patients were informed that the irrigation process 
should be gentle and should not be uncomfortable in any way. Once the water 
flow had stopped, patients waited for 1–2 minutes before removing the cone, 
resulting in an immediate evacuation of water and stool. This irrigation process 
was undertaken three times. Normally, the first irrigation is followed by hard 
pellet-like / semisolid cleanse, the second by a brown fluid and the third by near 
normal clear water.  
Patients were told to expect an urge to defaecate 10–15 mins after the third 
irrigation, but should not experience the urge to defaecate again for 12–
24 hours. Once proficient, patients were encouraged to adopt the volume of 
water and frequency of irrigation to suit their own needs. All patients were 
provided with both verbal and written instructions, and contact numbers for help 
and advice. Specialist nurses offered regular follow-up for as long as needed. 
Data collection: Patients were given dairies and questionnaires to fill in. 
Dairies consisted of incontinence and bowel movement details. The 
questionnaires constituted the generalized standardized questionnaire, general 
health outcome measure SF-36, and health related quality of life questionnaire 
FIQL. In addition, a linear scale was used to quantify reduction in the severity of 
the symptoms after rectal irrigation to produce a visual analogue score (VAS).  
Statistical analysis: An SPSS and SF-36 analysis package was used for 
analysis (SPSS® version 11.5, Chicago, Illinois, USA). 
Results:  
A total of 175 patients’ data was collected for this study. 111 cases are 
successful cases, and 64 cases are failed cases. The patient groups are 
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predominantly female (n=154, 88%) with similar proportions of female patients 
in both the successful (n=97, 87.4%) and failed cases (n=57, 89.1%). The mean 
age of the patient group was 52.6 years (SD 15.08)  
 
SF-36, FIQL, and general standardized questionnaires were analysed pre and 
post RI. Analysis is done only for the successful ones. 
 
SF-36: 71 of the 111 patients completed the SF-36 questionnaire pre treatment 
and 43 of these patients also completed the questionnaire post treatment. 
Subscales are calculated on a score of 0 to 100, with 0 being the ‘worst’ score 
and 100 being the ‘best’. The higher scores mean a better quality of life. 
Table 8: shows the median pre RI and median post RI for each of the 
subscales. There has been an improvement in quality of life post RI. 
Table 8. SF36 (pre and post RI) 
SF-36 sub-scale Pre-RI median 
value (IQR) 
Post-RI median 
value (IQR) 
Physical function (PF) 66.6 ( 32.5, 88.1) 75  (40, 100) 
Physical health (PH) 12.5 (0,100) 50  (0, 100) 
Emotional problems (EP) 33.3 (0,100) 66.6 (0,100) 
Energy fatigue / vitality (EF) 37.5 (15, 50) 40  (25,50) 
Emotional wellbeing / mental 
health (EW/MH) 55  (40, 60) 60  (50, 75) 
Social functioning (SF) 50  (25, 75) 62.5 (50, 87.5) 
Pain (P) 40  (22.5, 67.5) 55  (32.5, 90) 
General health (GH) 45  (20, 65) 50  (33.3, 75) 
 
Comparison of various components of SF-36 pre and post RI using non 
parametric tests showed a significant difference in PF, SF and GH (95% CI) as 
shown in Table 9. 
 
Table 9. SF-36 components pre and post RI using non parametric tests 
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SF-36 sub-
scale 
Negative 
ranks 
Positive 
ranks 
Tied 
ranks 
Z 
value 
(** 95% CI, * 
90% CI) 
PF 8 20 14 -2.34 0.020** 
PH 8 12 20 -1.68 0.093* 
EP 9 7 25 -0.08 0.937 
EF 18 15 8 -0.40 0.693 
EW 14 23 4 -1.84 0.066* 
SF 10 25 7 -2.17 0.030** 
P 13 19 10 -1.87 0.061* 
GH 14 25 3 -1.97 0.049** 
 
* Significant difference at 95% confidence interval. 
** Significant difference at 99% confidence interval. 
 
Wilcoxon signed rank test demonstrated a significant difference in PF, SF and 
GH between the pre and post treatment. The table also shows that there are 
positive shifts in sub-scales PH, EW and P (these differences are significant at 
the 90% confidence level but not at the 95% confidence level). 
 
FIQL questionnaire: 32 of the 111 patients completed the FIQL questionnaire 
pre RI, and 22 of these patients also completed the questionnaire post RI.  
Table 10 below shows the median value pre and post RI for each of the 
subscales. The post median value is equal to or higher than the pre measure. 
This suggests that there has been a slight improvement in quality of life 
measured by the FIQL questionnaire post RI. Non parametric tests are shown in 
Table 11.  
 
Table 10. FIQL components pre and post RI 
  
FIQL sub-scale Pre-RI median value 
(IQR) 
Post-RI median value 
(IQR) 
Lifestyle 2.9 (2.0, 3.8) 3.1 (2.4, 3.5) 
Coping 2.3 (1.5, 3.7) 2.9 (1.7, 3.1) 
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Depression 3 (2.3, 4.0) 3.1 (2.3, 4.1) 
Embarrassment 2.7 (1.3, 3.8) 2.7 (1.7, 3.7) 
 
Table 11. FIQL components pre and post RI using non parametric tests 
 
FIQL sub-scale Negative 
ranks 
Positive 
ranks 
Tied 
ranks 
Z 
value 
(**95% CI, 
*90% CI) 
Lifestyle 5 5 0 0.000 1.000 
Coping 5 5 1 -0.15 0.878 
Depression 7 7 0 -1.16 0.245 
Embarrassment 4 3 3 -0.17 0.863 
 
Wilcoxon signed rank test demonstrates no significant difference in any of the 4 
quality of life subscales of FIQL. This may be due to the large numbers of 
missing data and ‘not applicable’ answers to the individual items on the 
questionnaire. 
 
General Standardized questionnaire: 72 of the 111 patients completed the 
general standardized questionnaire pre RI and 43 of these patients also 
completed the questionnaire post RI. The Questionnaire and responses for the 
GSQ pre and post RI are shown in Appendix 1. 
 
The standard questionnaire demonstrates no significant difference between the 
pre and post RI in frequency of bowel movement, consistency of the stools, 
mucous leakage, liquid leakage, solid leakage, wearing pad for bladder 
symptoms, wearing pad for bowel symptoms, swollen area between anus and 
vagina, feeling of bowel pushing forwards into vagina, rush to pass water, need 
to help yourself empty the bowel, and ever not make it in time to pass urine. A 
significant difference was noticed pre and post RI in the following symptoms, 
frequency of straining at stools, feeling of incomplete emptying, wind leakage, 
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pressure application on the area between the anus and vagina, leak urine on 
coughing, sneezing. No significant difference between the pre and post RI at 
the 95% CI, but a significant difference was found at 90% CI in urgency to 
empty the bowels, and bowel problems affecting life. 
 
The Visual Analog Scales (VAS) 
Sixty-eight of the 111 patients completed the VAS questions pre RI and 42 of 
these patients also completed the questions post RI. Evaluation of the two 
visual analog scales, one for bowels (Image 1) and one for urinary functions 
(Image 2) shows that there appears to be a reduction in the severity of the 
problem. 
Image 1. Reduction in the severity of the bowel problems affecting quality of 
life. 
 
Bowel function postBowel function pre
100
80
60
40
20
0
164
  
Image 2. Reduction in the severity of the bladder problems affecting quality of 
life. 
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Unrinary function postUrinary fuction pre
100
80
60
40
20
0
128
 
The median value for severity of bowel function affecting quality of life pre 
treatment is 90 (IQR, 80 to 100) and post treatment is 65 (IQR, 15 to 90). The 
median value for severity of urinary function affecting quality of life pre 
treatment is 12.5 (IQR, 0 to 50) and post treatment is 10 (IQR, 0 to 28.75). 
 
The Wilcoxon signed rank test is used to see if patients are recording a 
difference in the severity of their problems between pre and post RI on the VAS 
scales. Table 12 shows greater proportion of patients recording an improvement 
pre to post RI than a worsening of their problems. 
 
Table 12. Wilcoxon signed rank test shows improved Bowel and Bladder 
function post RI on the VAS 
 
VAS Negative 
ranks 
Positive 
ranks 
Tied 
ranks 
Z value (95% CI) 
Bowel 
function 28 5 6 -3.579 0.000** 
Urinary 
function 19 7 14 -2.329 0.020** 
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Discussion: 
History: Using water to cure ailments is not new to clinical practice. In 1923, Dr. 
Benedict Lust described hydrotherapy as ‘The Fountain of Youth; or, Curing by 
Water. How you may quickly overcome acute and chronic illness by the use of 
the biological blood washing bath’ (141). A rectal irrigator was in use during the 
early sixties (142). RI can also be seen in ancient medical papyri (143). 
 
Transrectal irrigation with tap water is shown to be a safe method to resolve 
constipation and faecal incontinence in children with myelomeningocele and 
neurogenic bowel dysfunction (144). RI has been shown to benefit a whole 
spectrum of pathologies from organic, inflammatory, to functional. RI with short-
chain fatty acids has shown to benefit distal ulcerative colitis in terms of 
reduction of disease activity to total resolution of the symptoms (145) . RI has 
been shown to reduce symptoms in functional bowel disorders (146) .  
 
Irrigation of the rectum has been tried in various ways. The Enema Continence 
Catheter (ECC) consists of a rectal catheter with an inflatable balloon, and has 
been shown to reduce symptoms in most children suffering from faecal 
incontinence or constipation, and in some adults with faecal incontinence (147). 
Rectal impaction in children was treated with pulsed-irrigation enhanced-
evacuation procedure with good outcome (148). Crawshaw et al showed from 
their retrospective study that RI relieves patients with faecal continence 
disorders of their symptoms, and improves their quality of life (138). Patients 
with spina bifida who have faecal incontinence can be managed by means of a 
large-volume saline enema (149). Studies have also evaluated long-term results 
of transanal irrigation for defecation disturbances, and have concluded that 
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transanal irrigation is simple and safe for long-term treatment for defecation 
disturbances, and shows the greatest benefit in patients with neurogenic bowel 
dysfunction (150). Gosselink et al evaluated the long term outcomes of 
retrograde colonic irrigation. Their overall success-rate was 45% (151). Koch et 
al showed that retrograde colonic irrigation as was an effective treatment for 
evacuatory disorders and demonstrated improved health outcome measures 
(152).  
 
In the context of this study, RI seems to help with both constipation and faecal 
incontinence. Predominant benefits are for those patients with outlet obstruction 
i.e. Intusseption, rectocoele, enterocoele etc. In patients with incontinence, RI 
helps by washing out the rectum, thereby giving them a window period for their 
activities, and thereby improving functional outcome. RI is of two types, one 
gravity assisted, the other pump assisted. The principle in both is the same, 
cleansing the rectum using tepid tap water under minimal pressure. The efficacy 
of both is good, though there is a study ongoing comparing the two.  
 
Technique: The volume of water that is used is around 1.5 lts. The water 
should be lukewarm tap water. The apparatus consists of a water container, 
plastic tubing, a funnel, and a connector. The funnel slides into the anal canal 
with lubrication using a water soluble gel or plain tap water. In the manually 
operated system, the stop value must be on when the funnel is inserted into the 
rectum. Once it is in place the stop value can be released which will infuse the 
rectum with water under pressure. An amount of 500mls is infused, and the 
patient must wait for a few minutes or till there is an urge for defecation before 
beginning the defecation process. 
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Complications from the procedure are rare, although a few reports from similar 
procedures to RI have been documented in the literature. Retrograde irrigation 
enemas common in the treatment of chronic constipation in elderly have caused 
perforations (153), and a case of colorectal perforation due to self-administered 
retrograde water enema in a 55 year-old, for treatment of chronic constipation, 
has been reported (154).  
 
Disorders of faecal continence cover a spectrum of conditions, from faecal 
incontinence, idiopathic constipation, to dyssynergic defaecation (139),(140). 
Patients can experience symptoms varying from urgency of defaecation and 
incontinence, to difficulty initiating defaecation and constipation. Sometimes the 
symptomatology can be overlapping, and around 30% of patients presenting 
with faecal incontinence also complain of difficulty evacuating their bowel 
(133),(155). It can be seen therefore that this paper attempts to study a rather 
amorphous population, who have exhausted other avenues of pharmacotherapy 
and conservative management that is hard to categorize and treat, because of 
the wide variety of symptomatology and etiology. 
 
There are difficulties in interpreting the results offered here, but this should not 
detract from the overall message that in this study population, patients had an 
improvement in their symptoms as indicated by the GSQ, and an improvement 
in the general quality of life measure SF36 and a minimal improvement in the 
health-related quality of life questionnaire FIQL, though not statistically 
significant. The VAS has not only demonstrated a clear benefit in terms of 
reduction of the severity of the symptoms in bowel function but also, to a limited 
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extent, in bladder function where there existed an associated bladder 
dysfunction.  
The number of people suffering from such symptoms in the general population 
is difficult to accurately quantify. Surveys suggest faecal incontinence affects 
over 1% of the population, with 0.7% having symptoms which impact on quality 
of life (156), and 2.6% suffering from some form of anal incontinence. For those 
reporting some faecal incontinence, 10% experience the problem at least 
weekly, yet only 36% had consulted their general practitioner (157). Self-
reported data on constipation suggests that 10% of women and 2% of men 
experience constipation, and, in an English population, 52% of women and 39% 
of men, reported regular straining to stool (158). There do not appear to be any 
figures available to give an indication of the numbers affected by incomplete 
evacuation. Such data are derived from those who have consulted a member of 
the health care team, or who have been approached and will admit to this 
problem. There may be many more too embarrassed to report these symptoms 
(159). 
Current study: The study looks at a complex problem in a difficult group of 
patients. The study is a retrospective review of a prospective database of 
patients who underwent RI for various evacuatory disorders. However, there are 
a few limitations which need highlighting. The analysis has been carried out 
only on successful cases, providing no information on cases that failed, and the 
reasons for failure. Analysis was not undertaken on an intention to treat basis, 
and this could have led to bias in statistical analysis. The poor return of 
completed questionnaires may reflect patient embarrassment due to the nature 
of the problem. Though there was noticeable improvement in the health-related 
                              Page 88 of 215 
quality of life questionnaire FIQL, it failed to reach statistical significance due to 
small numbers and too many responses of ‘Not applicable’. There could be a 
bias in the results to a more favorable outcome, as patients who have had an 
unfavorable experience or outcome from rectal irrigation may be less likely to 
respond to the questionnaire. Alternatively, those patients who are still using the 
technique and anticipate a need for further input from the Coloproctology clinic 
might be more motivated to respond. The questionnaire was a 'snap shot', 
documenting the patient condition at a single time point, asking them to recall 
their previous symptoms which in turn could bias these results. The complex 
symptomatology of this heterogeneous group makes quantitative assessment 
difficult, hence adding the visual analogue scale to rate the reduction in severity 
of the symptoms post RI. Overall rectal irrigation produced an improvement in 
self-reported bowel function in this non-selected group with multiple patho-
physiologies. An attempt to measure the quality of life both generic as well as 
specific using SF36 and health-related quality of life- FIQL has been made. 
Instruction in rectal irrigation requires the input of a specialist nurse, and the 
symptomatic improvement we have noted may be due in part to a placebo 
effect from the patient-specialist interaction. Studies examining the effect of 
biofeedback on faecal incontinence compared to simple sphincter exercises 
alone suggest that biofeedback produces better results, but whether this due to 
a placebo interaction with the therapist rather than the treatment itself is 
debatable (155). Initial results suggest intensive nursing input plays an 
important role in the treatment of these patients. However, the sustained 
improvement in bowel control noted in the patients responding to RI in this 
study suggests the beneficial effect is more than just a placebo effect. If the 
benefit was a simple placebo effect one would expect to see the improvement in 
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symptomatology diminish over time, as the input from the specialist nurse 
reduced.  
RI is a method of management that is time consuming, and therefore requires 
commitment from the participants. It has no apparent side-effects and can be 
discontinued or recommenced at any time. It is cheap; kits cost £20 and last 
approximately 6 months for gravity assisted kit. The pump assisted kit costs 
£300, and lasts for a few years. Both kits are easily supervised by nursing staff, 
thus freeing time at otherwise busy colorectal clinics. 
Summary: The study demonstrates quality of life improvement in the subscales 
of PF, SF and GH significantly (95% CI), and PH, EW and P (90% CI) using the 
generic quality of life measure. Health-related quality of life measure FIQL 
shows slight improvement in quality of life, though statistically not significant. 
This might be due to the large numbers of missing data. The standard 
questionnaire demonstrates no significant difference between the pre and post 
RI in frequency of bowel movement, consistency of the stools, mucous leakage, 
liquid leakage, solid leakage, wearing pad for bladder symptoms, wearing pad 
for bowel symptoms, swollen area between anus and vagina, feeling of bowel 
pushing forwards into vagina, rush to pass water, need to help yourself empty 
the bowel, and ever not make it in time to pass urine. A significant difference 
was noticed pre and post RI in the following symptoms, frequency of straining at 
stools, feeling of incomplete emptying, wind leakage, pressure application on 
the area between the anus and vagina, and leak urine on coughing and 
sneezing. At 90% CI there was improvement in urgency to empty the bowels, 
and bowel problems affecting life. 
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Conclusion: RI can offer symptomatic improvement to patients with faecal 
evacuatory disorders where other conservative and pharmaco-therapies have 
failed. Most patients find the treatment acceptable which was well tolerated and 
pain free. The use of RI via either the gravity assisted or pump assisted kit, as 
an intermediary treatment post conservative and pharmacotherapy and pre 
surgery is therefore recommended. 
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12.5 Malignant colorectal conditions 
 
Decision making processes in malignant colorectal conditions were 
methodologically evaluated using mixed methods. Qualitative tools used 
included focus group discussions, and quantitative studies were in the form of 
questionnaire surveys. 
 
Methodological approach (qualitative): The qualitative study design, given 
the exploratory nature of the inquiry and the limited existing evidence on 
decision making in surgery and cancer care, was adopted. Focus groups were 
used to capitalise on group interactions, and to elicit rich experiential data by 
exploring participants’ knowledge and experiences (160). In addition, focus 
groups are suitable for examining how knowledge and, more importantly, ideas 
develop and operate within a given cultural context (161).  
 
Focus group: A focus group is a formal discussion with 8–12 people on a 
specific topic. The group is facilitated by a moderator who keeps participants 
focused on the topic of interest. The purpose of a focus group is to collect in-
depth information from a group of people who represent the population of 
interest. This useful, qualitative research tool has been an underutilized 
research technique for improving theory and practice in health education (162) , 
(163). 
 
Sampling and data collection: Three focus groups discussions were held. 
Focus groups constituted members of the academic surgical unit, colorectal 
multidisciplinary team, and the head and neck tumour board. To maximise the 
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socio-demographic and cultural diversity, and attain a global perspective of the 
patient populations focus group discussions were held in England (Hull), Wales 
(Bridgend) and India (Bangalore). Purposive sampling was used to select focus 
groups from healthcare professionals who make surgical and cancer care 
decisions routinely.  
 
The stimulus material (Appendix 4) for use in focus group discussions was 
developed following a review of the literature. Abstracts of the relevant papers 
on decision making and patient preferences were used. In addition, there were 
standard questions used by the moderator of the focus group discussion, in this 
case the researcher. The abstracts and the questions used as stimulus material 
are illustrated in Appendix 4. 
 
The focus group discussion was always preceded by a standard presentation 
by the researcher on the focus group discussions and a brief introduction to 
decision making in surgery and cancer care. This was followed by distribution of 
stimulus material, with time to read the abstracts. The researcher would initiate 
the discussion and moderate the session.  
 
Analysis: With the consent of participants, the focus groups were tape 
recorded and transcribed verbatim. The data was anonymised.  Qualitative data 
analysis is a notice, collect, and think process (164). Interesting findings on the 
transcribed data were marked and coded alphabetically or numerically, as 
appropriate. The codes were then sorted and sifted through the data. Codes 
were summarized, synthesized, and sorted from many observations made from 
the data. The thinking process involved searching for types, classes, 
sequences, processes, patterns, or wholes. This process led to a reconstruction 
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of the data in a meaningful and comprehensible fashion, identifying recurrent 
concepts as themes. Two researchers read the transcripts individually (NS: 
author and BJ: co-researcher), and independently noted down the core themes 
that emerged. The notes were compared, and any discrepancies were resolved 
by consensus. Each researcher took the lead to identify sub themes (NS 
analysed the themes). Solutions were carved out for the problems identified 
from the focus group discussions, and these were called ‘outcomes’. 
Anonymised quotations were considered within the context of the focus group 
discussions, and the important ones with key messages are part of this 
document. The quotations have been selected to illustrate the themes raised by 
participants and they are indicative both of typical responses and of the diversity 
of views obtained. Following the initial pilot focus group discussion in England, 
further focus group discussions were held in Wales and India. 
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12.5 a 1: A qualitative analysis of a focus group discussion on decision 
making in cancer care – An English perspective. 
 
Introduction and background: 
Cancer accounted for 28 per cent of all deaths in males and 23 per cent in 
females in England in 2003 (165). In 2006, 293,601 people were diagnosed with 
cancer in the UK (166). Cancer management poses difficult choices in which 
the most appropriate treatment option is not always obvious. Different treatment 
options have their own risks of morbidity and mortality, weighing them in terms 
of quality of life and survival is important. Patient preferences should play an 
important role in clinical decision-making (167). The literature increasingly 
demonstrates that clinicians have divergent preferences for treatment options 
compared with their patients and with each other (10), (11) , (12). Thirty to forty 
percent of the critical medical decisions are made by doctors for their patients 
(13), (14), (15), (16), (17). This rate increases when patients are acutely unwell, 
elderly or dealing with cancer (14), (15). 
Cancer psychology is a vitally important part of cancer management. Qualitative 
research is a gateway to explore this. Weighing the treatment options in terms 
of quality of life and survival is important. Analysis of this area would provide 
information for patients and clinicians that would allow them to make 
appropriate individualized decisions on cancer management.  
 
Aims: The aim was to explore the thoughts of surgical colleagues about ‘patient 
decision making in cancer care’ and to identify factors that may have a role to 
play in decision-making in England. 
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Design: Qualitative study. 
 
Participants and methods:  
A prospective study was carried out at the academic surgical unit attached to 
the University of Hull, with robust research activity. Work was undertaken in 
collaboration with Hull and East Yorkshire NHS Trust. Members of the 
academic surgical unit formed the pilot focus group. Qualitative methods were 
used based on grounded theory. The study explored the thoughts and attitudes 
of the care providing clinicians about ‘patient decision making in cancer care’. 
The participating members were briefed in advance about the research project. 
A pilot focus group discussion was held during a dedicated research morning in 
the academic surgical unit. The pilot focus group discussion explored clinicians’ 
opinions and thoughts about patient decision making in cancer care. Focus 
group discussion involved members of the academic surgical unit. There were 
four surgical consultants, among whom were professorial chairs of colorectal 
and breast surgery. The remaining members of the focus group included two 
colorectal consultants, three surgical registrars and three surgical research 
fellows. The characteristics of participants in the focus group are as illustrated in 
Table 13. 
 
Table13. Characteristics of participants in focus group.  
 
Characteristic (job title) Focus group participants (n=10) 
Professors 2 (colorectal, breast) 
Surgical Consultants 2 (colorectal) 
Surgical Registrars 3  
Surgical research fellows 3 
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The focus group discussion was moderated by the chief investigator and the co-
investigator. Stimulus material in the form of abstracts from published papers 
relevant to decision making and patient preferences were given to the 
members. The focus group discussions were audio taped and transcribed by 
surgical secretaries. All the quotations were anonymised for confidentiality 
purposes. 
 Qualitative methodology was adopted for analysis. Thematic analysis using a 
framework approach was done, thereby identifying themes and outcomes. Two 
surgical research fellows analysed the data separately for accuracy and 
repetitiveness of the themes and outcomes. 
 
Data collection:  
Data was gathered from focus group discussions. Data was audio taped and 
transcribed by surgical secretaries. Quotations were anonymised for 
confidentiality reasons. 
 
Analysis:  
Thematic analysis of the collated data was done using the framework approach 
thereby identifying themes and outcomes. Analysis of qualitative research data 
was carried out using a validated technique.  
 
Results: The emerging themes and outcomes are shown in Table 14. 
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Table 14. Emerging themes and outcomes 
Emerging themes Derived outcomes 
Evidence based clinical practice To increase evidence base 
Knowledge To increase the clinician and patient 
knowledge 
Patient information and decision 
making 
Provide adequate information  
Decisions to be based on patients best 
interest 
Risk and communication Communicate risk in an understandable 
manner  
Take patients views, knowledge and 
demands into consideration 
Consent  
Socioeconomic factors  
Patient empowerment  
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Figure 3. Emerging themes 
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Figure 4. Derived outcomes 
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Patient decision making (PDM)  
 
Patient autonomy, empowerment and role in decision making are very topical. 
The majority of the cancer patient population want the cancer to be totally taken 
out, irrespective of the risk of mortality and morbidities associated with. A very 
small percentage of the population really weigh the benefits and risks when 
there is more than one treatment for the same disease pathology. The majority 
of the population trust the traditional procedures, although these are still 
associated with major risks. 
 
(Respondent)R-1: “Tell what we know”, “in majority there is no decision to be 
made”, “needs cancer to be taken out, majority agree”. “A small percentage 
have a real alternative option.” 
 
Evidence based clinical practice (EBCP)  
 
The team members were asked what they understood by the term ‘evidence 
based clinical practice’. Few of them had a defined answer. However, 
everybody agreed on the need to follow good evidence.  
R-3: “Informing patients and consent”, “Decision making based on current 
evidence and multidisciplinary team process”, “unusual for patients wanting trial 
data and outcomes.” 
 
Knowledge and risk  
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Clinician knowledge, technical skill and communication are important aspects of 
being a good clinician. Even when knowledge and skill have been acquired, 
poor communication can lead to patient harm.  
 
R-2: “You have to respect and understand what the clinician understands and 
knows. Having spent many years trying to teach some registrars and 
consultants what risk is, and how to communicate risk, I can assure you that the 
vast majority have absolutely no idea about how to communicate it. If the 
clinician does not know how to communicate risk, how on earth do you expect 
the patient to understand differences in risk?” 
 
Patient information  
 
R-2: “It’s how you inform them, that makes their choice; I don’t think anybody 
ever gets unbiased information.” 
 
Decision making 
 
R-2: “You do not lay all the data out to them and say, ‘You make the choice’. 
You steer them in a direction and they choose ... that direction [in] the vast 
majority of cases.” 
 
R-2: “One patient said to me, ‘Don’t tell me! Just do to me what you think is 
right, and I will go with it.’” 
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R-5: “Nobody can make a decision and they are least well suited at that time to 
make an objective decision, its all ‘smoke and mirrors’.”” 
 
R-2: “I don’t believe they do have a choice. From the minute they turn up they 
have got the disease, they come to someone they put their trust in to sort them 
out.” 
 
VQ- Socioeconomic factors 
 
R-2: “I think it’s cultural as well!” 
 
Informed Consent:  
 
There exists a dilemma in what is termed as ‘fully informed consent’. Some of 
the questions that arise in the process of acquiring consent are: How much 
information is to be given? What is adequate information?  What if the person 
receiving the information refuses to receive full information?. 
On the other hand, if the patient decides on a procedure and insists on it, is the 
clinician obliged to provide that service? If the patient requests for the clinician’s 
performance statistics, is there a system to provide that information along with 
the national averages. These are some of the issues that need consideration. 
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13. Discussion:  
 
Decisions: When making decisions it is important that patients’ views are taken 
into account, an understanding of their level of knowledge and demands is 
important. 
 
PDM in cancer care: Although patient decision making in cancer care is a 
passive process in the majority of the population, active decision making is 
slowly evolving – albeit in a minority. This minority requires in depth knowledge 
of the disease process, available treatment options, and the complications 
associated with it. 
 
The future: With increasing active involvement and participation of this minority 
of patients, they will play an increased role when making decisions in the future. 
 
Tradeoffs and risks: Tradeoffs and risks between survival and quality of life 
will be considered when decision making in the minority group of patients who 
take active part making decisions about their treatment. 
 
Bias reducing factors: To overcome the bias that may be associated with 
gathering data, a second moderator was involved in the focus group discussion. 
This second moderator also took part in thematically analyzing the qualitative 
data, to overcome bias. The themes and outcomes from both researchers were 
compared to derive reoccurring themes and outcomes.   
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Conclusions:  
 
It is important that patients’ views, knowledge and demand are all taken into 
account when decision making. Patient decision making in cancer care is slowly 
increasing, although it is still only present in a minority of patients. This minority 
of the patient population will play an increased role in current decision making, 
and will possibly drive decision making in future. Tradeoffs and risks between 
survival and quality of life will be considered by this active minority. 
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12.5 a 2: A qualitative analysis of a focus group discussion on decision 
making in cancer care – A Welsh perspective 
 
Introduction and background: 
 
In addition to the background described in the above chapter, it is important to 
emphasise that there is a significant educational and socio-economic variation 
between England and Wales. There is also a discrepancy in the healthcare 
provision between the two regions.  
 
Aims and objectives:  
The aim is to explore the thoughts of surgical colleagues about patient decision 
making in cancer care and to identify factors that may have a role to play in 
decision-making in Wales. 
 
Design: Qualitative study. 
 
Participants and methods: This is a prospective study that was carried out at 
Princess of Wales hospital, Bridgend, attached to Abertawe Bro Morgannwg 
(ABM) University Health board in Wales. A qualitative study by methodology, 
focus group discussions were used as a research tool.  
 
The study explores the thoughts and attitudes of the care providing clinicians 
about patient decision making in cancer care. They are members of the 
colorectal cancer multidisciplinary team. The participating members were 
briefed in advance about the research project. 
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A focus group discussion was held during a dedicated research afternoon in 
the multidisciplinary team meeting room. The focus group discussion explored 
clinicians’ opinions and thoughts about patient decision making in cancer care. 
Focus group discussion involved members of the colorectal multidisciplinary 
team. There were three surgical colleagues in addition to the researcher, 
pathologists, radiologists, medical oncologists, and colorectal nurse 
practitioners. The characteristics of participants in the focus group are 
illustrated in Table 15. 
 
Table 15. Characteristics of participants in focus group.  
 
Characteristic (job title) Focus group participants (n=15) 
Surgical Consultants 2 (Colorectal) 
Surgical Registrars 2  
Oncologists 2 
Radiologists 3 
Pathologists 2 
Specialist nurse practitioners 2 (Colorectal) 
Allied health professional  2 (MDT coordinators) 
 
 
A brief PowerPoint presentation was given on qualitative research. This was 
followed by a focus group discussion. The focus group discussion was 
moderated by the chief investigator and the co-investigator. Stimulus material in 
the form of abstracts from published papers relevant to decision making and 
patient preferences were given to the members. The focus group discussions 
were audio taped and transcribed by surgical secretaries. All the quotations 
were anonymised for confidentiality purposes. 
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Qualitative methodology was adopted for the analysis. Thematic analysis using 
a framework approach was done by identifying themes and outcomes. Two 
clinicians skilled in qualitative research analysed the data separately for 
accuracy and repetitiveness of the themes and outcomes. 
Data collection: Data was gathered from focus group discussions. Data was 
audio taped and transcribed by surgical secretaries. Quotations were 
anonymised for confidentiality reasons. 
 
Analysis: Thematic analysis of the collated data was done using the framework 
approach, thereby identifying themes and outcomes. Analysis of qualitative 
research data was carried out using a validated technique.  
 
Results:  
Themes that emerged revolved around patient, clinician, and nursing factors. 
Patient factors included evidence based patient choice, patient individuality, 
socioeconomic factors, autonomy/empowerment, beliefs, trust in clinicians, 
information, experiences, and decision making. Clinician factors were efficacy of 
risk communication, consent, steering decision making process, and continuity of 
care and support. There were a number of themes arising from the nursing 
perspective, included continued care, keeping patients informed, being a good 
communicator, providing information, helping in decision making, and providing 
help as and when required.  
 
Outcomes derived are to individualise treatment based on patient factors and in 
the patient’s best interest, to take patients’ views, knowledge and demands into 
consideration, to tailor information to patient’s need, and to direct them to 
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evidence based, reliable, speciality based websites. Further outcomes were to 
communicate risk in an understandable manner, which should include the 
consenting process and risk communication training for clinicians. Provision of 
continuing care, support with the decision making process, and availability of 
help when required were some of the other outcomes. 
The emerging themes and outcomes are shown in Tables 16 and 17. 
 
Table 16. Emerging themes 
Emerging Themes 
Patient factors Evidence based patient choice 
Patient individuality  
Socioeconomic factors 
Autonomy/empowerment 
Beliefs/trust in clinicians 
Information 
Experiences and decision making 
Clinician factors Efficacy of risk communication 
Consent 
Steering decision making process 
Continuity of care and support 
Nursing factors Continued care 
Keeping patients informed 
Being a good communicator 
Providing information 
Helping in decision making 
Providing help as and when required 
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Table 17. Emerging outcomes 
 
Emerging outcomes 
Patient factors Individualise treatment based on patient factors and in 
patient’s best interest  
Take patient’s views, knowledge and demands into 
consideration  
Tailor information to patients need  
Direct patients to evidence based, reliable, speciality 
based websites  
Clinician factors Communicate risk in an understandable manner 
including the consenting process  
Risk communication training for clinicians 
Nursing factors Provide continuing care 
Provide support with decision making process 
Availability of help when required 
 
Factors affecting decision making:  
 
Evidence based patient choice (EBPC):  
 
R: “I personally would explain to my patients, and try to give them enough 
information for them to make a decision based on their own beliefs, but if you 
know what the evidence shows as best practice, you do tend to try and steer 
them in that direction. However, I think as long as you give them enough 
opportunities to ask the questions that they want to ask and you can answer 
them as truthfully as you can, then you know you have given all the information 
you can to enable them to make their own decisions.”  
 
R: “Going back to pathology, we talked about the evidence base ... You tend to 
get reports from pathologists, and ... the reports were taken almost as dogma, 
and the problem is that there is an awful lot in pathology we do not know, we do 
not understand. There are lots of situations we come up with where we squeeze 
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them into these classifications; we squeeze cases into staging things and they 
don’t really go because the evidence isn’t there.” 
 
R: “For many common clinical diseases we just don’t have the pathological 
understanding of how those diseases behave. It is an assumption. There is no 
evidence base for it. So I really wonder even where you have got what you are 
thinking is solid evidence, e.g. the path report  - there is an awful lot of shaky 
ground under that, so I do worry about this ... taking our reports as being the 
only bit of concrete you have got; it is probably the crumbliest bit of concrete 
you have got, actually.” 
 
R: “About patient choice? Well, we’re actually not, as you know, directly 
involved. I have likened this before to a bit like World War II bomber pilots – we 
write our bombs, which are our reports and by the time they go off we are 
nowhere to be seen, we are gone, and we don’t see the effects.”  
 
Patient factors:  
 
Individualize treatment:  
R: “I think we need to take a step back, because you cannot just characterise 
patients into groups and I think that’s the danger of modern medical practice, 
particularly in the NHS.”  
 
R: “You cannot follow a flow chart for every single patient, the patients carry a 
lot of baggage with them. That is a prime example of ... saying you are 
completely making a subjective scenario completely objective, and you are 
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labelling a tumour essentially, and that tumour is attached to someone with a lot 
of circumstances with an age and lots of other factors that you need to take into 
account, and I think that is the danger, and that is what’s happening a lot. A 
prime example we had earlier; a patient who is too large to have any surgery, 
but the protocol means he gets followed up ... in a year with a CT. What we can 
do about it? Nothing! What’s the point, but that’s the protocol.” 
 
Socio-economic/geographic factors: 
R: “There are differences and the differences socio economically ... [are] 
important because expectations are different, patient groups are different.” 
 
R:  “You know the patient populations are very different, aren’t they?” 
 
Patients own beliefs:  
R: “I personally would explain that to my patients, and try to give them enough 
information for them to make a decision based on their own beliefs.” 
 
Trust and belief in clinicians:  
R: “Patient groups are different because a certain group of patients (although 
they are fewer these days), they sort of say, ‘Anything you say, you know I will 
do, doc.’, and some don’t want any information at all, so any efforts you make to 
explain to them what you are going to do, or what the best test is, or what the 
best treatment is, you spend half an hour talking to them and they will turn 
around and tell you, ‘Well, it’s up to you, what do you think is the best thing to 
do?’” 
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Information/internet:  
R: “Some patients will ... have trawled through the internet and have a whole 
raft of information with them, some of it false, and some of it correct, and again 
you know they are going to be influenced by what they have read on the 
internet, and how you actually present that data to them. So, I don’t think there 
are any hard or fast rules really as to what we can do.” 
R: “Are we giving them too much information?” 
R:  “I was just going to say that as well!”  
R: “Some take in only half of the information, don’t they? – They get information 
overload, ... There is a big issue around patient choice, but can they actually 
compute all that information and make logical sense out of it?”  
R: “Yes! I think it is part of our job to try to help them through that whole mêlée 
of information, and try to make sense of it, because sometimes you can give 
them too much information and they are sitting there thinking, ‘Well, where do I 
go next?’ and, as you said, the ones that have gone against the multidisciplinary 
team decisions have been ones where patient choice has come into it, so one 
would question whether the patient fully understands the implications of their 
decision making in that context because they can’t cope with all the 
information.” 
R: “Having had personal experience with going through this process recently, 
the first thing I would say is, you are absolutely right, it is too much information. 
The situation I was in with two medical professionals having to assess the 
information was extremely difficult, there was too much there, we did use the 
internet, and got totally confused, because two very different sites were actually 
saying completely opposite things, so it is confusing for professionals, let alone 
people who do not have a medical background.” 
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R: “But I think it is daunting to have to look at all this information, and, as I said, 
[particularly so] when you have got clearly very professional outfits on the 
internet giving totally different advice, you know, 180° different from each other.”  
R: “You can try to steer them towards reputable sites, such as Cancerbackup.”  
R: “Yes, certainly ...  on our information leaflets that we give them at diagnosis, 
we have got recommended websites that they should look at  rather than 
randomly googling sites all day.”  
 
Patient rights / autonomy:  
R: “I mean nobody can force a patient to do something they don’t want to do.” 
 
Other patient experiences:  
R: “Having gone through personally with my dad with this, one thing patients do 
look at is what has happened to somebody else with a similar problem. That 
strikes them as more important than anything that comes of the internet, or 
some details from the clinic, e.g. one of the relatives or somebody who has 
recently had a lap surgery and say came through well … that’s very important.”  
 
R: “However good the surgery or any intervention is, if they are seeing 
somebody who has had a bad experience, they tend to avoid it as well. It is 
probably quite an important point.” 
 
Clinician factors: 
 
Risk communication:  
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R: “What the approach for the colonoscopy and polypectomies is, is we always 
send an information pack to the patient with a consent form, so that the patient 
has [plenty of] time at home to read the information available, about the risk of 
the colonoscopy with or without polypectomy. This information is provided 
before they sign the consent, so they are aware of the risks.” 
R: “Are they actually 100% sure what the risks are, or what is the actual the 
risk? I doubt it, the surgical chance of perforation is 1 in 2000. It doesn’t mention 
that if you have a polyp that becomes 1 in a 1000, or 1 in 500. So the 
information is there, but I don’t think the patient takes it seriously unless you do 
something that goes wrong, then they take it more seriously.” 
 
R: The other thing I would mention when we are talking about risk is that the 
consent form that was signed – the benefits had one entry – possible risks had 
40, and, as my wife commented, how the hell do you get anyone to sign one of 
these I do not know, so, again, I think there is a lot of information overload. How 
patients manage with it, particularly patients who do not have any medical 
understanding, is quite beyond me, I find it difficult enough even with medical 
understanding.” 
  
Steer DM process:  
R: “I think it is largely in certain patient groups, how you phrase the information 
that you give them really.”  
R: “There will be certain patients who have made up their minds before they 
even come and see you about what they want to do, and what they don’t want 
to do. For the ones that haven’t, it very much depends on what track you take, 
and how you steer them, because there are obviously certain cases where you 
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don’t really know what the right answer is, because there is no evidence to tell 
you.” 
R: “If you know what the evidence shows as best practice, you do tend to try 
and steer them in that direction, but I think as long as you give them enough 
opportunities to ask the questions that they want to ask, and you can answer 
them as truthfully as you can, then you know you have given all the information 
you can to [enable them to] make their own decisions.” 
 
Continuity of care/giving more time/decision making: 
R: “I have patients who, half-way through their chemotherapy, are then ready to 
discuss the possibilities of what they were meant to do, and you know, you have 
to sit down with them and make more time then, and usually they will realise 
that they have made the right decision, but that’s when they’re ready to make it, 
two months later because they have kind of got to grips with things and it is too 
late to make the decisions they needed to make earlier.”  
 
Nursing factors:  
 
Continuity of care: 
R: “I think from a nursing point of view it is very important for us in colorectal 
surgery to see all patients at diagnosis in endoscopy, bowel screening, and 
obviously in clinic.”  
 
Keeping patients informed:  
R: “We make it very clear to the patient so that [they understand] any 
information that is given to them, and that they understand what they are being 
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told, e.g. ‘you are being discussed at MDT.’ What does MDT mean to a patient? 
It could mean a medical terminology; they might be thinking it is something to 
do with their cancer. But if you sit down and explain to them that it is a meeting, 
and that we all meet, and so from a very early stage we are explaining all the 
basics to them, from diagnosis, so when we ring them following MDT we tell 
them the result and what is happening next, they are informed all the way along. 
I think our patients would probably be less likely to look on the internet and 
things like that because we are keeping them informed all the way along their 
journey, so that they should hopefully not feel the need to look on the internet 
because I hope that they would feel that we are giving them sufficient 
information. As nurses we support them when we are seeing them with the 
consultant, and then we will take them off, so, like you were saying earlier what 
do the patients take in at that consultation? Probably nothing, hence why we are 
there to take them aside, and go through it all”.  
 
Avoid medical jargon:  
R: “We make it very clear to the patient so that [they understand] any 
information that is given to them; that they understand what they are being told 
e.g. ‘You are being discussed at MDT.’ What does MDT mean to a patient? It 
could mean a medical terminology; they might be thinking it is something to do 
with their cancer?” 
 
Helping decision making: 
R: “I think if you are meeting [the patients] continuously along that journey, you 
can  ... get them on your side and steer them away from that, but if you just 
leave them to it ... I think you get the patient that doesn’t want to know anything, 
                              Page 117 of 215 
or will just go with whatever the doctor tells them, or you get the patient that 
feels that they have got to get all this information that is out there to make the 
best decision, and they just get totally confused, and they end up probably 
making worse decisions because they get so confused. So I think we play a big 
role in that certainly.” 
R: “Absolutely, and it’s like the debate about having a low anastomosis and no 
stoma, and then being incontinent ... and then there are a lot of these decisions 
that patients have to make, and when they are looking on the internet at having 
these ultra low anastomosis, there is a lot of stuff out there that they don’t 
understand, that needs explaining further.”  
 
Journey of decision making:  
R: “I honestly don’t know ... I’ve thought about it and wondered how you could 
improve it, it’s just the [mindset] at the moment within the NHS that you have to 
give everything, and particularly you have to give all the possible complications, 
no matter how uncommon they might be and, granted, if it does happen with 
somebody it is 100%, you know, they have got it, that’s it, it doesn’t make any 
difference, but actually 1 in a 1000 to them is a 100%.” 
 
R: “But I think it is daunting to have to look at all this information and, as I said, 
even when you have got clearly very professional outfits on the internet giving 
totally different advice, you know, 180° different from each other. Well, how do 
you reconcile that, even as the professionals we find that difficult. How the 
public reconcile that is quite beyond me, I really don’t know.” 
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Discussion: Multidisciplinary teamwork is a process where decisions are made 
about an individual. Literature suggests that there is a drop out on the 
multidisciplinary team decisions, and that not all multidisciplinary team decisions 
are implemented (168) . One of the possible ways, the multidisciplinary team 
process could be improved in terms of efficacy and efficiency is to bring these 
patients to the multidisciplinary team meetings so that they could choose their 
treatment. This should be undertaken only where there is a conflict in decision 
making. Given the time pressure, it might sound impractical, however, if it can 
save time and resources in following clinics, it might be worthwhile.  
Family members can certainly play a significant role in helping the patient arrive 
at a decision. Again, this varies with socio-cultural differences. With an 
increasing ethnic population in the UK, this is something that we encounter 
more and more, particularly amongst the Asian population. 
There has been an overwhelming discussion about the redundant, inappropriate 
information available on the internet. The outcomes derived suggest that the 
patients should be diverted to reliable speciality based websites, from the 
specialist societies. Also, the speciality journals publish website reviews on 
specific pathologies which can prove to be very useful. 
There was an emphasis on the role of nurses, from breaking bad news to 
maintaining communication, in addition to the provision of help when necessary. 
Given the skill and the experience of the nursing colleagues, it might be a good 
idea to consider the concept of decision making liaison nurses. It should be 
recommended that the breast/colorectal/upper gastrointestinal nurses take up 
the roles of decision making liaison nurses, after adequate training. 
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One of the important themes generated from the focus group discussion was 
the process of risk communication and the consent process. The clinicians felt 
the consent process to be tedious and labour intensive paperwork. 
Having undertaken the focus group interviews in England, Wales and India, 
detailed below, an overwhelming factor is the role of socio-economic and 
cultural factors in decision making. In this globalised world, with a cross-cultural 
population, it is important to take into account the patient’s socio-cultural factors 
in the decision making process. 
One of the other convergent themes from all the focus groups was the way 
decisions were steered in line with the clinician’s preference. Generally 
speaking, in Wales there is a preference towards joint decision making.   
                                                                                                                                                                               
Conclusions:  
 
Decision making in cancer care is a complex physical and cognitive process 
based on evidence base, patient needs, clinician experience, judgement and, 
more importantly, patient preference. The focus group discussion demonstrates 
the importance of the members of the multidisciplinary team in the decision 
making process for an individual patient, with a drive towards joint decision 
making in the Welsh population. In the years to come, patients will probably have 
an increased involvement and role within the multidisciplinary team setting, when 
decisions are made about them.  
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12.5 a. 3: A qualitative analysis of a focus group discussion on decision 
making in cancer care – An Indian perspective 
 
Introduction and background: 
It is vital to mention that there exists a wide variation in healthcare provision 
between UK and India. Not only this, but within India itself there exists 
significant variation, in relation to educational, social, economic and religious 
factors, which certainly has implications for the decision making process. 
Cancer psychology is a vitally important part of cancer management. Qualitative 
research is a gateway to exploring this. Weighing the treatment options in terms 
of quality of life and survival is important. Given the globalisation of healthcare 
seen in the last decade, the exploration of the decision making process in a 
developing nation was deemed highly appropriate. 
 
Aims and objectives:  
 The aim is to explore the thoughts of surgical colleagues and care providing 
clinicians about patient decision making in cancer care in developing countries, 
with special reference to India. The secondary objective was to identify factors 
that may have a role to play in decision making in India.  
 
Design: Qualitative study. 
 
Participants and methods: This was a prospective qualitative study. The 
exercise was carried out at Kiran Mazumdhar shah cancer centre. The hospital 
is a tertiary referral centre for cancer services in the southern city of Bangalore, 
India. A qualitative study by methodology, a focus group discussion was 
undertaken with the members of the head and neck tumour board. The study 
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explores the thoughts and attitudes of the care providing clinicians about 
patient decision making in cancer care. The participating members were 
briefed in advance about the research project. The focus group discussion was 
held prior to a scheduled tumour board meeting. The characteristics of 
participants in the focus group are illustrated in Table 18. 
 
Table 18. Characteristics of participants in focus group.  
 
Characteristic (job title) Focus group participants (n=12) 
Professors  1 (Head and neck) 
Surgical Consultant /Senior lecturer 1 (Colorectal) 
Clinical oncologists 3 
Surgical Registrars 4  
Allied health professional  3 (Psychosocial workers) 
 
 
The focus group discussion explored clinicians’ opinions and thoughts about 
patient decision making in cancer care in an Indian context. The focus group 
included head and neck surgeons, oncologists, radiotherapists, psychosocial 
workers in addition to a senior lecturer and surgeon from Cardiff University, 
along with the chief investigator, who was running the focus group discussion. 
The focus group discussion was moderated by the chief investigator and the co-
investigator. Stimulus material in the form of abstracts from published papers 
relevant to decision making, and patient preferences were given to the 
members. The focus group discussion was audio taped and transcribed. All 
quotations were anonymised for confidentiality purposes. Qualitative 
methodology was adopted for analysis. Thematic analysis using a framework 
approach was done to identify themes and outcomes. Two surgical research 
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fellows analysed the data separately for accuracy and repetitiveness of the 
themes and outcomes. 
 
Data collection:  
Data was gathered from focus group discussions. Data was audio taped and 
transcribed. Quotations were anonymised for confidentiality reasons. 
 
Analysis:  
Thematic analysis of the collated data was done using the framework approach, 
thereby identifying themes and outcomes. Analysis of qualitative research data 
was carried out using a validated technique.  
 
Results:  
The emerging themes and outcomes are shown in Table 19. 
Table 19. Emerging themes and outcomes 
Emerging themes Derived outcomes 
Patient factors 
Cost and affordability  Shift from health care provider and to 
health care Insurer 
Quality of life Raising awareness of health outcome 
measures 
Patient choice and demand Respect patient choice/demand/trust 
and beliefs Trust and beliefs 
Patient knowledge Raise patient knowledge 
Socio-economic and educational 
status 
Consider socio-economic / educational 
status while decision making 
Family and social support   
Clinician and clinical factors 
Communication, risk and consent    Train clinicians in risk 
communication/consent 
Patient advocate Encourage patient groups/voice 
Information technology Direct patients to evidence based, 
reliable, speciality based websites 
Clinician knowledge Raise Clinician knowledge 
Psychosocial workers/nursing  
Sharing and support Increase nursing input in patient care 
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Quotations: 
 
Cost and affordability:  
R: “Money is the first thing ... actually the most important factor, if they cannot 
afford the treatment, there is no point in telling [the patient about it].”  
R: “When the patient comes to the hospital in Britain, nobody talks of money. 
Here, the first thing is how much it costs.”  
 
Quality of life: 
R: “They do not talk about quality of life.”  
R: “The best option, whether it is debilitating or low quality of life, we have to 
offer it. He has an option of refusing it, but just because you may not like it, we 
should not refuse that option.” 
R: “When the patient comes to the hospital in Britain, nobody talks of money. 
Here, the first thing is how much it costs. They do not talk about quality of life 
that is all.” 
 
Case complexity and choice of therapy: 
R: “If there is a clear-cut answer to a problem, there is no discussion. A 
discussion comes when there are multiple options.”  
 
Ease of communication:  
R: “Patients feel [more] comfortable communicating with doctors than nurses.”  
 
Decision making:  
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R: “They know what was discussed here, that will be conveyed to the patient 
and then we come up with a decision.” 
 
Patient choice and demand: 
R: “We will have some definite plan that was made, and sometimes the patient 
has a completely opposing treatment plan, and we strongly feel that patient 
needs to be counselled, therefore we try our best to counsel, but sometime the 
patient will be against us.” 
R: “We have had a few patients who come demanding for a particular type of 
therapy.” 
R: “I mean it is not really uncommon for people to come with some particular 
treatment in their mind, it need not be the best possible option.” 
 
Trust and beliefs: 
R: “Totally curable, but patient is going to go for Siddha ayurvedic treatment. 
We tried to explain that this is curable, but he is against it, we cannot force the 
patient, but we said we will keep an eye on the patient. I am helpless.” 
 
R: “I have belief in surgery, but sometimes belief is what patients [have too]. So, 
all of us have certain bias based on it. Patients have their own perspective 
about life and treatment.”  
R: “A man working at a vice president level in an IT company is telling me that 
his uncle told him that radiotherapy will disfigure her, so she did not take 
radiotherapy, now she is left with an expected life survival of three months. So, 
it is an interesting concept, but there are lots of social issues attached to it and 
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we will be very happy to choose the patients who get involved during decision 
making.” 
 
R: “One of our very senior oncologists is considered as God in India. They will 
go and touch his feet, the only thing he does is to tell to them, they will be 
cured. We know that he is giving the patient hope. He sells hope. He is so 
popular that he travels across India. He sees patients in the airport, anywhere 
and everywhere, and he is God, people love him.” 
 
Evidence-based patient preferences, patient choice, or patient decision 
making: 
Financially driven: 
R: “In India, it is a completely different scenario. Our practice is a very bad 
practice. If he does not like me or the other surgeon, there are enough 
renowned hospitals in the city where patients can go and if, you know, there are 
hospitals where the doctors will do whatever the patient say. So, it is a 
completely different concept.” 
 
R: “That is exactly opposite what happens in India. The patient has enough and 
more choices. We see so many patients who shop around the whole of the 
country and then come to us.”  
 
Affordability:  
R: “Affordability is the first thing that is actually the most important factor, if they 
cannot afford the treatment, there is no point in telling them the various options.” 
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R: “When the patient comes to the hospital in Britain, nobody talks of money. 
Here, the first thing is how much it costs. They do not talk about quality of life.” 
 
Socio-economic and educational status: 
R: “The level of understanding and education, it is very different among 
patients. Dr [X] has worked in a centre where the financial status of the patients 
was very different, so I am sure he has a prospective of that, compared to this 
hospital where we see more of humble background patients.”  
 
R: “You know, lot of patients are not educated. They do not understand what is 
happening.  In fact, they do not know what is happening with them.”  
 
Clinician and patient knowledge: 
R: “So, to involve them, you know, you can make a decision if you have 
knowledge. We see some patients who do extensive internet search, come to 
us and seek treatment. That may or may not be the right treatment for them. If 
somebody does not have the knowledge, it is very difficult to make the patient 
understand the whole process.” 
 
R: “I am talking about patients’ knowledge. See, day before yesterday I saw one 
patient, a man working at a senior position in IT Company, somewhere in his 
50s, came to me with his wife’s records. She had recurrent astrocytoma grade 
3, operated one year back. She did not receive any radiotherapy, because his 
uncle told him that radiotherapy will disfigure her.”   
 
Family and social support:  
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R: “They do not understand what is happening with them. There is a decision 
maker in the family who takes all the decision.” 
  
R: “Sometime I do not communicate everything to the patients; difference being 
family psychology in India is different from UK.” 
  
R: “Here sometimes, there is one leader in the family, or we might talk to that 
particular person and then they will communicate gradually to the patients. So, 
we may not deliver everything to the patient. The family network is very, very 
strong in India.”  
 
Information technology: 
R: “They could do internet search. Most of the search is done on websites like 
Google, which will not give you what is the best therapeutic option for the 
patient. It will just give some kind of a treatment and majority of the patients 
come with treatment options which are not actually significant.” 
 
R: “We see a lot of patients who come [asking for] interesting drugs or 
techniques which are in phase 1 and phase 2 trials, because that is what forms 
headlines in newspapers or articles. So, we always face this problem.”  
 
R: “We did try to divert them to more reliable sites. We offered them what we 
have.” 
 
Analysis of multidisciplinary team/tumour board meetings:  
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R: “I think that it is the rule for the Tumour Board to make the right decision. Of 
course, the patient has choices to schedule the treatment.”  
 
Patient advocate:  
R: “As a clinician, we have a tradition of making the right decision for the 
patient.” 
 
R: “The ultimate aim of the clinician is to work for the patient, but at the same 
time, it is our job to make right decision.”  
 
Communication with patients/risk communication:  
R: “We fight for the patient, we try to bring the family and discuss in detail, and 
communication can be a problem.”  
 
R: “Let’s say that, I have a break in my communication, sometimes you do not 
gel well with the patient, and then I feel that you should seek a colleague’s 
help.”  
R: “I think that we cannot ask the nurse to communicate for you.” 
R: “But, we cannot delegate a nurse to communicate fully, that is not we are 
working for. We should make time for communication with patients.” 
   
R: “In fact, the initial communication is the key, you can step aside after the 
treatment is initiated, but if the initial communication is lacking, I think there is a 
major error.” 
 
R: “If time is an issue, increase the manpower.” 
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R: “Nurses in the UK know the patient very well, but some patients need things 
to be told 10 times for them to remember. That is where those nurses kick up 
that extra number of conversations.”  
 
R: “I will say what the expected complications or sequela of the treatment are.”  
 
Nurses:  
R: “In India, the role of nurses in communication with regard to the cancer care 
is minimal. Most of it is done by the clinicians.” 
 
R: “I think that we cannot ask the nurse to communicate for you.” 
 
R: “But, we cannot delegate nurses to communicate fully. That is not we are 
working for.” 
R: “Nurses in the UK know the patient very well, but some patients need things 
to be told 10 times for them to remember. That is where those nurses kick up 
that extra number of conversations.” 
 
Medical social workers:  
R: “Medical social worker, he plays the same role in communication as a 
specialist nurse practitioner. His background is science graduate, he has done a 
Masters in medical social work, and when they, he/she, comes to us, he may 
not have much experience in cancer, and they sit with us in the Tumour Board 
meetings, and learn what is necessary.”  
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Sharing and support: 
R: “We do not have, but we are trying to develop patient support groups.” 
 
Patient voice:  
R: “I think we need the patient voice to say what is important.” 
 
Individualisation of treatment:  
R: “We have to individualize treatment.”  
 
Consent: 
R: “The consent process is not very, very strict. We would tell everything, but 
we do not write down all the possible complications. I heard [that in the] US that 
they write down every possible individualized consent form, write everything 
possible. You can imagine that consent form.”  
 
R: “That will protect you, medico-legally to certain extent.” 
 
Discussion:  
There is some literature available on the delivery of pain relief and palliative 
care in developing countries, but very little data on decision making. A search of 
the literature revealed a number of ethical dilemmas and challenges that 
professionals, cancer patients, and their families encountered during palliative 
care. It was noted that patients' preferences and decisions are influenced by 
family members (169). When making decisions, it is important that patients’ 
views are taken into account, in addition to their level of knowledge and 
demands.  
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Patient choice has not developed to any large extent in the developing world. 
This is due to a number of factors, including cost and affordability, illiteracy, 
tradition, and lack of awareness. There is also a spiritual aspect in the decision 
making process. There does not seem to be much of an emphasis on quality of 
life. 
 
There has been an enormous amount of discussion about the redundant 
information available on the internet, especially on search engines such as 
Google. The consensus is that most of the available information is unreliable, 
and it is important for the care providing clinicians to direct patients to 
appropriately reliable speciality websites, and web publications from the 
relevant medical societies (such as ASCRS, ACPGBI, BASO, ASGBI.)  
 
Evaluation of the quality of multidisciplinary team Tumour board decision-
making is important. The proportions of decisions implemented are grossly 
unknown. One such study was from Wood et al, a group in Bristol who 
evaluated the treatment decisions of the colorectal cancer multidisciplinary team 
(168). This study examined multidisciplinary team decision-making by studying 
whether multidisciplinary team treatment decisions were implemented, and 
investigated the reasons why some decisions changed after the meeting. The 
vast majority of colorectal multidisciplinary team decisions were implemented, 
and when decisions changed, it was mostly because of patient factors that had 
not been taken into account. This raises the question whether involvement of 
patients in the multidisciplinary team process would help with better decision 
making. 
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Attitudes of clinicians differ towards the nurses with respect to the roles they 
can undertake in the developing world. In the western world, nurses are in the 
forefront of patient care. This does not seem to be the case in the developing 
world. Some of the responsibilities of the specialist nurses are undertaken by 
the medical social workers. Medical social work is a sub-discipline of social 
work, also known as hospital social work. Medical social workers typically work 
in a hospital, skilled nursing facility, or hospice, have a graduate degree in the 
field, and work with patients and their families in need of psychosocial help. 
Medical social workers assess the psychosocial functioning of patients and 
families, and intervene as necessary. Interventions may include connecting 
patients and families to necessary resources and supports in the community, 
providing psychotherapy, supportive counselling, or grief counselling, or helping 
a patient to expand and strengthen their network of social supports. Medical 
social workers typically work on an interdisciplinary team with professionals of 
other disciplines (such as medicine, nursing, physical, occupational, speech, 
and recreational therapy). 
 
Bias reducing factors: To overcome bias that may be associated with 
gathering data, a second moderator was involved in the focus group discussion. 
The second moderator also took part in thematically analyzing the qualitative 
data, to help overcome bias. The themes and outcomes from both researchers 
were compared to derive reoccurring themes and outcomes. 
 
Conclusions:  
Decision making in cancer care is a complex physical and cognitive process 
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based on evidence, patient needs, clinician experience, judgement, and patient 
preference. In India (a developing country), evidence based patient choice 
(EBPC) has not developed to a large extent, when compared to the western 
world. Decisions seem to be predominantly clinician led. Attitudes of clinicians 
differ towards the role of nurses. There is not much of an emphasis on quality of 
life, and there is a clear need for patient groups and a patient voice. In the future, 
patients should have increased involvement in decisions made about them. The 
process of decision making is slowly evolving, and will see metamorphosis in 
future. It is important for the clinicians and nurses to play a role leading to this 
change. Decision making has to be handled delicately and sensitively in cancer 
care, within the framework of the traditions and culture of the society and financial 
constraints.  
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12.5 a. 4: Decision making in surgery and cancer care – A comparative 
analysis between England, Wales and India. 
 
Healthcare is in a rapid globalisation phase. As a result,  it is imperative to look 
into the decision making process in the developed, developing, and the 
underdeveloped world. From the focus group discussions in the developed and 
the developing world, there were interesting diverging and converging themes. 
Table 20 and Chart 1 illustrate this. There has been increased activity with 
respect to decision making all around the world. Pope, from the Health law 
institute in Delaware, USA, in his article ‘Legal briefing: informed consent’ 
highlights the importance of shared decision making (170). The findings from 
the study presented here suggest that the majority in the developed world are in 
favour of joint decision making, although for a small minority there is a 
significant element of patient decision making in surgery and cancer care. In 
comparison, the study from India indicates that, in a majority, it is the clinicians 
who lead the decision making.  
 
Table 20. Converging and diverging themes between developed and 
developing countries. 
CONVERGENT THEMES DIVERGENT THEMES 
Patient factors 
Patient individuality Cost and affordability 
Educational, socioeconomic and 
cultural factors 
Patient choice  
Patient empowerment Trust and beliefs 
 Role of family members in DM 
 Less emphasis on quality of life 
 Lack of patient voice/groups 
Clinician & clinical factors 
Evidence based clinical practice Demand for good/famous clinicians 
Clinician knowledge Alternate forms of medicine 
Information and consent Low emphasis on consent 
Risk and communication (training)  
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Steering decision making process  
Patient advocate  
Information technology  
Nursing care 
Continuity of care and support Role of psychosocial workers 
Providing help when required No role of specialist nurses 
 
The common convergent themes were patient Individuality, patient 
empowerment, and educational, socioeconomic, and cultural factors. Themes 
related to clinician and clinical factors included evidence based clinical practice, 
clinician knowledge, information and consent, risk communication, steering 
decision making process, patient advocacy and information technology. 
Continuity of care and support, and providing help when required are two of the 
nursing care related themes. 
 
The divergent themes included cost and affordability, patient choice, trust and 
beliefs, the role of family members in decision making, decreased emphasis on 
quality of life, and a lack of patient voice/groups. Demand for good/famous 
clinicians, alternate forms of medicine, and decreased emphasis on consent, 
are some of the clinician related divergent themes. The role of psychosocial 
workers, and the lack of specialist nurses, were the nursing related divergent 
themes. 
The derived outcomes included: increase the evidence base, clinician and 
patient knowledge; provide adequate information, tailor information to patients 
needs, and direct them to evidence based, reliable, specialty based websites. It 
is important to take patient’s views, knowledge and demands into consideration. 
Risk should be communicated in an understandable manner, including the 
consenting process, and risk communication training should be given to 
clinicians. Individualized decisions should be taken based on patient factors and 
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best interests. Continuing care, and support with the decision making process 
should be provided, and help should be made available when required. From a 
perspective of a developing country, the outcomes in addition to the above 
included changing role of the government from being a health care provider to 
health care insurer, increasing awareness of health outcome measures, 
respecting patient choice/demands/trust and beliefs, and encourage patient 
groups/voice.  
Conclusion:  
Decision making in cancer care is a complex physical and cognitive process 
based on the evidence base, patient needs, clinician experience, judgment and 
patient preference. Patient decision making in cancer care is slowly evolving in 
England. Time is a factor and in the future, patients will play an increased role in 
choosing their treatments, taking into account tradeoffs and risks between 
survival and quality of life.  
In Wales, the focus group discussions demonstrate the importance of the 
members of the multidisciplinary team in the decision making process for an 
individual patient, with a drive towards joint decision making. In the future, 
patients will probably have an increased involvement and role within the 
multidisciplinary team setting, when decisions are made about them.  
In India (a developing country), evidence based clinical practice has not 
developed to a large extent, when compared to the western world. Decisions 
seem to be predominantly clinician led. Attitudes of clinicians differ towards the 
role of nurses. There is not much of an emphasis on quality of life and there is a 
need for patient groups/patient voice. In the future, patients will have an 
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increased involvement/role within the multidisciplinary team setting. The 
process of decision making is slowly evolving and will see metamorphosis in 
future. It is important for clinicians and nurses to play a role leading to this 
change. 
Discussion:  
There are a number of reasons for the variation seen amongst the clinicians in 
England, Wales, and India. The majority of the differences are due to the socio-
economic variation. There are certainly lessons to be learnt from the 
comparison.  
In Indian, trust and beliefs play a significant role in decision making. The 
background to this could be because of the role of alternative medicines in 
India. In Western culture, ‘alternative medicine’ is any healing practice ‘that 
does not fall within the realm of conventional medicine’ (176). The 
American National Centre for Complementary and Alternative 
Medicine (NCCAM) cites examples including naturopathy, chiropractic 
medicine, herbalism, traditional Chinese medicine, Ayurveda, 
meditation, yoga, biofeedback, hypnosis, homeopathy, acupuncture, 
and nutritional-based therapies, in addition to a range of other practices (171) . 
A 1998 systematic review of studies assessing its prevalence in 13 countries 
concluded that about 31% of cancer patients use some form of complementary 
and alternative medicine (172).  
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12. 5 b National questionnaire survey of the members of the ACPGBI after 
the Preliminary results of the MRC CR07/NCIC CO16 randomised trial  
 
How do we manage early rectal cancer? A National Questionnaire survey 
among members of the ACPGBI after the Preliminary results of the MRC 
CR07/NCIC CO16 randomised trial. 
 
Introduction:  
Colorectal cancer is the second most common cause of death from malignant 
disease in the United Kingdom, with about 20,000 deaths each year. Around 
one million new cases (9% of all cancers) are diagnosed each year worldwide 
(173).  As the UK population ages, the incidence is predicted to rise. The current 
gold standard treatment is surgical resection of the primary tumour. Reported 
recurrence rates following surgical resection of rectal cancer vary widely from 
3–50% (174) (175). It is well accepted that involvement of the circumferential 
resection margin predicts a high rate of local recurrence.  
 
Improvement in the surgical technique (176) and delivery of radiotherapy (177), 
(178), (179) are proving to be of benefit in terms of local control and prevention 
of local recurrence . The benefit of neo-adjuvant short course radiotherapy is 
currently the subject of considerable international debate (180). 
 
Although low rates of local recurrence have been reported following total 
mesorectal excision alone, increasingly, a number of randomised controlled 
trials have demonstrated improved 5 year disease free and overall survival for 
pre-operative radiotherapy, compared to post operative regimes (181), (182), 
(183) . Nevertheless, there remains a wide variation in the use of radiotherapy 
throughout the UK (184) .  
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Increasingly, a number of RCTs have favoured preoperative over post-operative 
radiotherapy in reducing the local reoccurrence (185), (186), (187).  In the 
absence of a clear consensus with regard to use of neo-adjuvant radiotherapy, 
the CRO7 trial was set up and funded by the Medical Research Council.           
The CRO7 trial included all patients with operable adenocarcinoma of the 
rectum <15 cm from the anal verge, with no metastases. Patients were 
randomized either to receive pre-operative RT 25 Gy in 5 fractions, followed by 
surgery or surgery with use of adjuvant chemo radiotherapy, should the 
circumferential margin be positive on pathological examination of the resected 
specimen. Both groups received adjuvant chemotherapy according to local 
policy. 
 
The preliminary results from the trial demonstrated that patients with resectable 
tumours benefited from preoperative radiotherapy whatever the stage and 
position of the cancer (188), in terms of both local recurrence and disease free 
survival . 
                     
 In the light of these preliminary results, a national questionnaire survey to 
assess the current pattern of practice in the UK was undertaken by the author. 
The aim of this study was to determine any change in current practice 
consequent to the early dissemination of the trial data, in advance of the 
publication of the full paper. 
 
Materials and methods: A national questionnaire survey amongst the 
Association of Coloproctology of Great Britain and Ireland (ACPGBI) members. 
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The ACPGBI is the sub-specialty association for colorectal surgery in the UK. A 
specifically designed postal questionnaire was distributed among all 400 active 
consultant members of the ACPGBI. This is a 14-item questionnaire enquiring 
on clinical management of operable rectal cancers, use of neo-adjuvant short 
course radiotherapy, and the influence of preliminary results of CRO7 on their 
practice (see questionnaire in Appendix 2). The questionnaire, along with a 
personalized covering letter and a self addressed stamped envelope were 
posted. No reminders were sent for unreplied questionnaires. All the 
questionnaires were anonymised. The questionnaire was developed using 
expert opinions in the field of colorectal surgery, and was internally validated 
amongst the members of the academic surgical unit at Hull. 
 
Results:  
Of 400 questionnaires, 200 (50%) were returned fully completed. 166(83%) of 
surgeons did not routinely use neo-adjuvant short course radiotherapy 
(NASCRT) in clinically operable rectal cancers (T1/T2) <15cm from anal verge 
with no metastases (the CR07 eligible cohort). Sixty-four (32%) used NASCRT 
for T3 cancers routinely, whereas 76(38%) used neo-adjuvant long course 
radiotherapy instead. 
One hundred and fifty-six (78%) of the surgeons felt the height of the tumour 
from the anal verge influenced their decision on NASCRT, while 104(52%) felt 
position was important (anterior/posterior). Positive circumferential resection 
margin (CRM) on MRI was a deciding factor for 185(92.5%) of surgeons in 
favour of neo-adjuvant therapy. Post-operatively in patients who have not had 
pre-operative radiotherapy, 154(77%) recommended radiotherapy, and 
155(77.5%) recommended chemotherapy if the CRM was positive on final 
pathology. 
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Seventy-eight (39%) of the surgeons had changed their practice after the 
preliminary results of the CRO7 were published, by adopting neo-adjuvant short 
course radiotherapy for treating early rectal cancers.  
 
There is significant variation in the treatment of patients who have had pre-operative 
short course radio-therapy and those who, post-operatively, have CRM involvement. 
Ninety-four (47%) of the surgeons opted for post operative adjuvant chemotherapy, 
while 24 (12%) chose either radiotherapy or chemo- radiotherapy. Ten (5%) of the 
surgeons decided to follow up the patient with ‘watchful waiting’. 
For patients who had preoperative long course radiotherapy, 145 (72.5%) of 
surgeons used post operative chemotherapy, while 6 (3%) opted for either 
radiotherapy or chemo-radio therapy. Nineteen (9.5%) of the surgeons preferred a 
wait and watch policy. 
For 143(71.5%) of the surgeons, chemotherapy was predominantly directed solely 
by oncologists, while joint decisions through multidisciplinary teams accounted for 
the remaining 52 (26%). No surgeon made a sole decision regarding adjuvant 
chemotherapy. The choice of the chemotherapeutic agent varied but was largely 5 
FU based regimens, followed by Oxaliplatin and Capecitabine. 
 
Qualitative methodology was adopted to analyze the comments section. Out of 
200 fully completed questionnaires, only 52 (26%) of surgeons completed the 
comments section. A number of themes emerged from thematic analysis. These 
included:  
§ Difficult treatment group, 
§  Individualizing treatment (no one size fits all) 
§ Concerns about radiotherapy 
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§ Service provisions 
§ Role of the multidisciplinary team 
§ Need for full evidence 
§ Lack of awareness of the evidence 
§ Role of uniform protocols and guidelines 
§ Lack of consensus amongst surgeons, oncologists and radiotherapists 
§ Slowly emerging consensus, and,  
§ Delay in implementation of evidence based practice. 
 
 
Discussion: 
The CRO7 trial was set up with the objective of evaluating the effect of 
preoperative short course radiotherapy on operable rectal cancers. The trial 
involved 69 centers in the United Kingdom, nine in Canada, and one each in 
South Africa and New Zealand. The early data has been presented at a number 
of international and UK scientific meetings and published in abstract form only.    
The preliminary results showed that pre-operative short course radiotherapy in 
patients with operable rectal cancer resulted in a lower rate of local recurrence 
than selective pathology guided postoperative chemo radiotherapy. Patients 
with resectable tumors benefited from preoperative radiotherapy whatever the 
size (T stage) and position of the cancer, or the quality of the excision (TME) 
(188). Quality of surgical removal (TME grade) was directly related to the risk of 
recurrence. Combining preoperative radiotherapy with the ‘best surgery’ 
reduced the risk of recurrence of tumors to 1%.  
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The trial found that preoperative radiotherapy improves three year survival. The 
rate of pelvic recurrence after five years was 5% in the preoperative treatment 
group, across all qualities of surgery, and 17% in the postoperative group. The 
probability of disease free survival at five years was 75% for those who were 
treated pre-operatively and 67% for those treated postoperatively.  
The MRC CRO7 was designed in 1997, before the wide availability of MRI for 
staging rectal cancer. Studies suggest that high resolution magnetic resonance 
imaging could predict tumour at the potential circumferential resection margin if 
the tumour was within 1mm of the mesorectal fascia on the scan(189), (190), 
(191). Studies by the MERCURY group suggest high resolution magnetic 
resonance imaging can accurately predict the surgical resection margin, thus 
potentially enabling selection of patients for preoperative treatment (192). In the 
study discussed here, positive CRM on MRI was a deciding factor for 185 
(92.5%) of surgeons in favour of neo-adjuvant therapy and MRI will be a major 
influence on the choice of patients for NASCRT. 
 
In the current survey, the response rate was 50%. Some of the factors that may 
have influenced the high rate of return are the personalized covering letter and 
self-addressed envelope (198). 
The results from this survey demonstrate a highly variable approach to the use 
of radiotherapy across the UK, in many instances showing a certain reluctance 
to adopt evidence based practice. Perhaps when the mature trial data is 
available, more surgeons would be willing to utilize routine use of SCNART, and 
a further survey of practice may be warranted after that time. However, the 
survey does demonstrate that almost 40% of surgeons have already altered 
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their practice before the publication of full trial data. It is believed that this figure 
will likely rise even further at that time. 
There are many barriers to evidence based clinical practice. One of them is 
adopting research findings into practice (193).  
 
While this national survey among members of the ACPGBI does show delay in 
implementing evidence based clinical practice based on previously published 
data, the results suggest that the MRC trial has already had an impact on 
clinical practice in the UK.  
Conclusion: Even though the CR07 data has yet to be published in full paper 
format, 39% of surgeons have already altered their treatment policies, 
suggesting that RCT data of sufficient quality does influence surgical practice. 
However, the mature trial data are yet to be published, and a further survey of 
practice is warranted after that publication. CR07 is likely to result in 
fundamental changes to the management of rectal cancer in the UK. 
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 12.5 c: Qualitative analysis of the National questionnaire survey on CRO7 
results. 
Introduction: 
A consensus has not yet been reached on the role of neo-adjuvant therapy in 
the management of rectal cancers in colorectal surgical practice. In the light of 
the preliminary results of the CRO7 trial, a national questionnaire survey was 
undertaken to assess the current pattern of practice in the UK. The results 
suggested that despite the evidence of the CRO7 trial supporting the use of 
NASCRT for operable rectal cancer, approximately two-third of consultant 
surgeons in the UK have yet to implement this treatment regime routinely. 
However, 39% of surgeons have changed their practice following the early 
dissemination of trial results (194). 
 
Change in clinical practice is driven by a number of factors (195), (196) . 
Available data is one of them, but may not be the most important factor (197).   
 
Aim: The aim was to explore factors driving change in clinical practice, using 
the context of radiotherapy in rectal cancer. This study aimed to consider why 
some clinicians adopt change while others do not. It considered whether 
change in practice is only guided by scientific evidence, or whether there might 
be other factors which influence change. 
 
 Materials and methods: The study used a national questionnaire survey of 
the ACPGBI members. A specifically designed postal questionnaire was 
distributed among all 400 active consultant members of the ACPGBI. This was 
a 14-item questionnaire asking about the clinical management of operable 
rectal cancers, and a separate question allowed for comments, suggestions and 
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thoughts about the issue. Details of the active members of the ACPGBI were 
gathered from the association’s database. A questionnaire, along with a 
personalized covering letter and a self-addressed stamped envelope were 
posted during the beginning of the week using second class postage. No 
reminders were sent. All the questionnaires were anonymised. Qualitative data 
for this article has been drawn from a subset of results analyzing the comments 
section of the questionnaire. Qualitative methodology was adopted to analyze 
the qualitative data to derive themes and outcomes. 
 
Results:  
Of 400 questionnaires, 200 (50%) were returned completed. Of these, only 52 
(26%) of surgeons completed the comments section. Qualitative methodology 
was adopted to analyze the comments section. Themes that emerged from 
thematic analysis are patient groups, treatment, evidence based practice, 
professional consensus, and service provisions. The outcomes carved out are 
to individualize treatment, difficult elderly treatment group, provide safer and 
less harmful treatment due to the complications associated with radiotherapy, 
increase role of multidisciplinary teams to overcome lack of consensus, 
increase awareness of the current evidence based literature to address the 
existing weakness in evidence based practice, develop protocols and 
guidelines, and shorten the delay in implementing evidence based practice. 
Service provisions, infrastructure and resource availability should also be 
improved. 
Some of factors responsible for change in the clinical practice are clinical 
decision making (patient groups, treatment, and professional consensus), 
evidence based practice/education, research translation, organizational factors, 
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and infrastructure / resources. Some of them are being elaborated using 
quotations. 
 
 
Clinical decision making (patient groups, treatment, and professional 
consensus).  
 
Patient groups: The general consensus was to tailor the treatment to individual 
patient need, rather than taking a blanket approach.  
 
R1: “Always remember to treat a patient as an individual, especially with an 
ageing population.” 
 
R21: “Individualise management, but adjuvant therapies are probably over 
used.” 
 
Treatment: Various factors such as age, co-morbidities, functional outcome, 
and complications associated with the treatment, should be considered before 
treating. 
 
R37: “The treatment of rectal cancer is complicated and there is ‘No one size 
fits all’. Very low recurrence and excellent long term survival is possible with a 
tailored approach.” 
 
R18: “Increased likelihood to offer SC pre-op DXT to T1/T2, but still concerns 
overall about post treatment morbidity.” 
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R36: “I think that the functional morbidity of both short and long course pre-op 
radiotherapy has been underestimated.” 
 
Professional Consensus: Lack of professional consensus and the role of 
multidisciplinary teams were highlighted. 
 
R7: “A lot of management is decided by clinical oncologists these days.” 
 
R31: “Would prefer to use long course RT in all T3 cancers,(whenever RT 
indicated, but radiotherapy department still feels evidence not conclusive for 
proven benefit.” 
 
R43: “CRO7 has changed our multidisciplinary team practice with mid and low 
rectal cancers.” 
 
R44: “All decisions are joint with oncologists in the multidisciplinary team on, an 
individual patient basis.”  
 
R51: “DXT for rectal cancer, has been confusing, of late, I believe a consensus 
is however, beginning to emerge.” 
 
Evidence based practice/education:  There is a gradually evolving evidence 
base. Though one third of the clinician population has changed their clinical 
practice based on the preliminary results, the majority of them are waiting to see 
the full publication. 
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R12: “Our local Network Site Specific Groups (NSSG) is waiting to see the full 
CRO7 publication before changing practice.” 
 
R13: “CRO7 has turned practice on its head.” 
 
R17: “Still awaiting full backup of CRO7.” 
 
R25: “We are about to discuss practice following CRO7 results.” 
 
R32: “Policy changed in September 06 to reflect preliminary CRO7 figures.” 
 
R37: “The CRO7 results are interesting, but already historical.” 
 
R45: “We all know the results are but slow to act on them.” 
 
R46: “Would be useful to know CRO7 results.” 
 
Research translation: The consultants are in various stages  of implementing 
research findings into clinical practice.  
 
R48: “CRO7 being discussed and network guidelines being 
changed/formulated.” 
 
R52: “CRO7 may change my practice when full information is available in a 
peer reviewed publication”. 
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Organisational factors and infrastructure/service provisions: Lack of 
adequate infrastructure and resources necessary for providing radiotherapy 
services is certainly an issue. 
 
R4: “Difficult to arrange for pre-operative neo-adjuvant DXT due to the fact that 
[location] is isolated, and it is difficult to arrange travel for patients to UK.” 
 
Discussion: The preliminary results of CRO7, a large international RCT 
showed that ’patients with resectable tumours benefited from preoperative 
radiotherapy whatever the stage and position of the cancer, in terms of both 
local recurrence and disease free survival’ (198). The preliminary results 
concluded by saying further follow up is required to determine any difference 
in overall survival. Data suggests that meticulous surgery alone in favourable 
tumours is not enough. The CRO7 trial is a large international RCT which 
suggested that most patients should receive preoperative RT of some form - 
short course/long course. The trial indicated a need for much wider use of 
short course radiotherapy.  
 
A national questionnaire survey was undertaken to explore the current pattern 
of practice in the UK and to see if clinical practice had changed from the time 
the trial was set up to the dissemination of preliminary results as oral 
presentations and abstracts, awaiting full publication. The results demonstrated 
that 78 (39%) changed practice (194). 
 
Change in clinical practice is driven by a number of factors (195), (196) . 
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Available data is one of them, although it may not be the most significant one 
though (197). Thus, it was desirable that the factors driving current practice and 
the ones influencing change in practice should be explored. 
  
In the current survey, given that no reminders were sent, the return rate was 
50%. Although the return rate was reasonable, the number of respondents who 
answered the comments section was low, at 52 (26%). 
The data was analysed using a qualitative approach. Qualitative analysis is a 
systematic process by which data is analysed to derive the most commonly 
reoccurring concepts, called themes. The solutions carved out of this data are 
outcomes. Five themes were consistently derived from the comments section of 
the questionnaire. Each theme produced outcomes, sometimes one, and 
sometimes more than one.  
 
Use of radiotherapy, as well as timing, is a highly contentious issue in the 
management of rectal cancer. The survey results demonstrate highly variable 
approaches to the use of radiotherapy across the UK, in many instances 
showing a certain reluctance to adopt evidence based practice. Analysis of the 
qualitative data illuminates factors influencing changes in clinical practice. Some 
of them include the non-availability of the mature trial data, barriers to evidence 
based clinical practice as defined by Haynes et al (193), inadequacy of 
infrastructure and resources, lack of evidence based practice/education, and 
inappropriate clinical decision making. 
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Perhaps when the mature trial data is available, more surgeons would be willing 
to utilize routine short course neo-adjuvant radiotherapy, and a further survey of 
practice may be warranted after that time. 
There are many barriers to evidence based clinical practice. One of them is 
adopting research findings into practice. This gap needs to be bridged. It is vital 
to not only extract the evidence from research, but also to encourage early 
adoption of it in clinical practice. Haynes et al (193) described the problems in 
implementing evidence based medicine, and suggested possible solutions. 
Some of the important solutions are: to integrate current best evidence from 
research with clinical policy and practice, to use new evidence based services 
to access current best evidence, and ensure that evidence and policy are 
applied at the right time. 
Working through the various stages of generating evidence from research to 
making clinical decisions, numerous issues have to be addressed. Some of 
them are issues relating to the synthesis of the evidence (COCHRANE Library), 
creating evidence based clinical policies (development of guidelines), and 
applying evidence based policy into practice. What is noted in the current study 
is that clinicians are at various phases for research translation, beginning with 
some who are unaware of the results, all the way through to some who have 
already implemented the change. 
While making clinical decisions the clinician has to take into consideration, 
along with the evidence, the patient’s wishes and circumstances. Other factors 
that might play a role are organizational factors, infrastructure and resources. 
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Our national questionnaire survey among members of the ACPGBI after the 
preliminary results of the MRC CR07/NCIC CO16 randomised trial does show 
delay in implementing evidence based clinical practice in two thirds of the 
surveyed consultant surgeons. A possible reason for this is that the evidence 
generated is going through the phase of synthesizing the evidence and creating 
evidence based clinical policies, along with other contributing factors 
responsible for change in practice.  
Allery et al (195) showed that doctors recognise organisational factors, 
education, and contact with other professionals as influential in changing their 
clinical practice . Education formed a major component, providing one sixth of 
the reasons for change, and was involved in one third of the changes. The 
average number of reasons per change was three. 
Quantitative studies have provided objective evidence of the effectiveness of 
continuing medical education programmes in changing physician performance 
or health care (199), (200), (201), (202). 
Wergin et al believe that the impact of continuing education can be understood 
only within the context of other important intervening variables (203). Graham 
has emphasized the importance of researching the beliefs of clinicians, if 
strategies to influence doctors’ behaviour are to succeed (204). 
Studies have shown that nearly all changes in doctors' clinical behaviour are 
due to a combination of factors (195). Reasons for change are numerous and 
wide ranging (203), (205). 
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Kerr et al found that for consultants, the two most frequently mentioned 
educational reasons for change were reading medical journals and 
correspondence, and attending scientific meetings (206).  
Limitations: Being a questionnaire study, the return rate was reasonable at 
50%; however the number of responses for the comments section was only 52 
(26%). It is possible that reminders would have helped provide a better 
response rate (207). Studies have shown that response rates with questionnaire 
studies are in the range of 50–55% for medical questionnaires (208). 
Nevertheless, the qualitative nature of the study leads to early saturation of 
themes and outcomes.  
Conclusion: Change in clinical practice in the context of use of radiotherapy in 
rectal cancer is due to a combination of factors. The reasons for change were 
numerous and wide ranging. Some of them include: 
Clinical decision making: It is vital to provide safe and less harmful treatment, 
where possible. There is a need to increase the role of multidisciplinary teams, 
and adopt a tailored approach based on individual patient needs. 
 
Evidence based practice/education: There is a strong feeling among the 
consultants that they wish to view the CR07 data in full paper format, before they 
can adopt change. There is also the need to increase awareness of the current 
evidence based literature. 
 
Organizational factors, infrastructure and resources: Improvement of service 
provisions is necessary. 
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Translation of research evidence to clinical practice: It is necessary to 
overcome the barriers to evidence based practice by synthesizing available 
research evidence, developing protocols and guidelines, along with shortening 
the delay in implementing evidence based practice. 
 
In conclusion, change is a slow and complex process influenced not only by 
data and scientific evidence, but by a number of other factors. Some of the 
above conclusions will aid the policy makers and opinion leaders in the NHS.  
 
Future: It is intended to repeat the survey following a full publication of the 
CRO7 trial, and compare the results with this baseline survey.
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12.5 d: Thrombo-prophylaxis in colorectal surgery : A NQS of ACPGBI 
members 
Thrombo-Prophylaxis (TP) In Colo-Rectal Surgery: A National Questionnaire 
Survey of the Members of the ACPGBI 
 
Introduction:  
Colorectal cancer is the second most common cause of death from malignant 
disease in the United Kingdom (173). There are approximately 30,000 new 
cases and 20,000 deaths per year in the England and Wales (209). As the UK 
population ages the incidence is predicted to rise. 
 
Venous thromboembolism associated with malignancy reduces survival (210), 
(211). Pulmonary embolism is the second most common cause of death in 
patients with cancer (212), (213), (214), (215). Post operatively, deep vein 
thrombosis (DVT) and pulmonary embolism are twice and thrice more common 
respectively, in cancer patients compared to the ones operated for benign 
causes (210). Post-operation DVT prevalence in colorectal surgery is estimated 
to be around 20% (216) . Surgery on cancer patients is a significant risk factor 
for thrombosis. This could be attributed to disruption of Virchow’s triad, with 
prolonged immobilisation etc. Although the rate of prevalence of pre-operative 
DVT is unknown, it certainly is a risk factor for pulmonary embolism post 
operatively.  
 
There is no doubt that a standardised thrombo-prophylaxis is vital in this group 
of patients undergoing surgery. Anecdotal evidence suggests that there is a 
lack of standardisation and uniformity in thrombo-prophylaxis practice in the UK. 
A national survey aiming to assess the current practice amongst the active 
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consultant members of the ACPGBI was undertaken to evaluate whether there 
is any uniformity in the post-operative thrombo-prophylaxis practice in colorectal 
surgery, and whether this practice is based on the available guidelines from 
ACPGBI and NICE.  
 
ACPGBI guidelines from 2007 state that a combination of graduated 
compression stockings and heparin should be used for thrombo-prophylaxis 
for patients undergoing colorectal surgery (217). NICE recommends that 
patients having general surgery with one or more risk factors for venous 
thromboembolism should be offered mechanical prophylaxis and either LMWH 
or fondaparinux (218).  
 
A national questionnaire survey aiming to assess the current pattern of 
thrombo-prophylaxis in post operative major colorectal surgical practice in the 
UK was undertaken, and the results compared with the available guidelines 
from ACPGBI and NICE. 
 
Materials and methods: A national questionnaire survey of the ACPGBI 
members was carried out. A specifically designed postal questionnaire was 
distributed among all 490 active consultant surgical members of the ACPGBI. 
This is a 10 item questionnaire enquiring into the current management strategy 
of post-operative thrombo-prophylaxis in colorectal surgery, and evaluates the 
influence of recent post-operative thrombo-prophylaxis guidelines from ACPGBI 
and NICE (see Appendix 3). The questionnaire, along with a personalized 
covering letter and a self addressed stamped envelope were posted during the 
beginning of the week using second class postage. No reminders were sent. 
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The data was anonymised prior to dissemination. The questionnaire was 
developed based on common strategies of thrombo-prophylaxis in practice. It 
had expert input and was validated amongst the members of the academic 
surgical unit. 
 
Results: Of 490 questionnaires, 259 (52.8 %) were returned fully completed. 
243(93.8%) of surgeons used departmental guidelines for thrombo-prophylaxis 
in colorectal surgery. All 259 (100%) of them routinely used thrombo-
prophylaxis. The majority of them used combined chemo and mechanical 
prophylaxis at 247 (95.40%), while 12 (4.6%) used chemo-prophylaxis only.  
As a chemotherapeutic agent of choice, the majority of them opted for LMWH at 
243 (93.8%), whilst 9 (3.5%) chose UFH. The time of starting chemo-
prophylaxis varied amongst surgeons - 176 (68%) started chemo-prophylaxis 
on admission, 22 (8.5%) on induction, 38 (14.7%) 6 hrs post-operatively and 6 
(2.3%) 24 hrs post-operatively. The majority of them discontinued chemo-
prophylaxis upon discharge 201(77.6%), whilst 31 (12.0%) discontinued prior to 
discharge. Thirteen (5.0%) discontinued on mobilisation, whilst 4 (1.5%) 
discontinued 6 weeks following discharge. 
 
Use of combinations of agents for mechanical thrombo-prophylaxis was seen. 
154 (59.5%) used a combination of TED stockings and Flowtron boots, 10 
(3.9%) used TED stockings with foot and ankle pumps, and 9 (3.5%) used a 
combination of TED stockings, foot and ankle pumps and Flowtron boots. 
In isolation, TED stockings were used by 56 (21.6%) and Flowtron boots by 19 
(7.3%). More than half, 137 (52.9%), discontinued mechanical prophylaxis upon 
discharge, 41 (15.8%) discontinued on mobilisation. While 23 (8.9%) 
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discontinued 6 weeks after discharge, 18 (6.9%) did so prior to discharge. 
Twenty-two  (8.5%) respondents chose not to answer this question. When 
asked about recommending continuing prophylaxis after hospital discharge 71 
(27.4%) did so, whilst 178 (68%) were against it. 
 
Discussion: A large evidence base has favoured post–operative thrombo-
prophylaxis for many years, with wide international variation in the different 
approaches. 
 
In the current survey, the response rate was nearly 53%. It is believed that 
some of the factors that favoured a better return rate were the personalized 
covering letter, the inclusion of the self-addressed envelope, and the posting 
during the beginning of the week using second class postage (219). 
These results demonstrate a highly variable approach to the use of thrombo-
prophylaxis across the UK. Translation of research evidence to clinical practice 
does take time, and there are many barriers to evidence based clinical practice. 
One of them is adopting research findings into practice (193).  
 
There are recent NICE guidelines on venous thromboembolism prophylaxis. 
NICE guidelines from January 2010 (220) recommend a combined thrombo-
prophylaxis for gastro-intestinal surgical procedures with increased risk of 
venous thromboembolism and low risk of major bleeding. The mechanical 
venous thromboembolism prophylaxis should commence at admission, and 
continue until mobility is no longer significantly reduced. The mechanical 
venous thromboembolism prophylaxis includes anti-embolism stockings (thigh 
or knee length), foot impulse devices, or intermittent pneumatic compression 
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devices (thigh or knee length). For chemo-prophylaxis fondaparinux, LMWH, or 
UFH ( for renal failure patients) is recommended to be continued until mobility is 
no longer significantly reduced (generally 5–7 days). 
The current guideline also lays emphasis on patient centred care (220). The 
document states that ‘Treatment and care should take into account patients’ 
individual needs and preferences. Good communication is essential, supported 
by evidence-based information, to allow patients to reach informed decisions 
about their care. If the patient agrees, families and carers should have the 
opportunity to be involved in decisions about treatment and care’. 
  
Questionnaire: This was a simple study designed using a 10 item 
questionnaire. It inquired into the current management strategy of thrombo-
prophylaxis in colorectal surgical practice. There are limitations. It is a very short 
questionnaire with a yes/no response to many of the questions. 
It did not allow an assessment of ‘always, sometimes, occasionally, never’ for 
certain indications. Reasons were not asked as to why respondents did or did 
not use a specific agent, or what information would lead people to change 
practice. 
 
Limitations of the study:  
The study did have the limitations of a questionnaire study in that the response 
rate was only 53%. The responses may not be representative of the whole 
membership that was surveyed. Also, reminders were not sent; these could 
have improved the response rate. 
 
Conclusion: In this national survey questionnaire, a small percentage of the 
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consultants are using chemo-prophylaxis in isolation. In a majority, thrombo-
prophylaxis is not continued post-operatively for the recommended period of 
time as per guidelines. Although current thrombo-prophylaxis practice is 
acceptable, the use of available national guidelines would further improve the 
thrombo-prophylaxis practice. However, patient compliance and resources are 
factors that need consideration. 
  
Future: It would be useful to gather data pertaining to causes of cancer related 
mortality in the community. This would help in targeting thrombo-prophylaxis 
use in a better way.  
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13.0 Discussion 
 
Here is an outline of the various studies that link to the central concept of 
decision making in surgery and cancer care.  
 
A. Health outcome measures. 
12.1  Quality of life and its measurements:  
12.2 Quality of life, health-related quality of life and breast surgery:  
The background knowledge about health outcome measures and their 
applications in various sub-specialities of surgery is important in the decision 
making process in surgery. They influence care providing clinicians as well as 
the patients in the decision making process. The subsection on health outcome 
measures in reconstruction and aesthetic breast surgery would influence the 
relevant clinicians and the patients in the decision making process. 
 
B. Benign breast conditions  
12.3 a: Quality of life issues in aesthetic breast surgery : 
This section reviews studies involving health outcome measures in aesthetic 
breast surgery. The work undertaken has tried to create an awareness of health 
outcome measures in aesthetic breast surgery. This should help clinicians 
decide when and to whom to offer aesthetic procedures. It will also make them 
consider the psycho-social issues and body dysmorphic disorder before 
decision making. 
12.3 b Risk factors for complications following reduction mammoplasty:  
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Higher resect weight, increased BMI, older age, and smoking are some of the 
risk factors associated with complications in reduction mammoplasty. It is 
therefore necessary that every attempt is made to reduce modifiable risk 
factors. Patients should be adequately counselled about losing weight and 
stopping smoking. Clinical preventive services and health advocates might have 
an increased role to play in the coming future. These factors should help the 
clinicians and patients in decision making for reduction mammoplasty.  
 
 
 
12.4 . Benign colorectal conditions & quality of life 
 
12. 4 a. Rectal irrigation in the treatment of disorders of faecal continence 
Management of evacuatory disorders can be a true challenge. Reflected in this 
chapter are the generic and specific health outcome measures in relation to 
rectal irrigation in the treatment of faecal continence disorders. Rectal irrigation 
can offer symptomatic improvement to patients with faecal evacuatory disorders 
where other conservative and pharmaco-therapies have failed. Most patients 
find the treatment acceptable. This will help clinicians to provide information to 
the patients on the effectiveness and efficacy of rectal irrigation, and to make 
better decisions in the management of faecal continence disorders.  
 
12.5. Malignant Colorectal, Breast, Head and Neck conditions 
 
 
12.5 a. 1- 4 : A qualitative analysis of a focus group discussion on decision 
making in cancer care 
Qualitative research based on grounded theory was used to organise focus 
group discussion to evaluate the decision making process. This was 
undertaken amongst the care providing clinicians. The focus groups 
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discussions have added an enormous amount of information to this work. They 
enabled the identification of the various factors playing a role in decision 
making, and in particular the role of clinicians, nurses and the patients 
themselves. It was interesting to analyse what clinicians felt about patient 
decision making in surgery and cancer care.  
The generated themes and outcomes were certainly thought provoking. 
Common themes and outcomes were generated from the focus group 
discussions undertaken in England, Wales and India. Decision making in 
cancer care is a complex physical and cognitive process based on evidence, 
patient needs, clinician experience, judgement and patient preference. Patient 
views, knowledge and demands are all taken into account, along with socio-
cultural differences. In England, patient decision making in cancer care is slowly 
growing, albeit currently only occurring in a minority of cases. This minority will 
play an increased role in decision making in the future and will possibly come to 
drive decision making. Tradeoffs and risks between survival and quality of life 
will be considered in decision making in this minority.  
In the Welsh population, a drive towards joint decision making is seen. In the 
future, patients will probably have an increased involvement and role within the 
multidisciplinary setting. In contrast, the finding from India show that evidence 
based patient choice has not developed to a large extent, when compared to 
the western world. Decisions seem to be predominantly clinician led. Attitudes 
of clinicians differ towards the role of nurses. There is not much of an emphasis 
on quality of life, and there is a need for patient groups and a stronger patient 
voice.  
Globally in future, patients will probably have an increased involvement/role 
within the multidisciplinary team setting. The process of decision making is 
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slowly evolving and will see metamorphosis in future. It is important for 
clinicians and nurses to play a role leading to this change. Decision making has 
to be handled delicately and sensitively in cancer care, within the framework of 
the traditions and culture of the society, and financial constraints.  
 
Questionnaire surveys play an important role in research translation, in 
addition to assessing the current pattern of practice.  
12. 5 b – d : National questionnaire surveys of the members of the ACPGBI 
The above questionnaire surveys assessed the translational practice which is 
vital for implementation of research evidence into clinical practice. Evaluation of 
the current practice of neo-adjuvant short course radiotherapy in rectal cancer 
and thrombo-prophylaxis in colorectal surgery were undertaken. The above 
studies gave an insight into the factors delaying the implementation of evidence 
based practice. Translational research is something that should be 
concentrated on to bring change to the way we practice, taking care of other 
factors. Some of the key lessons learnt were: provide safe and less harmful 
treatment, increase the role of multidisciplinary teams, and adopt a tailored 
approach based on individual patient needs. A need to increase awareness of 
the current evidence based literature, A need to improve service provisions, and 
to overcome barriers to evidence based practice by synthesizing available 
research evidence, developing protocols and guidelines, along with shortening 
the delay in implementing evidence based practice, was highlighted. Change is 
a slow and complex process influenced not only by scientific data and scientific 
evidence, but by a number of other factors. Some of the above conclusions will 
aid policy makers and opinion leaders in the NHS. In addition, they provide 
significant help in decision making amongst clinicians.  
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Decision making in surgery and cancer care is an important, challenging field in 
its own right. Clinicians have to consider that clinical decision making is a 
complex process driven by a multitude of factors. Some of these are evidence 
based quantitative data, health outcome measures, clinician factors, patient 
factors, themes and outcomes generated from the qualitative data, translational 
factors, evidence based guidelines, feedback from audits, surveys and 
questionnaire studies, infrastructure/resources and nursing factors. Within the 
above factors, there is an extensive variability in terms of clinician knowledge, 
experience, intuition and judgement. The patient factors include education, 
patient circumstances, socio-cultural factors, trust-beliefs and patient 
preferences. Nursing colleagues not only have a role to play in communicating 
and supporting patients, but also take a role in their decision making. In 
addition, infrastructure and resources also play a role.  
Emerging models in decision making are the use of decision aids and decision 
trees. There are a number of issues that need to be addressed. Some of them 
involve education and training clinicians in the process of risk communication 
and the consenting process. Building a robust evidence base by undertaking 
good prospective studies, creating awareness of health outcome measures 
amongst clinicians, improving clinician and patient knowledge, considering 
patient factors when decision making and improving infrastructure and 
resources will assist in addressing these issues. It is very likely that the 
evidence provided here help opinion leaders and managers in the NHS to 
allocate funds and resources for better patient care. 
It is important to individualise decision making. Decision aids, decision trees, 
discharge liaison nurses and an active role by patients in the multidisciplinary 
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team process are some of the things clinicians will encounter more. Because of 
this, clinicians should act as catalysts and leaders for this improved decision 
making in surgery and cancer care.  
 
Diagram 2 illustrates the multi-factorial nature of decision making. The results of 
these studies have demonstrated that decision making does not rely just on the 
hard quantitative data, but is an amalgamation of a number of factors. This 
disproves the hypothesis that clinical decisions are not multi-factorial and are 
solely based/dependent on hard quantitative research data. The quantitative 
evidence base is only one of the factors aiding decision making. There are, as 
has been shown, a number of other factors which are less explored, yet still 
play an important role in decision making. 
 
The chapters on health outcome measures, and their relevance to oncology and 
aesthetics demonstrate their importance in decision making. The reviews and 
questionnaire studies have generated quantitative data. Focus group 
discussions have provided an enormous amount of qualitative data.  
The work undertaken has demonstrated the interplay between clinicians, 
nurses, patients and their families in the decision making process. Research 
translational factors, infrastructure and resources are other factors that play a 
role in decision making. The clinician factors (knowledge, skill, expertise, 
judgment), patient factors (socio-economic, education, cultural) and nursing 
factors all play a vital role in the whole process of decision making.  
Decision making is a dynamic process and clinicians need to understand this 
multi-factorial process well, enabling the adoption and training required to help 
patients in decision making, whilst not forgetting that the patient is at the centre 
of the whole process. 
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Diagram 2. Multifactorial nature of decision making. 
 
 
 
 
 
This work is timely in shedding light on current practice in decision making in 
surgery and cancer care, and the role patients play within this process, an issue 
that has taken a centre stage with the patient at the heart of healthcare. The 
evidence that has been generated can be used to improve the decision making 
process in everyday practice. Based on the work undertaken, it is not only 
important to generate scientific data, but also look into all the factors that have 
an impact on clinical decision making. Translational research is important for 
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implementing research evidence into clinical practice, infrastructure and 
resources need consideration, along with the continued medical education of 
clinicians, involving training on risk communication, keeping up with audit and 
research, seeking patients opinions and measuring health outcome measures. 
These should all be a part of the process in improving the decision making 
process. Healthcare is in a globalisation phase. It is important to understand 
and respect the cultural variation that exists in different parts of the world while 
decision making.  
To the best of the author’s knowledge, this study is the first to explore how 
clinical decisions are made in a developing country and to compare this process 
with the west. 
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14.0 Conclusions  
 
In conclusion, the results from our studies show that the decision making 
process is multi-factorial. Quantitative data is only a contributing factor in the 
process and it is vital that qualitative data, nursing factors, patient factors, 
translational research, health outcome measures, infrastructure and resources, 
socio-economic and cultural factors, in addition to patient preferences  are 
considered in the decision making process. Currently, in the western world, the 
majority of decisions are made jointly between the clinicians and patients, 
although there is a small minority of patients who are leading the process. In the 
developing world, decisions currently seem to be clinician led. 
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15.0 Thesis – Limitations  
 
The lack of research in the area of decision making in surgery and cancer care 
was certainly a disadvantage, leaving a minimal foundation to build on. 
Adopting qualitative research methods and tools, which do not sit easily with 
quantitative methods, into the research was a challenge. It is hoped that the 
mixed methodology, combining the elements of psychology, sociology and 
surgery, has been successfully demonstrated. 
 
I would have preferred to involve patients as participants and provide them with 
hypothetical scenarios, and evaluate the decision making process. In the 
process, I wanted to adopt the principles of prospective measure of 
preferences. The prospective measures of preferences (221)  bring the 
concepts of ‘Willingness to Trade’ and ‘Willingness to Gamble’. This would have 
thrown light on the way patients would trade and gamble the length of survival 
to quality of life and vice-versa. Unfortunately, this was not possible due to 
ethical issues.  
 
Involving patient representatives, nursing colleagues and specialist nurse 
practitioners in this research from the beginning would have made the process 
easier. In the initial chapters, the literature reviews would have been improved if 
a systematic approach was adopted, rather than general literature reviews. 
Focus group discussions involving patients would have given us the patients’ 
views on decision making. However, obtaining ethical approval for this was not 
possible in the form presented. As highlighted earlier, help from patient 
representatives, nurses and specialist nurse practitioners is vital in the process. 
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A sizable portion of this research work is in the form of questionnaire studies. It 
carries the inherent bias of lack of data from the non-responders. While there 
was a 50–60% response rate, which is normal for questionnaire surveys, 
reminders might have increased the response rate. 
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16.0 The future: 
 
This academic exercise has provided the basis for more thoughts, ideas and 
stimulation for further work. There are several elements; practical and 
theoretical, requiring further investigation that has been identified by this thesis: 
There are issues regarding previously unrecorded cultural and socioeconomic 
parameters that have been demonstrated by this work. It is clear that even 
within the UK there are differences that affect the decision making process. This 
requires further work to evaluate it more clearly as, unlike the USA and Europe, 
UK patients are not willing to travel to obtain what is perceived as the best 
treatment, and therefore some form of homogeneity must be maintained if 
standard treatment opportunities and outcomes are to be equal. If the difference 
is necessary for socioeconomic or other reasons, the contextual heterogeneity 
must be recognized in order to facilitate true patient choice.  
The role of patients in the multidisciplinary team needs to be explored and 
developed accordingly, along with further studies into preferences using the 
concepts of willingness to trade and willingness of gamble, and their influencing 
factors.  
Patient preferences should play an important role in clinical decision making. 
For this, it is important that actual patient preferences are determined. The 
literature increasingly demonstrates that surgeons and physicians have 
divergent preferences for treatment options compared with both their patients 
and each other (10), (11), (12).Thirty to forty percent of critical medical 
decisions are made by doctors for their patients (13), (14), (15), (16), (17) . This 
rate increases when patients are acutely unwell, elderly, or dealing with cancer 
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(14), (15). When this is the case, it is important to know what influences clinician 
decision making. Solomon et al (10) in their study titled “What 
do patients want? Patient preferences and surrogate decision making in 
the treatment of colorectal cancer.” demonstrated that patients are willing to 
trade survival for quality of life and can do so differentially between treatment 
scenarios. They proved that patients’ preferences do not always accord with 
those of clinicians. They stated that unless patients' preferences are explicitly 
sought and incorporated into clinical decision making, patients may not receive 
the treatment that is best for them. ................................................................... 21 
Focus group: A focus group is a formal discussion with 8–12 people on a 
specific topic. The group is facilitated by a moderator who keeps participants 
focused on the topic of interest. The purpose of a focus group is to collect in-
depth information from a group of people who represent the population of 
interest. This useful, qualitative research tool has been an underutilized 
research technique for improving theory and practice in health education (162) , 
(163). ................................................................................................................ 91 
SL no.7 ........................................................................................................... 191 
SL no. 08 ........................................................................................................ 193 
Practically, it is clear clinicians need to be educated in communication of risk 
and informed consent. The recent GMC guidance on consent is an illustration of 
this (222). Clinicians need to be aware of the complex process of decision 
making and the factors that may influence it. Only then can clinicians truly begin 
to form a partnership with patients in order to, not only provide them not only 
with the care we think they need, but also with the care they actually want.  
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In the near future, I hope to integrate the available quantitative and qualitative 
data from my thesis in a systematic manner using the newer techniques of 
triangulation protocol, following the thread, and mixed methods matrix.  
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17.0 Appendix 
 
Appendix 1: Questionnaire and responses for the GSQ pre and post RI 
 
   Pre Post 
Q1 How often do you empty 
your bowel 
More than 6 times 
per day 1.4% 0.0% 
 4-5 times per day 11.4% 7.3% 
 2-3 times per day 32.9% 14.6% 
 Once per day 14.3% 46.3% 
 4 times a week 7.1% 9.8% 
 2-3 times per week 18.6% 17.1% 
 Once per week 2.9% 2.4% 
 
Less than once per 
week 11.4% 2.4% 
 
There is no significant difference between the pre and post values,  
z=-0.684, p=0.494. 
 
   Pre Post 
Q2 Are your bowel 
motions mostly...  Liquid 11.3% 2.4% 
 semi-solid 22.5% 22.0% 
 Formed 25.4% 31.7% 
 Soft 21.1% 24.4% 
 Hard 14.1% 14.6% 
 Pellets 5.6% 4.9% 
 
 
There is no significant difference between the pre and post values, z=-0.187, 
p=0.852. 
 
   Pre Post 
Q3 Ever strain to empty 
your bowel  Always 52.2% 14.0% 
 Daily 20.3% 23.3% 
 Weekly 11.6% 18.6% 
 Monthly 4.3% 11.6% 
 Rarely 8.7% 23.3% 
 Never 2.9% 9.3% 
 
There is a significant difference between the pre and post values, z=-3.70, 
p=0.000**. 
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   Pre       Post 
Q4 Ever feel your haven't 
completely emptied Always 69.0% 23.8% 
 Daily 23.9% 21.4% 
 Weekly 4.2% 23.8% 
 Monthly 0.0% 4.8% 
 Rarely 1.4% 16.7% 
 Never 1.4% 9.5% 
 
There is a significant difference between the pre and post values, z=-3.844, 
p=0.000**. 
 
   Pre Post 
Q5 Ever need to rush to 
empty your bowel Always 10.1% 7.3% 
 Daily 14.5% 2.4% 
 Weekly 17.4% 19.5% 
 Monthly 7.2% 12.2% 
 Rarely 30.4% 29.3% 
 Never 20.3% 29.3% 
 
There is no significant difference between the pre and post values at the 95% 
confidence level, but there is at the 90% confidence level, z=-1.948, p=0.051*. 
 
   Pre Post 
Q6 Wind 
leakage  2 or more per day 59.7% 39.5% 
 once per day 6.5% 7.9% 
 2 or more pre week 8.1% 2.6% 
 once per week 3.2% 13.2% 
 1-3 times a month 8.1% 18.4% 
 Never 14.5% 18.4% 
 
There is a significant difference between the pre and post values, z=-2.533, 
p=0.011**. 
 
   Pre Post 
Q7 Mucous 
leakage 2 or more per day 12.5% 0.0% 
 once per day 7.1% 7.9% 
 2 or more pre week 5.4% 2.6% 
 once per week 3.6% 5.3% 
 1-3 times a month 16.1% 10.5% 
 Never 55.4% 73.7% 
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There is no significant difference between the pre and post values, z=-0.366, 
p=0.714. 
 
   Pre Post 
Q8 Liquid 
leakage 2 or more per day 12.7% 5.3% 
 once per day 3.6% 5.3% 
 2 or more pre week 10.9% 5.3% 
 once per week 7.3% 7.9% 
 1-3 times a month 9.1% 7.9% 
 Never 56.4% 68.4% 
 
There is no significant difference between the pre and post values, z=-0.905, 
p=0.365. 
 
   Pre Post 
Q9 Solid 
leakage  2 or more per day 1.8% 2.6% 
 once per day 0.0% 2.6% 
 2 or more pre week 8.8% 5.3% 
 once per week 3.5% 2.6% 
 1-3 times a month 14.0% 10.5% 
 Never 71.9% 76.3% 
 
 
 
There is no significant difference between the pre and post values, z=-0.144, 
p=0.886. 
 
   Pre Post 
Q10 Do you ever wear a pad for 
urinary symptoms Yes 29.0% 19.5% 
 No 71.0% 80.5% 
 
There is no significant difference between the pre and post values, z=0.000, 
p=1.000. 
 
   Pre Post 
Q11Do you ever wear a pad for 
bowel symptoms  Yes 24.3% 16.7% 
 No 75.7% 83.3% 
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There is no significant difference between the pre and post values, z=-0.577, 
p=0.564. 
 
   Pre Post 
Q12 Does your bowel problem 
affect your life  Yes 88.7% 69.0% 
 No 11.3% 31.0% 
 
There is no significant difference between the pre and post values at the 95% 
confidence level, but there is at the 90% confidence level, z=-1.941, p=0.052*. 
 
   Pre Post 
Q13 Ever feel like the area between your 
anus & vagina is swollen  All of the time 8.9% 3.3% 
 most of the time 20.0% 10.0% 
 some of the time 42.2% 43.3% 
 A little of the time 11.1% 13.3% 
 none of the time 17.8% 30.0% 
 
There is no significant difference between the pre and post values, z=-1.058, 
p=0.290. 
 
   Pre Post 
Q14 Ever feel your bowel is pushing 
forwards into your vagina All of the time 23.3% 3.6% 
 
most of the 
time 20.9% 10.7% 
 
some of the 
time 39.5% 46.4% 
 
A little of the 
time 0.0% 7.1% 
 
none of the 
time 16.3% 32.1% 
 
There is no significant difference between the pre and post values, z=-1.655, 
p=0.100. 
 
   Pre Post 
Q15 Ever need to apply pressure on 
the area between the anus & vagina All of the time 20.0% 0.0% 
 
most of the 
time 24.4% 27.6% 
 
some of the 
time 28.9% 20.7% 
 A little of the 2.2% 10.3% 
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time 
 
none of the 
time 24.4% 41.4% 
 
There is a significant difference between the pre and post values, z=-2.598, 
p=0.009**. 
 
   Pre Post 
Q16 Ever need to help yourself 
empty the bowel  All of the time 9.3% 6.5% 
 most of the time 25.6% 12.9% 
 some of the time 27.9% 19.4% 
 a little of the time 20.9% 19.4% 
 none of the time 16.3% 41.9% 
 
There is no significant difference between the pre and post values, z=-1.610, 
p=0.107. 
 
   Pre Post 
Q17 Do you ever rush to pass 
water  Always 11.1% 2.6% 
 Daily 27.0% 12.8% 
 Weekly 0.0% 5.1% 
 Monthly 6.3% 12.8% 
 Rarely 44.4% 46.2% 
 Never 11.1% 20.5% 
 
There is no significant difference between the pre and post values, z=-1.235, 
p=0.217. 
 
   Pre Post 
Q18 Do you ever leak urine if you 
cough, sneeze Always 21.5% 14.6% 
 Daily 13.8% 7.3% 
 Weekly 13.8% 2.4% 
 Monthly 7.7% 19.5% 
 Rarely 21.5% 34.1% 
 Never 21.5% 22.0% 
 
There is a significant difference between the pre and post values, z=-2.034, 
p=0.042**. 
 
   Pre Post 
Q19 Do you ever not make it in Daily 9.4% 0.0% 
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time to pass urine 
 Weekly 1.6% 5.1% 
 Monthly 3.1% 2.6% 
 Rarely 43.8% 48.7% 
 Never 42.2% 43.6% 
 
There is no significant difference between the pre and post values, z=-0.299, 
p=0.765. 
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Appendix 2: Questionnaire – A NQS on preliminary results of CRO7 survey 
Questionnaire 
Pre - Operative 
 
Q 1. In clinically operable rectal cancer <15cm from anal verge with no metastases, i.e. 
     T1/T2,  do you routinely use Neo – Adjuvant short course DXT  ? 
    Yes         No      
 
Q 2.  For T3 rectal cancer do you routinely use Neo Adjuvant short course DXT? 
     Yes         No      
 
Q 3. For T3 rectal cancer do you routinely use Neo Adjuvant long course DXT? 
    Yes         No      
 
Q 4. Does your decision to use Neo-adjuvant treatment depend on the Tumour position i.e. 
    height from the anal verge? 
    Yes         No      
 
Q 5. Does your decision to use Neo-adjuvant treatment depend on whether the  
     tumour is located anterior or posterior                                                                                     
    Yes         No      
 
Q 6. Does your decision to use neo-adjuvant treatment depend on +ve CRM on MRI? 
     Yes         No      
 
 
Post – Operative 
 
Q 7. In patients who have not had pre-operative DXT, do you routinely give post –  
     operative DXT if the CRM was +ve histologically? 
     Yes         No      
 
Q 8. Do you give Chemotherapy post – operatively if the CRM was +ve histologically? 
    Yes         No      
 
Q 9. How do you treat patients who have had pre – operative Short course DXT and 
     post – operatively have CRM involvement? 
      ------------------------------------------------------------------------------------------------- 
 
Q 10. How do you treat patients who have had pre – operative long course DXT and 
     post – operatively have CRM involvement? 
      -------------------------------------------------------------------------------------------------- 
Q 11. With the preliminary results of the CRO7 trial, has there been any change in  
      your practice? 
      Yes         No      
 
Q 12. Who is responsible for directing chemotherapy in your unit? 
      Colorectal Surgeons        Oncologists      
 
Q 13. If you direct the adjuvant chemotherapy, which agent is used as per your local policy? 
      -------------------------------------------------------------------------------------------------- 
 
Q 14. Please write your comments here 
     -------------------------------------------------------------------------------------------------- 
 
Thank you for your time! 
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Appendix 3: Questionnaire – A NQS on Thrombo-prophylaxis in Colo-rectal surgery. 
 
National Questionnaire survey amongst the consultant members of the ACPGBI on Thrombo-
prophylaxis (TP) in major colorectal surgery. 
 
Q 1. Are there any departmental guidelines in use for thrombo-prophylaxis in colorectal surgery?  
 
    Yes           No      
 
Q 2.  Do you routinely use Thrombo-prophylaxis for major colorectal resections?  
 
     Yes          No      
 
Q 3. Which type of TP do you use in your Colo-rectal resection patients?  
     
     Chemoprophylaxis         Mechanical           Both   
 
Q 4. If you use Chemo-prophylaxis which agents do you use? (You can mark more than one). 
 
    Aspirin      Unfractionated Heparin    LMW Heparin     Heparin      Others    
    
     Others …………………….. 
 
Q 5. When do you start chemoprophylaxis on patients? 
                                                                                     
     On Admission      On Induction       6 hours Post-op     24 hours post-op   
 
Q 6. At what stage do you discontinue chemoprophylaxis? 
      
    On mobilization      prior to discharge    Upon discharge     6 weeks after discharge     
     
    Others   …………………………………… 
 
Q 7. What mechanical devices do you use for Thrombo-prophylaxis? (You can mark more than one)
 
     TED stocking    Foot & Ankle pump    Flowtron boots    Others  …………………………… 
 
Q 8. At what stage do you discontinue mechanical Thrombo-prophylaxis? 
 
     On mobilization      prior to discharge    Upon discharge     6 weeks after discharge     
     
    Others  ……………………………………… 
 
Q 9. “Do you recommend continuing prophylaxis after hospital discharge?” 
    
     Yes          No          
    
     If “Yes”, How long for? …………………………….. What agent? ……………………………… 
 
 
Q 10. Please write your comments here  ………………………………………………………………… 
 
Thank you for your time and co-operation! 
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Appendix 4: Stimulus material for focus group discussions (Abstracts of 
publications and title guide) 
 
SL no. 01 
 
An economic perspective on evidence-based patient choice in surgery. 
 
The aim of the present paper is to provide an economic perspective on current 
and emerging issues relating to surgical decision-making. The central issue 
discussed in the paper is choice and how this relates to patient management. 
The paper explores three factors that may influence the nature of choice; they 
are--evidence-based medicine, patient involvement in making choices and the 
role of cost-effectiveness analysis in surgery. Together, these factors are 
driving a shift from the traditional model of care based on medical beneficence 
to one based more on individual patient autonomy. This shift has been 
described as a move towards 'evidence-based patient choice' (EBPC). The 
concept of EBPC is relatively new and ill defined. Yet it encapsulates what is 
happening now and what will occur more dramatically in the future; that is, the 
nature of the relationship between surgeon and patient is changing. We hope 
that this paper will provoke discussion on the concept of EBPC and cost-
effectiveness analysis in surgical decision-making
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SL no. 02 
 
What do patients want? Patient preferences and surrogate decision-
making in the treatment of colorectal cancer. 
 
PURPOSE: Clinicians often make decisions for their patients, despite evidence 
that suggests that correspondence between patient and clinician decision 
making is poor. The management of colorectal cancer presents difficult 
decisions because the impact of treatment on quality of life might overshadow 
its survival efficacy. This study investigated whether patients are able to trade 
survival for quality of life as a means to express their preference for treatment 
options and to compare their preferences with those expressed by clinicians.  
 
METHODS: Patients undergoing curative surgery for colorectal cancer were 
interviewed postoperatively to elicit their preferences in four hypothetical 
treatment scenarios. A questionnaire was mailed to all Australian colorectal 
surgeons and medical oncologists that asked them to respond as if they 
themselves were patients.  
 
RESULTS: One hundred patients (91 percent), 43 colorectal surgeons (77 
percent), and 103 medical oncologists (50 percent) participated. In all four 
scenarios, patients were able to trade survival for quality of life. Patients' 
responses varied between scenarios, both in willingness to trade and the 
average amount traded. There were significant differences between patients 
and clinicians. Clinicians were more willing than patients to trade survival to 
avoid a permanent colostomy in favour of chemo radiotherapy. Patients' 
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strongest preference was to avoid chemotherapy, more than to avoid a 
permanent colostomy.  
 
CONCLUSIONS: Patients are able to trade survival as a measure of 
preference for quality of life and can do so differentially between treatment 
scenarios. Patients' preferences do not always accord with those of clinicians. 
Unless patients' preferences are explicitly sought and incorporated into clinical 
decision-making, patients may not receive the treatment that is best for them. 
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SL no. 03 
 
Lack of congruence in the ratings of patients' health status by patients 
and their physicians. 
 
PURPOSE: The purpose of this study was to examine if physician assessments 
of their patients' health status after the medical encounter are comparable to 
their patients' self-assessment of their own health.  
 
METHODS: Consecutive patients with musculoskeletal diseases were recruited 
when they attended 1 of the rheumatology outpatient clinics selected for the 
study. Five physicians participated in the study, 4 based at an academic centre 
and 1 in the community. Patients were interviewed after seeing the physician; 
they completed health status questionnaires (mHAQ and SF-12) and rated their 
pain, worry about disease, and overall health status on visual analog scales. 
Standard gamble techniques were used to obtain patient utilities in relation to 
their health status, "gambling" on the probability of obtaining perfect health from 
an intervention with varying risks of death. After the medical encounter, 
physicians were asked to rate their patients' health status with similar 
instruments and with standard gamble elicitation techniques, blinded to the 
patients' responses.  
 
RESULTS: A total of 105 patients participated in the study; 70% were female; 
mean age was 54+/-16 years; 64% had a connective tissue disease, most 
commonly rheumatoid arthritis; and the other diseases in this group included 
soft tissue rheumatism, osteoarthritis, or low back pain. Statistically significant 
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differences were observed between patient and physician ratings for pain, 
overall health, and standard gamble. On average, physicians rated their 
patients' health status higher than the patients themselves and were less willing 
to gamble on the risk of death versus perfect health. Intra-class correlation 
coefficients (ICC) were low: 0.42 for pain, 0.11 for worry, 0.11 for overall health, 
and 0.04 for standard gamble utilities. Similar findings were observed when 
subgroup analysis was performed for individual physicians and for patients with 
connective tissue diseases. No specific patient characteristic consistently 
related to increased divergence in the ratings.  
 
CONCLUSIONS: These findings suggest that the communication between 
physicians and their patients at the time of the medical encounter needs to be 
enhanced. An understanding of their patients' health perceptions may assist 
physicians in suggesting appropriate interventions, taking into account their 
patients' benefit-risk preferences. 
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SL no. 04 
 
Treatment decisions for breast carcinoma: patient preferences and 
physician perceptions. 
 
BACKGROUND: Patient autonomy and participation in treatment decision 
making have been encouraged in recent years. However, patients and 
physicians frequently disagree with regard to the patient's needs and 
perceptions of their illness. To the authors' knowledge to date only limited 
research has assessed physicians' perceptions of patients' decision-making 
preferences. The purpose of the current prospective study was to determine the 
agreement between patient decision-making preferences and physician 
perceptions of those preferences.  
 
METHODS: Women with breast carcinoma who were attending their first 
outpatient consultation with a breast medical oncologist in a university cancer 
centre were enrolled in the current study. At the end of the consultation, the 
patients were given a survey regarding their treatment decision-making 
preferences that included active, shared, and passive roles in decision-making 
and the patients' attending physicians also were given a survey regarding their 
perceptions of the patients' decision-making preferences.  
 
RESULTS: Fifty-seven patients had complete data and were analyzed. 
Approximately 89% of these 57 patients preferred either an active or a shared 
role in decision making. The agreement between patients and physicians with 
regard to decision-making preference only occurred in 24 cases (42%). The 
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majority of covariates such as age, education, and income were not found to be 
statistically significant with regard to patient preferences or to the proportion of 
patients and physicians who agreed on the patient's preferences.  
 
CONCLUSIONS: Women with breast carcinoma appear to have a strong desire 
for involvement in making decisions regarding their treatment. However, 
physicians do not appear to be consistently able to predict the decision-making 
preferences of their patients. Enhanced agreement between patient preferences 
and physician expectations mostly likely will improve communication and patient 
satisfaction with the treatment decision-making process. 
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SL no.7 
 
The impact of patients' preferences on the treatment of atrial fibrillation: 
observational study of patient based decision analysis 
 
OBJECTIVE: To investigate the impact of patients' preferences for the 
treatment of atrial fibrillation, by using individualised decision analysis 
combining probability and utility assessments into a decision tree.  
 
DESIGN: Observational study based on interviews with patients.  
 
SETTING: Eight general practices in Avon.  
 
PARTICIPANTS: 260 randomly selected patients aged 70-85 years with atrial 
fibrillation.  
 
MAIN OUTCOME MEASURES: Patients' treatment preferences regarding 
anticoagulation treatment (warfarin) after individualised decision analysis; 
comparison of these preferences with treatment guidelines on the basis of co-
morbidity and absolute risk and compared with current prescription.  
 
RESULTS: Of 195 eligible patients, 97 participated in decision making using 
decision analysis. Among these 97, the decision analysis indicated that 59 
(61%; 95% confidence interval 50% to 71%) would prefer anticoagulation 
treatment-considerably fewer than those who would be recommended treatment 
according to guidelines. There was marked disagreement between the decision 
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analysis and guideline recommendations (kappa=0.25 or less). Of 38 patients 
whose decision analysis indicated a preference for anticoagulation, 17 (45%) 
were being prescribed warfarin; on the other hand, 28 (47%) of 59 patients were 
not being prescribed warfarin although the results of their decision analysis 
suggested they wanted to be.  
 
CONCLUSIONS: In the context of shared decision making, individualised 
decision analysis is valuable in a sizeable proportion of elderly patients with 
atrial fibrillation. Taking account of patients' preferences would lead to fewer 
prescriptions for warfarin than under published guideline recommendations. 
Decision analysis as a shared decision making tool should be evaluated in a 
randomised controlled trial. 
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SL no. 08 
 
Preference-based anti-thrombotic therapy in atrial fibrillation: implications 
for clinical decision making 
 
BACKGROUND: Patient preferences and expert-generated clinical practice 
guidelines regarding treatment decisions may not be identical. The authors 
compared the thresholds for anti-thrombotic treatment from studies that 
determined or modelled the treatment preferences of patients with atrial 
fibrillation with recommendations from clinical practice guidelines.  
 
METHODS: Methods included MEDLINE identification, systematic review, and 
pooling with some reanalysis of primary data from relevant studies.  
 
RESULTS: Eight pertinent studies, including 890 patients, were identified. 
These studies used 3 methods (decision analysis, probability trade-off, and 
decision aids) to determine or model patient preferences. All methods 
highlighted that the threshold above which warfarin was preferred over aspirin 
was highly variable. In 6 of 8 studies, patient preferences indicated that fewer 
patients would take warfarin compared to the recommendations of the 
guidelines. In general, at a stroke rate of 1% with aspirin, half of the participants 
would prefer warfarin, and at a rate of 2% with aspirin, two thirds would prefer 
warfarin. In 3 studies, warfarin must provide at least a 0.9% to 3.0% per year 
absolute reduction in stroke risk for patients to be willing to take it, 
corresponding to a stroke rate of 2% to 6% on aspirin.  
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CONCLUSIONS: For patients with atrial fibrillation, treatment recommendations 
from clinical practice guidelines often differ from patient preferences, with 
substantial heterogeneity in their individual preferences. Since patient 
preferences can have a substantial impact on the clinical decision-making 
process, acknowledgment of their importance should be incorporated into 
clinical practice guidelines. Practicing physicians need to balance the patient 
preferences with the treatment recommendations from clinical practice 
guidelines.
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SL no. 09 
 
Treatment decision-making and its relation to the sense of coherence and 
the meaning of the disease in a group of patients with colorectal cancer. 
 
The aims of the present study were to describe the preferred and the actual 
participating roles in treatment decision-making in relation to patients with newly 
diagnosed, colorectal cancer and to relate this result to the socio-demographic 
data, the Sense of Coherence Scale (SOC) and the patients' meaning of the 
disease. Eighty-six patients were studied. The following instruments were used: 
the Control Preferences Scale (CPS); the eight Lipowski categories of the 
meaning of the disease (LCMD); and the SOC. The results showed that 62% of 
the patients preferred a collaborative role and 28% a passive role in treatment 
decision-making. Agreement between the preferred and the actual participating 
roles was achieved by 44% of the patients. Seventy-one per cent of the patients 
showed an optimistic understanding of their disease. The mean SOC score was 
150. There was no statistically significant difference between the CPS groups 
as regarded the socio-demographic data, the SOC and the LCMD. Conclusion: 
Socio-demographic data, the perceived meaning of the disease as well as the 
patients' sense of coherence were not related to the decision-making 
preferences in the investigated group of patients. Therefore, further 
investigations are needed to get an understanding of influencing factors of the 
decision-making preferences. 
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SL no. 10 
 
Lay constructions of decision-making in cancer. 
 
 In recent years there has been increased emphasis on involving people in 
decision-making about their medical care. However, few studies have 
addressed the questions of why women with cancer want information, and what 
they believe to be the important factors influencing their decision-making. In 
order to examine these questions 20 women with cancer were interviewed via 
telephone 2 weeks after their first consultation with one of 6 medical 
oncologists. Recruitment continued until informational redundancy was 
achieved. While women cited the risk of recurrence, life expectancy, side-
effects, and quality of life as influencing their decisions, they placed at least as 
much emphasis on their personal relationship with the specialist. These 
'personal' factors included: feeling that the doctor cared for, understood and 
respected them; that they could trust and have confidence in the doctor; that the 
doctor would give them enough time; that they would be listened to; and that the 
doctor would be open and honest. If these factors were felt to be present, many 
women were happy to accept the doctor's recommendation, confident that they 
would receive the optimum treatment. However, many women felt there was no 
decision to be made: further treatment must be undertaken to reduce risk, and 
minor variations in the treatment protocol were of little significance. These 
results underline the importance of establishing patient priorities and concerns 
before embarking on discussions about treatment.  
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SL no. 11 
 
Can the standard gamble be used to determine utilities for uncertain 
health states? An example using postoperative maintenance therapy in 
Crohn's disease. 
 
 The objective of this study was to determine whether patients with Crohn's 
disease (CD) value the absolute reduction in postoperative recurrence risk 
attributable to therapy with mesalamine (5-ASA). One hundred subjects 
evaluated state A (taking 5-ASA; 25% risk of recurrence), state B (not taking 5-
ASA; 40% risk of recurrence), and state C (100% risk of recurrence) by rank 
order, visual analog scale (VAS), and standard gamble (SG). Sixty-five of 91 
patients (71%) with completed and usable questionnaires had the same 
preference order for state A (25% risk), state B (40% risk), and state C (100% 
risk) on both the VAS and the SG. The mean scores for state A (25% risk), 
state B (40% risk), and state C (100% risk), respectively, were 67.5, 49.8, and 
19.8 on the VAS and 0.977, 0.972, and 0.910 on the SG. Subgroup analyses 
using stepwise logistic regression showed that risk attitude seemed to be 
predictive of subjects' preferences for 5-ASA. These results suggest that most 
subjects seem to value the 15% absolute risk reduction offered by 5-ASA. 
Furthermore, the SG seems to be a feasible method for measuring utilities for 
uncertain health states in patients with CD. 
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SL no. 12 
 
Patient preference for cancer therapy: an overview of measurement 
approaches. 
 
PURPOSE: In the era of evidence-based medicine and shared decision 
making, the formal assessment of patient preference for treatments or 
treatment outcomes has attracted much attention. In this article, the two most 
common approaches to the evaluation of preference, i.e. utility assessment and 
probability trade-off assessment are described. The purpose is to provide 
clinicians with the background knowledge needed to interpret preference 
studies published in the literature and to judge whether the reported findings 
are relevant to their own patients.  
 
METHODS: An overview is given of the methods used to assess utilities and 
probability trade-off scores. Evidence on determinants of such scores is 
presented. Examples from oncology are provided. Because experience with the 
treatment plays an important role as a determinant of preferences for both 
treatments and treatment outcomes, special attention is paid to the 
interpretation of studies in the light of subject selection. Directions for future 
research are suggested.  
 
CONCLUSION: The choice of approach and the measuring instrument depend 
on the goal of the preference assessment. Normal psychological processes, 
such as coping, adaptation, and cognitive dissonance reduction, cause patients 
                              Page 199 of 215 
who are about to undergo a therapy or have experienced a therapy to rate it 
more favourably than other patients do. This should be remembered when 
using evidence from the literature to inform patients or for patient decision 
making. 
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SL no. 14 
 
Variability in physician opinion on limiting paediatric life support 
 
OBJECTIVE: We conducted this study to investigate how physicians in a 
paediatric intensive care unit (ICU) currently make decisions to withdraw and 
withhold life support. Consultation with the patient's primary caregiver often 
precedes decisions about withdrawal and limitation of life support in chronically 
ill patients. In these scenarios, the patient's primary caregiver was the paediatric 
oncologist. To evaluate the influence of subspecialty training, we compared the 
attitudes of the paediatric intensivists and the oncologists using scenarios 
describing critically ill oncology patients.  
 
DESIGN: Cross-sectional survey. Each physician was randomly assigned 4 of 8 
potential case scenarios.  
 
SETTING: A total of 29 American paediatric ICUs.  
 
PARTICIPANTS: Paediatric intensive care and oncology attendings and fellows.  
 
INTERVENTION: Systematic manipulation of patient characteristics in two 
hypothetical case scenarios describing 6-year-old female oncology patients 
presenting to the ICU after the institution of mechanical ventilator support for 
acute respiratory failure. Cases 1 through 4 described a patient who, before 
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admission, had a 99% projected 1-year probability of survival from her 
underlying cancer and suffered from severe neurological disabilities. Cases 5 
through 8 described a patient who was neurologically normal before admission 
and had a <1% chance of surviving longer than 1 year because of her 
underlying cancer. Each physician was randomly assigned 2 cases from cases 
1 through 4 and 2 cases from cases 5 through 8. Within each of these case 
scenarios, parental preferences (withdraw or advance support or look for 
guidance from the caregivers) and probabilities of survival (5% vs. 40%) were 
manipulated. Before distribution, the survey instrument was pilot-tested and 
underwent a rigorous assessment for clinical sensibility.  
 
PRIMARY OUTCOME MEASURES: Physicians ratings of the importance of 10 
factors considered in the decision to withdraw life support, and their decisions 
about the appropriate level of care to provide. Respondents were offered five 
management options representing five levels of care: 1) discontinue inotropes 
and mechanical ventilation but continue comfort measures; 2) discontinue 
inotropes and other maintenance therapy but continue mechanical ventilation 
and comfort measures; 3) continue with current management but add no new 
therapeutic intervention; 4) continue with current management, add additional 
inotropes, change antibiotics and the like as needed, but do not start dialysis; 
and 5) continue with full aggressive management and plan for dialysis if 
necessary. Respondents also were asked whether they would obtain an ethics 
consultation.  
RESULTS: A total of 270 physicians responded to our survey (165 of 198 
potentially eligible paediatric intensivists and 105 of 178 paediatric oncologists 
for response rates of 83% and 59%, respectively). The respondents considered 
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the probability of ICU survival and the wishes of the parents regarding the 
aggressiveness of care most important in the decision to limit life-support 
interventions. No clinically important differences were found when the 
responses of oncologists were compared with those of intensivists. In six of 
eight possible scenarios, the same level of intensity of care was chosen by less 
than half of all respondents. In three scenarios, >/=10% of respondents chose 
full aggressive management as the most appropriate level of care, whereas 
another >/=10% chose comfort measures only when viewing the same scenario. 
The most significant respondent factors affecting choices were professional 
status (attending vs fellow) and the self-rated importance of functional 
neurological status. The majority of respondents (83%) believed that the 
intensive care and the oncology staff were usually in agreement at their 
institution about the level of intervention to recommend to the parents. 
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Topic guides for participants 
 
• Patient decision making in cancer care 
 
• Journey from diagnosis to treatment decision 
 
• Who decides your treatment? 
 
• What matters? Length or quality of life? 
 
• Decision making pathway … WHO LEADS? 
 
• Patient preference and clinical decision making 
 
• Prospective measure of preferences 
         - Time trade off and standard gamble  
         - Willingness to trade (WTT) and Willingness to gamble (WTG) 
         - Prospective measure of preference – gamble (PMPg)   
         - Prospective measure of preference – trade (PMPt) 
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